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When I started this fantastic project more than four years ago, I knew that it 
was going to be challenging.  The idea of identifying new and conserved cell 
cycle regulators by systematically comparing the human and the Arabidopsis 
genome was exciting, but at the same time it brought to my mind the four 
basic questions that every researcher (or researcher-wannabe) has to ask to 
himself before starting any kind of project, or signing any kind of contract (for 
me was already too late giving that the contract was already signed and my 
intellectual motivation was already one hundred percent committed with the 
project): Is it possible to do such a thing in four years?. Assuming that is 
possible, which is the most effective and convincing way to do it? How to 
experimentally show that the chosen approach is valid? and, what kind of new 
useful knowledge are we going to generate, for the scientific community and for 
the society in general? By that time, not a lot of answers popped up into my 
mind, but with constant curiosity, lots of work and the most important, with the 
invaluable help of my promoters, my colleges and friends; at the end of this 
journey and after having a retrospective view of the whole project, I can say 
that we did the best we could.  With this I am not suggesting that the results 
that are described in this thesis are scientifically the best, important 
breakthroughs, or that the computational and experimental strategies that 
were followed were the most productive, simply I am trying to say that from a 
systemic perspective the four big questions were addressed and some answers 
and new insights are proposed in this document.  If I can suggest or convince  
to the reader that with this work we were able to show that besides the 
important evolutionary distance that exists between humans and plants, it is 
possible to find relevant conserved processes between them, cell cycle 
included, and even more, that it is possible to chase oncogenes starting the 
search from the Arabidopsis genome; that the developed integrative strategy is 
useful to reach the previously mentioned aim; that the experimental 
procedures sustain and validate the proposed computational strategy; and 
finally, that with this research we have generated tools that hopefully in the 
near future could be implemented for the better understanding of cancer, the 
mission was accomplished. If it was not, I kindly ask my promoters not to let 
the project die, I am totally convinced that only the systemic view of a complex 
phenotype, as cancer, is the only way of understanding  the intermingle 
mechanisms that lay beneath the disease. 
 
In spite of what can be proven or disproven in this work, plants have been 
fighting against cancer for centuries already. Some ancient tribes in South 
America have been using plants to treat or cure cancer-like diseases on a 
frequent basis.  Similarly, 2,500 plants are yearly tested by the National Cancer 
Institute, looking for endogenous anti-cancer compounds; one clear example of 
this is etoposide, an often used chemotherapeutic agent that inhibits the 
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enzyme topoisomerase II, causing DNA strand breaks that are difficult to repair 
for the cancer cells, inducing apoptosis. This chemical is purified from the 
mayapple plant and contributes extensively to the anti-cancer battle. From the 
very first moment, we believed that besides this botanical and chemical 
approach, plants can be important tools for the understanding of the multiple 
mechanisms that lead to cancer, and due to this; with this research, we tried to 
introduce new molecular and systemic perspectives to the cancer biology, in 
which plants are fundamental players.  
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Coordination of cell division with growth and development is essential for the 
survival of organisms. Mistakes made during the replication of the genetic 
material can result in cell death, growth defects, or cancer. Because of the 
essential role of the molecular machinery that controls DNA replication and 
mitosis during development, its high degree of conservation among organisms 
is not surprising. Mammalian cell cycle genes have orthologues with similar 
regulatory functions in plants, and vice versa. However, besides the many 
known and characterized proliferation genes, important still undiscovered 
regulatory genes are expected to exist with conserved functions in plants and 
humans. 
 
The principal objective of the current research was the identification of novel 
and conserved cell cycle regulators between plants and humans. 
Correspondingly, some of these new components of the cell cycle machinery 
might behave like oncogenes and/or tumor suppressors when misregulated in 
the animal model, representing an interesting group of targets that might be 
useful for therapeutic or diagnostic tool development in cancer research.  For 
doing this, an integrative strategy using different information sources and 
different strategies was generated and coupled to an experimental strategy in 
order to reach the main goal of this study from a systemic perspective. 
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The comparative cell cycle 
 
Is it possible to do it? 
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1.1 The cycle of life. 
Every cell in every living organism is committed to divide. The apparently 
“simple” fact of cell division has sustained life on our planet for millions of 
years and as long as cells keep cycling, life will persist on earth. For unicellular 
organisms such as bacteria, cell division is equivalent to reproduction, and 
thus the cell division process is the key element in the perpetuation of them as 
organism through evolution. Similarly, for multicellular organisms, the 
continuous and controlled cell division process is able to turn a couple of 
founder cells into a broad spectrum of differentiated cells that are able to 
organize in an orchestrated fashion to  form tissues, organs, and to structure 
ultimately a complete organism.  Some cells divide more than others, but all 
cells divide, even those types of cells that were subjected for years to the 
common notion that once differentiated they do not divide. This is the case of 
the cells that form the central nervous system. For decades the impossibility 
for the neurons to divide was taken as a fact, nevertheless, this assumption 
was proved wrong.  In the adult’s mouse brain, the subventricular zone is 
continuously self-renewed given rise to a progeny that migrates to the 
olfactory cortex where they differentiate into astrocytes, oligodendrocytes and 
neurons (Lois and Alvarez-Buylla 1994). 
 
It is difficult to think of one process more crucial to perpetuate life on earth 
than the cell division cycle, and because of this, cell division can be consider 
as the most important acquired novel phenotype for a primeval cell in order to 
perpetuate its present on earth, and in such a way perpetuate its existence. 
We can think of these particular cells that were able to persist by dividing as 
units of selection for the evolutionary process, and in the mechanisms that 
originated this evolutionary novelty as the mechanisms that allow a 
continuous presence of life on earth. In modern multicellular organisms, these 
primal mechanisms still persist but they have evolved differently according to 
the type of organism, its own environmental restrictions, and according to the 
specific cell types that  exerts a specific function in that particular organism; 
generating a wide spectrum of variants of the same process. Nevertheless, the 
ancestral division mechanisms are particularly evident in a specific subgroup of 
cells of multicellular organisms, the so called “stem cells”. Interestingly, the 
mechanisms and genes that are shared by this particular group of cells are 
phylogenetically conserved and are related with genes that facilitate self-
renewal (cell division genes) and mechanisms for bypassing programmed cell 
death (Seita and Weissman 2010).  We can think about these stem cells as 
the evolutionary prints of those previously mentioned selection units that after 
millions of years still persist in the modern multicellular organisms. 
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Commonly, the cell cycle is defined, as the process for which one mother cell 
is divided to produce two daughter cells being genetically identical. From the 
mechanistic point of view this is correct, but we need to extend this definition 
to other levels and perspectives. The cell cycle process is not only about 
dividing a cell, it is about dividing a cell at the proper moment, under the 
proper conditions, and in the proper developmental context. For doing so, any 
dividing cell should be able to couple in an orchestrated fashion environmental 
cues and developmental signals with specific cellular responses at the right 
moment and in the proper cellular type. Similarly, during cell cycle 
progression, the cell constantly scans for mistakes made during the replication 
of the genetic material, giving that erroneous or aberrant replicated material 
can result in cell death, growth defects, or cancer, doing of the cell cycle one 
of the most tightly, regulated and coordinated process in a living cell.  
 
Because of its essential role during growth and development it is not 
surprising to see that the molecular machinery controlling DNA replication and 
mitosis is highly conserved among organisms. This machinery encompasses 
and brings together different kind of solutions for the diverse and constant 
changing challenges that a cell must face during its lifespan. Because of this, 
the mechanistic view of the cell cycle, results not enough and if we want to 
understand the cell cycle progression and complex regulation we have to look 
much further than the primary consequence of cell division, the production of 
two daughter cells.  In order to give a coherent explanation of cell cycle 
progression and regulation, we have to go for a systemic perspective, and for 
doing so, it is mandatory to integrate different points of view, technologies, 
disciplines and scientific backgrounds, because by trying to understand the cell 
cycle, we are not just trying to understand a mere cell division mechanism, we 
are attempting to understand life itself. 
 
1.2. Arabidopsis thaliana a model organism, not only for plant 
research. 
Arabidopsis thaliana is a tiny weed, perhaps with a limited importance in the 
agronomic field, but with an enormous influence on biology and modern 
genetics.  Arabidopsis is an annual Brassicaceae native from Europe and Asia, 
which usually grows up to 25 cm tall in a typical rosette structure. This plant 
can complete its entire life cycle in six weeks. The central stem that produces 
flowers grows after about three weeks, and the flowers are naturally self-
pollinated producing after fertilization, a typical siliqua containing from 20 to 
30 seeds (Figure 1). 
 
By the beginning of 1900s, Arabidopsis had begun to be used in some 
developmental studies already. The first collection of its mutants was made 
around 1945. Since then, Arabidopsis has been used extensively in different 
plant research fields varying from genetics, evolution, population genetics, 
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Figure 1. Arabidopsis thaliana 
a model organism for plant 
biologist. 
ecology, and microbiology to molecular and cellular biology. Arabidopsis has 
been for plant biology what Drosophila melanogaster and Mus musculus has 
been for human’s biology.  This can be explain in terms of its rather simple 
genome (n=5), its great flexibility and adaptation to laboratory conditions, and 
its short life cycle, which allows the analysis of multiple generations in a short 
period of time.  In the same way its genome is fully sequenced (AGI 2000) 
and a complete collection of mutants (T-DNA insertion lines) is available and 
easily accessible for the scientific community. All these characteristics and 
properties have turned Arabidopsis into an excellent model for plant research, 
which is illustrated by the number of research papers that are published yearly 
using this model plant. By the end of 2002, just two years after the publication 
of the Arabidopsis genome, more than 2,500 papers were published focusing 
on Arabidopsis research (Somerville and Koornneef 2002). 
 
Remarkably, next to contributing to plant 
biology, Arabidopsis thaliana has also had a 
great impact in the dissection and 
understanding of different biological processes 
shared with other kingdoms. For the particular 
case of plants and humans, despite the 1.6 
billion years from their divergence, leading to 
different life styles, particular properties and 
characteristics derived from commonly shared 
pathways and cascades inherited from their 
last common ancestor still persist. For 
example, common fundamental processes and 
shared key regulators to maintain the 
homeostasis of the organism can be found in 
both genomes: NB-LRR proteins that are 
typical resistance genes in flowering plants 
have orthologues in humans, named 
NOD/CARD/CATERPILLAR proteins that are 
related with innate immunity (Jones and 
Dangl 2006; Ting, Kastner et al. 2006).  
 
Similarly, studying light signaling in plants led to the discovery of the COP9 
signalosome complex, representing a conserved set of proteins that regulate 
transcription, and lipid metabolism in metazoans (Yi and Deng 2005).  
Similarly, CRY1 and CRY2 proteins along with PER1 and PER2 form the core of 
the mammalian circadian clock for which orthologues were firstly discovered in 
plants with the name of cryptochromes (Thresher, Vitaterna et al. 1998). 
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Processes like DNA methylation or siRNA processing are also shared between 
plants and humans. Arabidopsis has orthologues of the two major human DNA 
methyl transferases, Dnmt1 and Dnmt3 (Chan, Henderson et al. 2005). 
Similarly, some of the first descriptions of homology-dependent gene silencing 
phenomena, such as co-suppression and the discovery of siRNAs and of the 
enzyme Dicer, were firstly made in plants (Matzke, Matzke et al. 2001). 
 
In the same way as Arabidopsis thaliana is a good model to understand key 
eukaryotic processes, it is also a very useful model to understand diseases and 
cancer. When the Arabidopsis genome sequence was completed in 2000, 
followed by the annotation of the human genome sequence three years later, 
it was evident that a big percentage of human genes known to play a role in 
disease had orthologues in Arabidopsis. This highly comparable repertory of 
“disease genes” is comparable to the one observed in other model organisms 
(Figure 2).  Nearly 70% of the genes implicated in cancer have Arabidopsis 
orthologues, whereas the percentage of orthologous genes in the fruit fly 
Drosophila melanogaster is 67%, in the worm Caenorhabditis elegans 72%, 
and in the budding yeast Saccharomyces cerevisiae is 41% (Jones, Chory et 
al. 2008). 
 
 
Figure 2. Arabidopsis contains a large set of human orthologues that have been 
implicated in the origin and/or progression of a variety of human diseases. This 
repertory of molecules is comparable with the set of “disease genes” that have been 
found in other model organism (taken from the Arabidopsis genome initiative, 2000). 
 
Thus, it can be concluded that Arabidopsis has had a profound impact in the 
dissection of several mechanisms particularly important not only for plant 
biology, but for multicellular organisms in general. Therefore, the evolutionary 
conservation of the cell cycle machinery would make of this model organism a 
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system suited for the understanding of cancer biology as well.  In the next 
paragraphs, we will address this issue and we will explore the kind of answers 
that we can extract by analyzing the Arabidopsis thaliana replicating 
machinery. 
 
1.3. Comparing the Arabidopsis and the human cell division cycles: 
what’s common? 
Broadly, cell replication can be ordered into four major phases: G1, S, G2 and 
M. In the G1 phase, dividing cells prepare for DNA synthesis, increasing their 
mass by synthesizing proteins, membrane lipids, and other essential 
components. During S phase, DNA synthesis and chromosome duplication 
occur, and in G2 the cell keeps adjusting the necessary components for the 
division of the genetic material. These three phases are collectively called the 
interphase, as microscopically little appears to be happening. The mitotic or M 
phase marks the end of the cell cycle and entails the separation of the sister 
chromatids and subsequent formation of two daughter cells. This phase is 
further subdivided into four mitotic sub-phases, for which the final outcome is 
the cytokinesis process. In the early prophase the sister chromatids condense, 
forming visible chromosomes and the nuclear membrane is dismantled. During 
metaphase a multi-protein complex called the kinetochore assembles at each 
chromosome centromere, providing the attachment points for the mitotic 
spindle. In the anaphase, through the activity of motor proteins acting on the 
microtubules, the principal spindle units separate the sister chromatids. Once 
the chromatids are separated, the microtubules depolymerize and the 
chromosomes relax, which coincides with the reformation of the nuclear 
envelope, finalizing in this way the cytokinesis process. 
 
In normal replicating cells, the above described processes occur sequentially 
and in an unidirectional fashion, for example, cytokinesis will not occur before 
chromatid separation, whereas the cell will not undergo a second round of 
DNA replication in the same cycle; this is due to the presence of specific cell 
cycle checkpoints that are defined as biochemical pathways that ensure 
dependence of one process upon another process that is biochemically 
unrelated (Schafer 1998). 
 
As it has been mentioned before, the cell cycle is one of the most conserved 
processes in life; the same gene families control cell division throughout the 
tree of life. The research of the past 30 years has provided us with a draft of 
the core cell cycle machinery, which appears to be universal among 
eukaryotes. The progression though the cell cycle is driven by a molecular 
complex formed by effector subunits, the Cyclin-Dependent-Kinases (CDKs), 
being serine/threonine kinases that through phosphorylation of specific targets 
lead the cell throughout the different cell cycle phases, and by its regulatory 
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partners, the Cyclins that control in time and place of action the CDKs. 
Although this complex structures the basic scaffold for cell replication in an 
evolutionary conserved manner, the mechanism of cell division control and 
regulation has become more kingdom-specific during evolution, and though 
many elements are still ubiquitous, their specific mode of action and regulation 
have shifted in a clade-dependent way (Figure 3). 
 
The last common ancestor of plants and animals lived 1.6 billion of years ago, 
but in spite of this considerable evolutionary distance, the molecular 
machinery that controls cell replication is similar. In mammalian cells, the 
entry to the cell cycle is mediated by the sensing of specific growth factors by 
the cell. These growth factors (TGF, EGF, cytokines and hormones), also 
known as mitogens, can be produced auto, para or endocrinally and are 
sensed by specific Tyrosine-Kinase-Receptors (RTKs) that upon binding to the 
specific ligands, dimerize triggering a transduction cascade mediated by 
different protein kinases (MAP-kinases for instance) that ultimately activate 
the D-type cyclins.  These types of cyclins are the integrators between the 
environmental and/or developmental cues sense by the cell and the activation 
of the cell division cycle.  Similarly, in plants the D-type cyclins are the key 
molecules involved in the integration of cell division signals like hormones or 
metabolites (auxins, brassinosteroids, gibberellins and sucrose) with the 
initiation of the G1 phase (Hartig and Beck 2006). 
 
For both, plants and mammals, once the D-type cyclins are activated, they 
interact with their respective CDK subunits, guiding the progression through 
the G1 phase. In the case of the mammalian cells, these subunits correspond 
to the CDK4 or CDK6 kinases. For plants, CDKA;1 is the most likely CDK 
driving this transition (Mironov, De Veylder et al. 1999). In animal cells, when 
activated, CDK4 and CDK6 phosphorylate the RB protein, rendering it to 
repression and liberating the E2F transcription factors that are master 
regulators of the G1-to-S transition. E2F transcriptionally activates a set of 
genes important for the replication of the DNA, including members of the 
Origin Recognition Complex (ORC) (Bosco, Du et al. 2001) and pre-replication 
complex (Hateboer, Wobst et al. 1998; Mukherjee, Cao et al. 2009). The RB-
E2F pathway also influences, the transcription of the E-type and the A-type 
cyclins that in turn, form active complexes with CDK2, guiding the transition 
through the G1-S and S phases of the cell cycle respectively (Schafer 1998). 
In plants progression through the S phase is highly similar. Here the Cyclin-
D/CDKA;1 complexes also phosphorylates the RB protein, liberating the E2F 
transcription factor (Oakenfull, Riou-Khamlichi et al. 2002). There exists a 
significant overlap in the target genes that are induced by the plant and 
mammalian E2F transcription factors (Vandepoele, Vlieghe et al. 2005). 
Different from mammalian cells, no plants orthologues for Cyclin-E has  been 
found, nevertheless it has been proposed that specific A-type cyclins with a 
The comparative cell cycle 
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strong oscillation during the G1-S transition, for instance Cyclin-D4;1, are 
taking over the role of Cyclin-E (Menges, de Jager et al. 2005). 
 
For both plants and animals, the progression through the cell cycle is 
controlled at different levels, not only being restricted to the transcription 
level. During the G1-to-S transition, CDK activity is regulated by positive and 
negative phosphorylation events. In mammalian cells, CDK inhibitors of the 
p16INK4 family specifically inhibit CDK6 and CDK4, while members of the 
Kip/Cip family (p21-kip1 and p57-Kip2) inhibit a broad spectrum of CDKs, 
including CDK4/6 and CDK2.  In a similar way, in plants, CDKA;1 activity is 
regulated by inhibitory phosphorylation events (Stals, Casteels et al. 2000). In 
Arabidopsis the CDKs-Kinase-Inhibitors (CKIs) that can be found are related 
with the KIP/Cip family of mammals, and hence were nominated Kip-Related 
Proteins (KRPs). Contrastingly, no counterparts of the p16INK4 inhibitory family 
are found in plants (Vandepoele, Raes et al. 2002). 
  
In animal cells, the transition from G2 to M is regulated by the CDK1/Cyclin-B 
complex. This move is controlled by the inhibitory phosphorylation of CDK1 by 
the Wee1 Kinase. Once the complex CDK1/Cyclin-B is formed and enters to 
the nucleus, Wee1 phosphorylates CDK1, protecting the nucleus from 
premature exposure to an active mitotic kinase. When the cells are ready to 
divide, the CDC25 phosphatase is activated and dephosphorylates the active 
site of the CDK1 kinase, turning it into its active form. In plants, the transition 
through M phase is controlled in a similar way. In one hand, CDKA;1, forms 
complexes with the B-type cyclins (CyclinB1;1 and CyclinB1;2) constituting 
the basic unit for mitotic progression, in the other hand, the B-type cyclins 
also form complexes with CDKBs. These particular type of CDKs are plant 
specific and are negative regulators of the inhibitory KRP molecule, which in 
turn represses the action of the CDKA;1/Cyclin-B complexes (De Veylder, 
Beeckman et al. 2001). The inhibitory Wee1 kinase is evolutionary conserved 
in plants, and correspondingly regulates the action of the mitotic complexes, 
nevertheless, its antagonist, the CDC25 phosphatase has not been found yet, 
although there are some molecular evidence regarding its existence (Fordham-
Skelton, Skipsey et al. 1999).  
 
One of the most important events during M phase is the even distribution of 
the genetic material by the separation of the sister chromatids. This process is 
remarkably conserved over eukaryotes, and among different molecules 
controlling this events, the correct distribution of the genetic material involves 
a major role for the Anaphase-Promoting-Complex-Cyclosome (APC/C). The 
APC/C is an E3 ubiquitin ligase complex that marks cell cycle proteins for 
degradation by the 26S proteasome. It has two main functions: firstly, the 
APC, degrades the mitotic cyclins after they have exerted their specific 
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functions, preparing the cell for the next cell cycle, and secondly, it activates 
the Separase, which is a site-specific protease that degrades the cohesins, a 
set of proteins that can be considered as the molecular glue that holds the 
sister chromatids together. Activation of Separase cleaves the cohesins, thus 
allowing sister chromatids to separate (Uhlmann 2001). 
 
 
Figure 3. Diagram, illustrating the distinctive phases of the cell division cycle and the 
most important molecules guiding the progression through them. In the inner part of 
the scheme the most important events leading the progression through the 
mammalian cell cycle are represented, while in the outer part of the diagram, the 
same events are represented but for plants. The color-code of the CDKs/Cyclins 
complexes indicates the respective phases of the cycle in which they are expressed 
and the arrows represent direct relations between molecules. Detailed description of 
the event here depicted can be found in the text. 
 
1.4. Comparing the Arabidopsis and the human cell division cycles: 
what’s different? 
The evolutionary conservation of the machinery regulating the cell cycle is 
notorious; nevertheless, some mechanisms evolved differently between plants 
and animals, mainly due to some unique features intrinsically related with the 
sessile life-style of plants (Figure 4). One clear example of this is the 
complexity of the cyclin gene family in Arabidopsis. Compared with humans 
Arabidopsis has 14 more A and B-type cyclins and seven more D-type cyclins 
(Vandepoele, Raes et al. 2002). This greater diversity might reflect the 
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diversification of the plant cell cycle machinery in order to cope with different 
and diverse environmental cues that are typical for a sessile life-style.  
 
Although the process of chromosome segregation is highly conserved in 
eukaryotes, the cytokinesis in plants is completely different from animal cells.  
These differences are based on the need to form a new cell wall between the 
two daughter cells. In plants, the rigid cell wall prevents constriction, thus, the 
final partition of the cell is carried out by a cell plate that grows at the equator 
of the dividing cell. At the end of this process, the cell plate fuses with the 
plasma membrane and the cell wall that surrounds the formed daughter cells.  
To accomplish this, plants have developed two unique cytoskeletal structures, 
the preprophase band (PPB) and the phragmoplast.  The presence of a cell 
wall has also another major implication for plants. Plants cells cannot move or 
migrate, and consequentially organogenesis, which in turn is dependent on cell 
division and cell expansion, is confined to specialized regions, the meristems. 
The cells that constitute the meristems are pluripotent, meaning that their 
progeny can specialize and differentiate into different cellular types (Takeda 
and Aida 2010). 
 
Another drastic difference between the animal and the plant cell is their 
response to environmental cues and/or genotoxic insults.  This means that 
their DNA stress checkpoints are different. As mentioned above, different 
growth developmental strategies bring different outcomes. Animal growth 
occurs via a predefined body’s stratification in which cell cycle progression and 
growth must be strictly coordinated, otherwise apoptosis will occur. 
Contrastingly, plant cells do not undergo programmed cell death when 
suffering from persistent DNA stress, but rather they will lose their capability 
to divide by the activation of differentiation processes (Cools and De Veylder 
2009). 
 
Different insults (UV light or chemical exposure) can break the phosphodiester 
bonds in the backbone of the DNA helix.  Sometimes, the phosphodiester bond 
is damaged in only one of the two DNA strands generating a single strand 
break (SSB), but occasionally, two of these breaks are close to each other, but 
on opposite strands, causing a double strand break (DSB). To optimally repair 
DNA damage, both, the animal and the plant cell, must couple the DNA 
repairing process itself with other cellular processes such as DNA replication or 
mitosis, in order to prevent the perpetuation of the damage in the following 
generations. Broadly talking, in mammals, the signal transduction cascades 
that sense DNA damage and induce DNA repair and trigger cell cycle 
checkpoints are governed by the ATM and/or ATR kinases. 
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Both, ATM and ATR are extremely large molecules (350 and 301 KD 
respectively) and are not functionally equivalent. ATM is more involved in the 
sensing of DSB while ATR detects SSB, but this is not the only difference that 
exists between them. Cells lacking ATM are viable, suggesting that this kinase 
is not critical for essential cellular functions such as normal cell cycle 
progression or cellular differentiation. Contrastingly, ATR activity is necessary 
for the development of viable organisms and it has been suggested that it is 
necessary for cell cycle progression, helping to structure the replication fork 
(Kastan and Bartek 2004).  When a DSB occurs, it causes a conformational 
change in the chromatin that is sensed by ATM. Afterwards, ATM, undergoes a 
conformational change and homodimerization, generating the active form of 
the kinase. SSB can be produced by hypoxia or UV irradiation, in these cases 
ATR is the one that is activated. ATR exists in a complex with the ATR-
Interacting-Protein   (ATRIP). The accumulation of SSB induces the 
recruitment of ATRIP, which in turn activates ATR. ATM and ATR mediated 
phosphorylation, triggers the activation of the CHK2 and CHK1 kinases 
respectively, which are the most important molecules encharged of 
transducing the signal. 
 
The dominant checkpoint response to DNA damage in mammalians cells works 
out through G1 and is: ATM-CHK2 or ATR-CHK1 phosphorylations, which main 
consequence is the ATM/ATR-dependent activation of p53 and the inhibition of 
MDM2, which is an ubiquitin ligase that marks p53 for degradation. Once p53 
is activated, it activates p21 which action is exerted by repressing the Cyclin-
E/CDK2 complex.  In animal cells an alternative pathway exists. This one is 
independent of p53 and its main effect is the repression of the cell cycle in the 
G2-M transition.  In this case the targeted molecule is the CDC25 phosphatase 
that is repressed by degradation or mislocalization, and thus, cannot activate 
the CDK1/Cyclin-B mitotic complex (Shimada and Nakanishi 2006). 
 
In plants, many of the previously mentioned mammalian molecules 
fundamental for the DNA-stress-response are lacking, including CHK1, CHK2, 
p53 and CDC25.  Probably due to this, the checkpoint genes in plants are not 
essential during normal growth. Even more, plant checkpoints seem less 
sensitive to DNA stress than their animal homologs (Cools and De Veylder 
2009). For the plant model, the WEE1 kinase is of great importance. In 
Arabidopsis, cells lacking a functional WEE1 do not accumulate phosphorylated 
CDKs, and probably enter to M phase with an incompletely or damaged 
replicated genome in the presence of DNA stress, triggering a growth arrest as 
a consequence (De Schutter, Joubes et al. 2007). Similarly, some plant-
specific CDK inhibitors such as the SIM-Related-Genes (SMR) are induced in 
an ATM-dependent manner by DNA stress, illustrating how plant-specific 
mechanism have evolved in order to respond to specific environmental cues 
(Culligan, Robertson et al. 2006). 
The comparative cell cycle 
13 
 
 
 
Figure 4. Venn’s diagrams illustrating the conserved and differentially evolved 
molecules and structures involved in different cell cycle-related processes for plants 
and mammals. In the intersection of every Venn’s diagram are depicted set of 
orthologous molecules and/or structure that regulated the respective indicated 
process.  
 
1.5. Cell cycle and cancer 
The first inconvenient, when we want to talk about cancer is the definition of 
cancer itself. Cancer is considered as a group of diseases for which the tumor 
of origin, gives the common distinctive characteristics of a particular cancer 
type. More than one hundred of human cancers have been classified, making 
extremely difficult the comprehensive understanding of all the molecular 
signals and altered transductional cascades that lead to the neoplastic 
transformation. Nevertheless, underlying the variability that can be found in 
different tumor and cancers, lays a relatively small number of critical events 
whose convergence is required for the development of any and all cancers. 
Although cancers are extremely diverse and heterogeneous, in almost all 
instances deregulated cell proliferation and suppressed cell death provide the 
underlying platform for neoplastic progression (Evan and Vousden 2001). 
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To sustain a multicellular organism, a really tightly regulated balance must 
exist, this balance can be describes as follows: find a way to allow cell 
proliferation when needed, while at the same time, efficiently suppressing the 
growth of mutated cells which alterations can lead to an uncontrolled 
proliferative state.  Multicellular organisms have developed different 
mechanisms for trying to maintain this balance, by limiting cell proliferation 
and by controlling deregulated growth.  
 
Among the different strategies to limit cell proliferation we can mention the 
inverse coupling of differentiation to proliferation that limits the number of cell 
divisions according to the cellular type. Unlimited proliferative potential is 
restricted to a small number of slowly replicating stem cells. Other strategies 
include cell-survival dependence upon the availability of trophic factors that 
are not permanently available for the cells and for mammalian cells, a limited 
number of cell divisions restricted by telomere’s erosion, and induction of 
apoptosis. Similarly, to control mutations that when transmitted to the next 
generation could represent a possibility of growth advantage to a specific cell 
that in normal conditions should not be able to proliferate, cells have evolved 
DNA checkpoints (briefly described in the previous section) that couple the 
sensing of those mutations with apoptosis, generally through p53 activation 
(Vazquez, Bond et al. 2008). 
 
Doubtless it is true, that cancer on its advanced stages involves a crosstalk of 
diverse pathways in differentially altered proportions and in different 
penetrance statuses. Hormonal imbalance, loss of cell identity, 
dedifferentiation and transdifferentiation, loss of cell adhesion and acquired-
migratory properties, are some of the principal events that lead to cancer 
progression, having a direct influence on cancer aggressiveness and 
metastatic behavior. Nevertheless, for these changes to happen it is necessary 
to have already a predefined scaffold to sustain and to give advantage to 
mutations that are going to accumulate a posteriori. This platform is given by 
a deregulated replication capacity in which malignant cells proliferate in 
conditions where normal cells do not, and by the ability to overcome cell 
death. It has been shown, that specific deregulated pathways exist for specific 
cancer, for instance, this is the case of bladder carcinoma where the 
suppression of the immune response is hallmark from this type of malignancy 
(Lindgren, Liedberg et al. 2006), or for colorectal cancers where the 
chromosomal instability is the distinctive acquired property (Barber, McManus 
et al. 2008; Moran, Ortega et al. 2010). Contrastingly, the analysis of multiple 
cancer-specific microarray experiments and the identification of the 
transcriptional master regulators altered in these experiments, has allowed the 
identification of cancer core-deregulated pathways. High proliferation is the 
general hallmark in cancer, represented by the up-regulation of specific Gene 
Ontology (GO) pathways such as mitotic cell cycle, DNA replication, DNA 
repair and chromatin assembly. These changes are mainly driven by the 
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altered expression of the E2F transcription factor (Goodarzi, Elemento et al. 
2009). These recent findings support previously shown genetic and functional 
evidence linking key characteristic of malignant cells with common aberrations 
among cell cycle regulators, in particular those governing G1 phase 
progression and the G1-to-S transition (Bartek, Bartkova et al. 1997). 
 
There are different ways to reach a deregulated cell proliferation and 
interestingly, a vast majority of them, are connected with the G1-S transition. 
Autocrine production of a normally limiting mitogen, mutations in the cascades 
that link the sensing of nutrients availability with the ultimate effectors (such 
as mutations in the RTKs, G protein signal transducers as RAS), mutations 
that deregulate the late G1 cell cycle check point by RB manipulation 
(deregulation of D-type cyclins, altered activity of the CDK4 and/or CDK6 
kinases and abolishment of RB itself), and the commonly altered p53 
expression, all of them are drastic changes connected with the G1-S transition 
of the cell cycle that lead to a deregulated cell proliferation that might 
represent a growth advantage for the mutated cell.  From this point of view, 
all those genes in the G1-S transition positively associated with cell cycle 
progression can be considered as proto-oncogenes:  D-type cyclins, CDK4 and 
CDK6, Cyclins-E and A, and CDK2. In the same way, all those cell cycle 
negative regulators can be considered as tumor suppressors, including the 
p16, p21 and p57 CDK inhibitors, and RB itself (Table 1). 
 
In agreement with the role of G1-S positive regulators as oncogenes, Cyclin-
D1 was previously known as the oncogene PRAD1 (Zukerberg, Yang et al. 
1995). Gene amplification of Cyclin-D1 has been identified in a variety of 
human neoplasm, including breast cancer and squamous cell carcinoma of the 
neck (Higuchi, Oridate et al. 2007). Similarly, in mantle cell B lymphomas, 
there is a chromosomal translocation between chromosomes 11 and 14 that 
produces a constitutive Cyclin-D1 overexpression (Swerdlow, Yang et al. 
1995). Likewise, Cyclin-E overexpression has been associated with the breast 
carcinomas (Shaye, Sahin et al. 2009), whereas it has also been shown that 
its differential expression has a direct prognosis relevance in breast tumors 
(Mehdipour, Pirouzpanah et al. 2009). Even more, Cyclin-E overexpression is a 
mechanism used for malignant cells to generate resistant to trastuzumab in 
HER2+ breast cancer patients (Scaltriti, Eichhorn et al. 2011). 
 
At the other hand, the value of a variety of negative cell cycle regulators as 
tumor suppressors has been also proven. In melanoma, in T-cell leukemia and 
in pancreatic carcinoma there is a total loss of p16 expression (Bartek, 
Bartkova et al. 1997). Similarly, the p16 promoter has been found to be 
hyper-methylated in gastric carcinomas (Hu, Kong et al. 2010), breast cancers 
(Radpour, Barekati et al. 2011), neck squamous cell carcinoma (Laytragoon-
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Lewin, Chen et al. 2010) and in colorectal cancers (Chang, Park et al. 2010). 
In colorectal cancers, loss of p27 a CDK4 inhibitor, combined with the 
overexpression of Cyclin-D1 has been associated with a poor prognosis 
(Bottini, Platini et al. 2009). But the most obvious examples regarding the role 
of cell cycle inhibitors as tumor suppressors are the RB protein and p53, both 
being two of the most studied tumor suppressors. Because of its association 
with the retinoblastoma pathology, the RB protein as the repressor unit of the 
E2F transcription factor is the archetypical example of a cell cycle regulator 
with a fundamental role in cancer progression (Lee, Bookstein et al. 1987; 
Bremner, Chen et al. 2004; Simpson, Mason-Richie et al. 2009; Cito, 
Pentimalli et al. 2010). In the case of p53, it is the most studied molecule in 
cancer biology, given that approximately more than 50% of all cancers show a 
deregulated p53 pathway, either on its role in cell cycle (Goh, Coffill et al. 
2011) or in apoptosis induction (Amaral, Xavier et al. 2010). 
 
Although the G1-S transition is the one with most impact in oncogenesis, 
some molecules related with the G2-M transition have been also implicated 
with cancer progression (Table 1).  This is the case of Cyclin-B1 which high 
expression has been associated recently with poor survival in breast cancers 
(Aaltonen, Amini et al. 2009). Similarly, the APC/C, activated by the Cdh1 
subunit, coordinately eliminates positive cell-cycle regulators as well as 
inhibitors of differentiation, thereby coupling cell-cycle exit and differentiation. 
In addition, APC/CCdh1 is required to maintain genomic stability emerging as a 
novel oncogene (Wasch, Robbins et al. 2010). 
 
Table 1.Principle cell cycle regulators and their carcinogenic role. 
Molecule Cell 
Cycle 
Phase 
Carcinogenic 
Role 
Malignancy Reference 
RTKs G1-S Oncogenes -Rhabdomyosarcoma 
-Thyroid Carcinoma 
-Leukemia 
-Crose (2011) 
-Castellone 
(2008) 
-Doepfner (2007) 
Cyclin D1 G1-S Oncogene -Mantle cell B 
lymphomas 
-Neck Squamous cell 
Carcinoma 
-Swerdlow (1995) 
-Higuchi (2007) 
RB G1-S Tumor 
Suppressor 
-Retinoblastoma 
-Lung Carcinoma 
-Breast Carcinoma 
-Gastric Carcinoma 
-Lee (1987) 
-Simpson (2009) 
-Ertel (2010) 
-Cito (2010) 
E2F G1-S Oncogene/Tumor 
Suppressor 
-Breast Carcinoma 
-Gastric Carcinoma 
-Eelen (2008) 
-Yan (2009) 
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-Prostate Carcinoma 
-Hepatocellular 
Carcinoma 
-Davis (2006) 
-Deng (2010) 
Cyclin-E G1-S Oncogene -Breast Carcinoma -Shaye 
(2009),Mehdipour 
(2009) &Scaltriti 
(2011) 
Cyclin-A G1-S Oncogene -Breast Carcinoma 
-Thyroid Carcinoma  
-Strand (2011) 
-Nar (2011) 
p16 G1-S Tumor 
Suppressor 
-Colorectal 
Carcinoma 
-Breast Carcinoma 
-Gastric Carcinoma 
-Neck Squamous cell 
Carcinoma 
-Chang (2010) 
 
-Radpour (2011) 
-Hu (2010) 
-Laytragoon 
(2010) 
p53 G1-S Tumor 
Suppressor 
-Misregulated in 
more than 50% of all 
cancers 
-Goh (2011), 
Smeenk (2010), 
Tapia (2010), 
Gonfloni (2010), 
Manfredi (2010) 
&Amaral (2010) 
Cyclin-B1 G2-M Oncogene -Breast Carcinoma Aaltonen (2009) 
CDC25 G2-M Oncogene -Vulvar squamous 
cell carcinoma 
-Glioblastoma 
-Wang (2010) 
 
-Yamashita 
(2010) 
APC/C G2-M Oncogene -Cellular study -Wasch (2010) 
 
1.6. Sharing phenotypes between plants and humans: the phenologs 
perspective. 
Phylogenetics can be defined as the study of the evolutionary relatedness 
among groups of organisms. These relations can be inferred through 
morphological data and by sequencing of specific molecules as genes and 
proteins. This means, that the associations that are deducted for organisms 
are based either on morphology or in molecular data and due to this, it is 
possible to talk about evolutionary linages and evolutionary relationships not 
only for organisms, but for genes as well. 
 
In the particular case of the genome, there exist different types of relations 
among different genes. Two of the most common evolutionary associations 
between two genes are the orthology and paralogy relations. The simplest 
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definition for these terms is the one that was proposed by Walter Fitch in the 
70s and that still persist: orthologues are genes related via speciation (vertical 
descent), whereas paralogues are genes related via gene duplication. These 
evolutionary scenarios have specific consequences. In the particular case of 
orthologous genes, these are homologous genes in different genomes that 
tend to be involved in the same biological process. Contrastingly, the paralogy 
relationship, defines groups of genes in a common genome that can be 
functionally redundant (involved in the same function), or in the case of 
ancient duplications, one copy of the gene can be evolving into a gene with a 
different function. 
 
The orthology relation among different homologous genes sustains that the 
biochemical and molecular functions of a given gene and the protein that it 
encodes is generally conserved among different organisms. Due to this, it is 
possible to use simple model organisms to explain phenomena that occur in 
more “advanced” organisms. For instance, this is the case of Drosophila 
melanogaster as a model organism to understand the complex neuronal 
networks that control the vertebrate´s brain, or Arabidopsis thaliana as a 
biological model organism for all the angiosperms. Nevertheless, even when a 
specific gene function is conserved, disruption of the same set of orthologous 
genes may give rise to radically different phenotypes in different organisms. 
The reason for this is because when a conserved gene is mutated, the 
resulting organism-level phenotype is an emergent property of the system, 
given the particular context (network architecture) in which that gene is 
expressed (Wolf 1997), thus, recognizing functionally equivalent organisms-
level phenotypes between model organisms can therefore be non-obvious, 
specially across large evolutionary distances. 
 
In order to bridge the possible differences between orthologous genes and the 
phenotypes that are produced when such a genes are disrupted in different 
organismal contexts, Kriston McGary and collaborators, defined a new term: 
Phenologs (McGary, Park et al. 2010). According to their definition, two 
phenotypes in two different organisms are orthologous phenotypes 
(Phenologs) if the genes that are associated with the occurrence of those 
particular phenotypes are also associated by an orthology relationship, even if 
the phenotypes that are produced by misregulation of those orthologues, may 
appear dissimilar. From this point of view, Phenologs reveal functionally 
coherent, evolutionarily conserved gene networks, many predating the plant-
animal divergence. 
 
To validate their approach, McGary and collaborators experimentally 
demonstrated the possibility of a set of orthologous genes to be involved in 
the origin of particular phenotypes in the organisms where these sets of 
orthologues belong.  For example, a plant-human phenolog was observed, 
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relating negative gravitropism defects in Arabidopsis to Waardenburg 
syndrome in humans, a genetic disorder that arises from defects in the neural 
crest formation. They showed that SEC23IP a human orthologue of the 
Arabidopsis SGR2 (AT1G31480) gene, which is involved with gravitropic 
responses, when down-regulated in Xenopus, affected the neural crest 
development. This gene had not been linked before with neural crest 
development, and because of this can be considered as a new gene related 
with the Waardenburg syndrome (McGary, Park et al. 2010). 
 
Phenologs can associate groups of orthologous genes with specific phenotypic 
responses even in distantly related organisms, highlighting the evolutionary 
importance of these conserved molecules, and their direct influence in the 
generation of particular phenotypes when deregulated. But the relation 
between gravitropism in Arabidopsis and the Waardenburg syndrome in 
humans is not the only phenolog that can be found between these two 
organisms. Similarly other orthologous phenotypes can be described, several 
ones, associated with different types of cancer in humans (Figure 5 and Table 
2).  
 
This is the case of the colorectal adenomatous polyposis. For this malignancy, 
28 genes have been reported to have a direct effect in the progression of the 
disease (www.phenologs.org). Eight out of these 28 genes have orthologues in 
Arabidopsis, and according to gene ontology there is a significant over-
representation (P-value of 4.91XE-10 according to the hypergeometric 
probability) of the GO category “mismatch repair” in this set of Arabidopsis 
genes. Given this, it is possible to suggest that the human phenotype 
“colorectal adenomatous polyposis” is related with the gene ontology 
phenotype “mismatch repair” in Arabidopsis (Figure 5A). Similarly, for breast 
carcinomas, 22 genes have been linked with this phenotype. Nine out of the 
22 genes associated with breast carcinomas in humans have orthologous 
genes in Arabidopsis and according to gene ontology there is a clear over-
representation of the term “DNA repair” in this subset of genes (P-value of 
7.76XE-08 according to the hypergeometric probability), suggesting a link 
between the breast carcinoma phenotype in humans and the gene ontology 
phenotype “DNA repair” in Arabidopsis (Figure 5B). 
 
1.7 Discussion 
Despite the 1.6 billion years of divergence between the animal and plant 
clades; commonly shared pathways and cascades inherited from their last 
common ancestor persist. Such pathways must be of great importance for 
both plants and animals, given their retention throughout evolution. The 
cascades and molecules that integrate the light signaling with the metabolic 
cycles in both organisms, innate immunity systems, methylation and RNAi 
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mechanisms, and the cell division cycle, are some of the key processes that 
are shared by plants and animals. Similarly, upon the comparison of the 
human and Arabidopsis genome sequence, it was clear that an important 
amount of genes implicated in the origin and progression of different human 
pathologies have orthologues in Arabidopsis. Similarly, from all the genes that 
have been related with cancer in humans, nearly 70% have orthologous genes 
in the Arabidopsis genome. This means that at least from the mechanistic 
point of view, Arabidopsis thaliana has the same potential as other model 
organisms like Drosophila and Caenorhabditis, to study specific human’s 
diseases, including cancer. 
 
 
 
Figure 5.Examples of cancer-related orthologous phenotypes (Phenologs) that can be 
found between Arabidopsis and human A. Colorectal adenomatous polyposis 
(humans)-Mismatch repair (plants) and B. Breast cancer (human)-DNA repair 
(plants). In the intersection of the Venn´s diagrams are the pairs of orthologous genes 
that are shared between the two phenotypes. The numbers outside the intersection 
represent the number of genes that are described for each phenotype according to the 
phenologs web site (www.phenologs.org). For Arabidopsis the phenotypes are 
represented for specific Gene Ontology (GO) categories. 
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Table 2. Arabidopsis-human orthologous gene pairs associated with cancer. 
AGI GO biological Function HGNC Related Carcinomas 
AT4G09140 Mismatch repair MLH1 Colorectal 
AT4G02070 Mismatch repair MSH6 Colorectal and ovarian 
AT3G12980 Protein acetylation EP300 Colorectal 
AT1G44120 Unknown CTNNB1 Colorectal, ovarian, and 
hepatocellular 
AT4G12740 DNA repair MUTYH Colorectal 
AT3G18524 Mismatch repair MSH2 Colorectal and ovarian 
AT2G33560 Mitotic cell cycle spindle 
assembly checkpoint 
BUB1 Colorectal 
AT4G02460 DNA recombination PMS2 Colorectal 
AT5G40770 Cell division PHB Breast and prostate 
AT4G21070 DNA recombination BRCA1 Breast and ovarian 
AT3G19210 DNA repair RAD54L Colon and breast 
AT1G04020 DNA repair BARD1 Breast 
AT4G00020 Embryo development BRCA2 Breast, prostate and 
pancreatic 
AT5G13860 Post-traslational protein 
modification 
TSG101 Breast 
AT5G57450 DNA repair XRCC3 Breast 
AT1G20720 Nucleic acid metabolic 
process 
BRIP1 Breast 
AT5G20850 DNA repair RAD51 Breast 
AT1G61790 Unknown TUSC3 Prostate 
AT5G49880 Mitotic cell cycle checkppoint MAD1L1 Prostate 
AT3G16260 Metabolic process tRNA 3'-
end processing 
ELAC2 Prostate 
AT1G77990 Sulfate transport SLC26A3 Colon Adenocarcinoma 
AT2G45490 Histone phosphorylation, AURKA Colon Adenocarcinoma 
AT1G25490 Abscisic acid mediated 
signaling pathway 
PPP2R1B Lung  
AT3G26180 Oxidation-reduction process CYP2A6 Lung Carcinoma 
AT4G11410 Oxidation-reduction process WWOX Esophageal  
AT1G79840 Regulation of transcription, 
DNA-dependent 
MSX1 Cleft lip/palate ectodermal 
dysplasia syndrome 
AT3G25900 Methioninebiosynthetic 
process 
MTR Cleft lip/palate ectodermal 
dysplasia syndrome 
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But from the organismic point of view is difficult to think about Arabidopsis as 
a model organism to study cancer, basically due to the observation that plants 
don’t get cancer. To address the question why plants don’t get cancer is not a 
trivial issue.  We can say that some mechanisms evolved differently between 
plants and animals and that the majority of those mechanisms are associated 
with the sessile-specific life style from plants. Plants can incorporate extra 
cells into their normal body plan and carry them on without any problem, for 
instance, increasing or decreasing the number of cells in Arabidopsis by 
boosting or inhibiting B-type cyclins in specific plant organs, makes little 
difference to how the plant looks like (Doerner, Jorgensen et al. 1996). 
Similarly, the over-expression of a master transcriptional activators like the 
E2Fa-DPa transcription factor, has no dramatic effects on the morphology of 
the plant (Vandepoele, Vlieghe et al. 2005). A possible explanation for this, is 
that plants undergo extensive post-embryonic organ formation, from 
undifferentiated proliferative zones (meristems).  As cells leave the 
meristimatic region, the division rate declines and cell identity is determined 
almost entirely by the position of a cell relative to its neighbors rather than 
genealogy (Doonan and Hunt). Stop in cell division represents to enter into a 
differentiation state, a different cellular program often associated with 
endoreduplication. In contrast, cell linage plays a major role in determining 
the identity of animal cells and it is mainly determined during the development 
of the embryo by tightly regulated events. 
 
Another drastic difference between plants and humans is the cellular response 
towards DNA damage. When a plant cell undergoes severe DNA damage, that 
particular cell is pushed into differentiation programs, rather than going to 
apoptosis. Similarly, because of the rigid cell wall, specific DNA mutations that 
might confer to a particular cell specific growth advantage are negligible due 
to the fact that cells are confined by the cell wall, and thus those mutated cells 
cannot migrate to different plant organs. In other words, it can’t metastasize.  
These facts, possibly explains, why important elements of the DNA damage-
scanning and repairing machinery such as p53, CHK1 and CHK2 kinases and 
the phosphatase CDC25 don’t exist in plants. 
 
Nevertheless, specific cancer events, like the loss of cell identity and the 
acquisition of migratory properties, are rather late events during the 
progression of the disease (Kraljevic Pavelic, Sedic et al. 2011), and thus are 
consequence of earlier events that drive the carcinogenic process. To 
distinguish, identify, and understand the early events during cancer 
development is the modern challenge of cancer research. Nowadays, an old 
paradigm has being reinforced, consisting of on the notion that underlying the 
variability that can be found in different tumor and cancers, lies a relatively 
small number of critical events whose convergence is required for the 
development of any cancer (Evan and Vousden 2001).  Recently, it has been 
shown that for almost all instances deregulation of cell proliferation and 
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suppression of cell death provide the underlying platform for neoplastic 
transformation. One example of this is the research carried out by Goodarzi 
and collaborators, in which by analyzing of near to 60 different types of 
cancers via microarray experiments, they were able to prove that in almost all 
instances there is a core mechanism of cancer represented by the deregulation 
of specific processes like mitotic cell cycle, DNA replication, DNA repair and 
chromatin assembly. Even more interesting, they were able to demonstrate 
that these specific alterations can be explained as a consequence of the 
misregulation of particular transcriptional regulators such as the E2F 
transcription factor (Goodarzi, Elemento et al. 2009). 
 
Similar to animal cells, plant cells proliferate, and interestingly, one of the 
most conserved pathways between plants and animals is the RB-E2F pathway. 
This is clearly exemplified by the significantly large amount of E2F target 
genes that are shared between both organisms, such as members from the 
MCM and ORC complexes. Similarly, important cell cycle regulators during the 
G1-S and G2-M phases that have been implicated in specific carcinogenic 
events as oncogenes and/or tumor suppressors have orthologous genes in 
Arabidopsis (Table 1). Given that abnormal cell proliferation is the current 
hallmark of cancer at early stages, and due to the fact that the machinery that 
regulates the cell division process is highly conserved between plants and 
animals, it might be possible to identify new cell cycle regulators with a 
specific role in carcinogenesis by systematically studying the cell replication 
machinery in Arabidopsis. From this point of view, the conserved gene 
systems revealed by the plant-vertebrate phenologs illustrate an ancient 
homology between the plant and the animal clades, which are representative 
of conserved networks. The existence of cancer-related phenologs between 
plants and humans brings attention to the potentially extensive molecular 
toolkit within the last common ancestor between these organisms, which 
facilitate the parallel evolution of complex multicellular organisms and even 
more, open the gate to Arabidopsis thaliana as a new model organism to study 
altered cell proliferation during cancer progression. 
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2.1. Introduction 
A wide spectrum of strategies has been used to identify new oncogenes or cell 
malignancy modulators, from proteomics studies (Srinivas, Verma et al. 
2002), cytogenetics (Pekarsky, Zanesi et al. 2002) to cancer epigenetics 
(Jones and Laird 1999). With the technological progress of gene expression 
techniques, methods such as digital differential display (Marone, Scambia et 
al. 1998; Scheurle, DeYoung et al. 2000) and serial analysis of gene 
expression (SAGE) (Argani, Rosty et al. 2001) have been used as tools to 
discover new oncogenes and tumor suppressors. Microarrays have been 
employed also as a highly preferred technology to characterize cancer-specific 
expression patterns (cancer fingerprints) and cancer-deregulated pathways 
(Alizadeh, Ross et al. 2001; Korkola, DeVries et al. 2003; Rhodes, Yu et al. 
2004; Neve, Chin et al. 2006; Miller and Liu 2007). Additionally, recent 
technological advances have provided platforms that allow hundreds of 
thousands of single nucleotide polymorphisms (SNPs) to be analysed in 
genome-wide association studies (GWAS), providing a basis for the 
identification of moderate-risk alleles that contribute to cancer progression 
(Easton, Pooley et al. 2007; Yeager, Orr et al. 2007; Amos, Wu et al. 2008). 
 
Nevertheless, in spite of the invaluable information that has been obtained 
using these tools, all of them have specific disadvantages. GWAS are highly 
time-consuming strategies, they require state-of-the-art technology, and a 
large sampling set. Similarly, proteomic techniques are very expensive and 
require sophisticated equipment, while in the case of the gene expression-
based techniques, the data interpretation obtained through differential display, 
SAGE, or microarrays remains challenging. Therefore, it is necessary to 
develop new rapid and economic approaches to identify oncogenes and tumor 
suppressor, preferably using as many sources of information as possible. The 
integration of different data sources representing complementary data 
(structural, transcriptional and phylogenetic information), can increase 
reliability by reducing the false-positives detection rate. 
 
As was shown in the introductory chapter, because of the essential role of the 
molecular machinery controlling DNA replication and mitosis during 
development, it is not surprising to see, that this machinery, is highly 
conserved among organisms. Mammalian cell cycle genes have orthologues 
that perform a similar regulatory function in plants, and vice versa. 
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Nevertheless, besides the many known and characterized proliferation genes, 
important still undiscovered regulatory genes are expected to exist with 
conserved functions in plants and humans. 
 
During the last decade, the massive production of genome-wide data 
describing both genome sequences and functional properties of genes in 
different model organisms has facilitated the development of systems biology 
approaches. For example, the use of microarray experiments to 
transcriptionally characterize the response of particular cells or organisms to 
specific treatments or environmental challenges has provided us with a 
massive amount of information regarding the transcriptional activity during 
development or upon specific environmental cues (Birnbaum, Shasha et al. 
2003; Schmid, Davison et al. 2005). This avalanche of genomic and functional 
information has created the need for looking for new ways and strategies to 
biologically interpret such amount of generated data. One clear example of 
this is the generation of coexpression networks based on the analysis of 
different microarray experiments.  
 
The gene coexpression networks are constructed from microarray gene 
expression profiles (Stuart, Segal et al. 2003; Persson, Wei et al. 2005). In 
this type of biological network, nodes represent microarray probe sets (or 
genes), whereas the edges between two nodes represent that these nodes are 
highly coexpressed according to their expression values across different 
microarray experiments, commonly defined by statistical methods such as the 
Pearson Correlation Coefficient (PCC). In many cases, the microarray samples 
cover multiple tissue types, growth stages, and experimental variables, 
representing this type of experiments a “global” approach for gene 
coexpression. Gene coexpression networks have been used in many biological 
problems, for example to identify conserved gene clusters across several 
species (Stuart, Segal et al. 2003), to identify functional gene modules in 
humans (Lee and Tzou 2009), for the identification of genes involved with 
cellulose synthase in Arabidopsis (Persson, Wei et al. 2005); to generate plant 
metabolic networks (Wei, Persson et al. 2006), or to identify biomarkers for 
glycerol kinase-deficient mice (MacLennan, Dong et al. 2009). 
 
In plants and animals, transcriptional regulation is mediated by a large 
number of transcription factors regulating the expression of hundreds of target 
genes in sometimes intertwined signal transduction cascades (Wellmer and 
Riechmann 2005). Whereas the similarity in gene expression patterns 
measured by coexpression profiles can be used to infer groups of genes that 
are coordinately expressed in response to a specific stimulus; the integration 
of expression and sequence data makes possible to identify cis-regulatory 
elements, the functional elements responsible for the timing and location of 
transcriptional activity (Haberer, Mader et al. 2006; Ma, Gong et al. 2007). 
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Transcription factors-binding sites (or DNA sequence motifs) are the functional 
elements that determine the timing and location of transcriptional activity and 
their over-representation in the promoter regions of groups of coexpressed 
genes can explain at least partially the way in which such coexpressed genes 
are concomitantly regulated. 
 
Given that the main objective of the present research is to find and 
characterized not only new but conserved cell cycle regulators for plants and 
humans, here, we applied a systemic approach. We combined different 
information sources and took advantage of the functional predictive value of 
coexpression patterns by integrating them with cis-regulatory elements and 
phylogenetic analyses. From this point of view, the use of integrative 
approaches and comparative genomics studies as  research tools have been 
useful, not only to acquire better insights about the evolutionary process itself 
(Koonin, Aravind et al. 2000; Postlethwait, Woods et al. 2000; Rubin, Yandell 
et al. 2000; Hardison 2003; Mans, Anantharaman et al. 2004; Nobrega and 
Pennacchio 2004; Paterson, Bowers et al. 2004), but also for applied research, 
including the development of vaccines (Behr 2001), identification of new 
target regions for human hypertension (Stoll, Kwitek-Black et al. 2000), 
recognition of evolutionary conserved siRNAs (Wassarman, Repoila et al. 
2001), and the prediction of disease genes (Ala, Piro et al. 2008; McGary, Park 
et al. 2010). 
 
The principal objective of this part of the research plan was to design a 
systemic reliable platform for the identification of novel conserved cell cycle 
regulators between plants and humans. As final outcome, a list of novel and 
conserved candidate genes with a high probability of involvement in cell 
division processes for both human and plants is suggested. 
 
2.2. Results 
To identify new genes playing a role in the regulation of the plant and human 
cell cycle, an integrative genomics strategy was applied (Figure 6). Starting 
from >200 microarray experiments (See appendix E), the expression levels for 
20,777 Arabidopsis genes were used to identify gene coexpression 
neighborhoods based on the Pearson correlation coefficient (PCC) (see 
material and methods of this section). Depending on the seed gene, 
neighborhood clusters of coexpressed genes contained between 10 and 450 
genes. Subsequently, each cluster of genes was tested for functional 
enrichment using Gene Ontology (GO). The terms “DNA-replication” 
(GO:0006260) and “DNA-repair” (GO:0006281) were scanned within the 
annotations of the coexpressed neighbors of all seed genes. In total, 3,251 
genes were significantly enriched (P-value < 0.05) for one or both of these 
terms (Appendix A). To identify within this list the genes with a putative role in 
DNA replication or DNA repair, the 1 Kb promoter regions of the 3,251 genes 
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were scanned for the presence of E2F cis-regulatory element using a Positional 
Weight Matrix (PWM) with a consensus sequence TTTssCGC. A total of 1,031 
Arabidopsis genes were found, harboring one or more predicted E2F binding 
site in their promoter region (Appendix B). Subsequently, to select only those 
genes with a putative conserved role across species, plant genes with a 
mammalian orthologue were identified using the OrthoMCL database (Li, 
Stoeckert et al. 2003), and subsequently sets of orthologues were verified by 
means of phylogenetic inference (see material and methods of this section and 
Figure S1).  For 515 genes at least one human orthologue was identified. As 
functional redundancy might obscure downstream functional analysis upon 
gene knock-out, we subsequently selected only those genes that are part of a 
low copy number family in both Arabidopsis thaliana and Homo sapiens. A 
total of 339 seeding genes fitted this criterion (Appendix C). 
 
 
Figure 6.Schematic representation of the applied methodology for the selection of 
target genes using data integration and comparative genomics. Numbers in 
parenthesis report the number of genes that were retained after each step. 
 
This list of 339 genes represents the central core of our systemic approach, 
containing a set of evolutionarily conserved molecules that rests at the heart 
of the replication machinery that has been kept stable during the evolutionary 
process. Some of these genes lack specific functional annotations and thus, 
given our integrative strategy and the specific functional filters that were 
applied, must represent novel cell cycle regulators for both, plants and 
humans. 
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2.3. Discussion 
Systemic approaches, based on the use and integration of different genomic 
data represents a complementary tool for cancer research. The application of 
these strategies, has been growing and evolving rapidly due to the massive 
amount of genomic data that has been generated during the last decade, and 
correspondingly, the use of these strategies for the discovery of new 
regulatory molecules is very economical because it relies mainly on the use of 
computational tools that are freely available for the scientific community. The 
genomes of Arabidopsis thaliana and Homo sapiens are well suited for 
comparisons given their high quality and fully complete sequences that are 
available in curate databases. Additionally, Arabidopsis has not only had a 
great impact in the understanding of the plant kingdom itself, but also it has 
extensively contributed in the dissection of specific mechanisms that have 
been evolutionary conserved. Innate immunity, circadian clock, ubiquitin cycle, 
RNAi processing mechanism, ion transport, G protein signaling and natural 
genetic variation are some of the traits first studied in Arabidopsis, that have 
been conserved during the evolutionary process (Jones, Chory et al. 2008).  
Given that the cell division cycle is highly conserved among different 
eukaryotes integrative strategies incorporating different genomic backgrounds, 
emerges as a novel strategy to find conserved new cell cycle regulators. 
 
Coexpression networks are able to offer an understandable view of the system 
from a functional perspective of co-modulated genes; nevertheless this 
systemic approach suffers from restrictions. First, they are limited to a single 
level of interaction, being gene coexpression, and thus, cannot provide a full 
perspective from the whole cell interacting landscape (protein-protein or 
transcription factor-protein interactions). Even, what is more important, the 
full set of genes that conform a specific genome cannot be measured in every 
condition, situation or treatment, and because of this, coexpression networks 
are not able to capture all possible relationships among genes (Lee and Tzou 
2009). To improve the functional prediction of genes based on coexpression 
networks; this strategy can be complemented with the integration of 
additional genomic data sources. For instance, sets of coexpressed genes 
usually are scrutinized for functional enrichments using Gene Ontology (GO) 
(Ashburner, Ball et al. 2000). In the same manner, in coexpression networks, 
cis-regulatory elements analysis can facilitate the detection of direct versus 
indirect regulatory interactions (Vandepoele, Quimbaya et al. 2009). Recently, 
it was shown that the discovery of pathways and regulatory networks which 
perturbation contributes to the neoplastic transformation can be efficiently 
extracted combining global gene expression profiles and cis-regulatory 
elements searching (Goodarzi, Elemento et al. 2009). 
 
Using Arabidopsis thaliana as a model, we were able to demonstrate that in 
this plant, coexpression alone performs poorly to infer known biological gene 
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functions given that in a majority of biological processes, many known GO 
associations cannot be deduced from the coexpression network (Vandepoele, 
Quimbaya et al. 2009). Here, to improve the predictive power of the 
coexpression networks, generating a reliable platform for the detection of 
novel-conserved cell cycle regulators, an integrative strategy compiled 
different informative sources was created. 
 
Different facts argue in favour of our list of new cell cycle regulators to hold 
important elements in the mammalian cell cycle. First, known proliferation 
genes populate our list of 339 candidate genes, encoding cell division control 
proteins, replication proteins, repair proteins and previously characterized 
oncogenes (Table 3). These genes can be considered as positive controls for 
our approach. Similarly, there is an important overlap in the set of orthologous 
genes that have evolutionarily conserved specific E2F binding sites (Table 4), 
clearly indicating that the transcriptional regulation for these sets of 
orthologues must be also conserved (Bracken, Ciro et al. 2004; Jensen, 
Jensen et al. 2006). As was stated in the previous chapter, it has been 
demonstrated that an altered RB-E2F pathway is one of the most important 
events that lead to tumorigenesis and cancer (Sherr and McCormick 2002; 
Chen, Tsai et al. 2009; Goodarzi, Elemento et al. 2009) and thus, genes that 
contain E2F responsive elements can be erroneously activated or deactivated 
upon RB-E2F pathway misregulation, typical from cancer cells. These 
arguments suggest that the novel candidate genes, which have not been 
associated before with carcinogenic events, might be considered as new cell 
cycle regulators with potential oncogenic activity. 
 
Table 3. In our final list of candidate genes (339 genes) it is possible to find pairs of 
orthologous genes between plants and humans that have been associated with specific 
cell division processes in both genomes.  
Functional Category Associated Genes 
Cell division control CDC6(AT1G07270), CDC7(AT4G16970), CDC27(AT2G20000), CDC45(AT3G25100) 
and RB(AT3G12280) 
DNA replication MCM2(AT1G44900), MCM3(AT5G46280), MCM4(AT2G16440), MCM5(AT2G07690), 
MCM7(AT4G02060), MCM8(AT3G09660), MCM9(AT2G14050), 
MCM10(AT2G20980), ORC1L(AT2G29680), ORC2L(AT2G37560), 
ORC3L(AT5G16690), ORC5L(AT4G29910), ORC6L(AT1G26840) and 
PCNA(AT1G07370) 
DNA repair WEE1(AT1G02970), PARP1(AT2G31320), RAD50(AT2G31970), 
RAD51C(AT2G45280), RAD9A(AT3G05480), RAD54B(AT3G19210), 
PMS2(AT4G02460), MLH1(AT4G09140), DDB1(AT4G21100), 
MRE11A(AT5G54260), FANCD2(AT4G14970) and FANCI (AT5G49110) 
Chromosome structure TPX2(AT1G03780), SMC2(AT3G47460), SMC5(AT5G15920), SMC6(AT5G07660), 
NCAPD2(AT3G57060) and NCAPG(AT5G37630) 
Oncogenes BARD1(AT1G04010), BRIP1(AT1G20720), API5(AT2G34040), ESPL1(AT4G22970) 
and TP53RK(AT5G26110) 
In parenthesis, the Arabidopsis orthologue of the human gene that is specified. 
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Some of the genes found in the present study might not fit the classical 
picture of tumor suppressors or oncogenes at first sight, like those related to 
ribosomes and ribogenesis (such as AT2G28450, AT3G02220 and AT3G49990 
genes, orthologues of the human genes TRMT2A, C9ORF85 and LTV1, 
respectively). Ribosomal proteins are ubiquitous and abundantly present; 
mostly regarded as constants in the cell. About 80 proteins have been 
reported to be part of the ribosomes and many more are involved in their 
biogenesis and assembly. However, recent data showed that some of these 
proteins appear to have extra-ribosomal functions (Lindstrom 2009; Warner 
and McIntosh 2009), and some are even linked to cancer (Lai and Xu 2007; 
Leontieva and Ionov 2009).The imbalance of ribosomal subunits leads to p53 
activation and apoptosis (Warner and McIntosh 2009). Additionally, in recent 
years, drugs that disrupt ribosome production such as rapamycin have been 
applied successfully to the treatment of cancer. As cell division requires the 
synthesis of a large amount of proteins, deregulation of ribosome biogenesis 
emerges as a novel strategy to control abnormal cell proliferation, given that 
without protein synthesis machinery that could cope with an altered DNA 
replication process, no division can occur. The best example for this, is that 
inactivation of SSF1 (orthologue of AT5G61770), involved in ribosome 
synthesis, leads to loss of contact inhibition. 
 
Recently, a change in cancer treatment has been suggested, targeting genes 
on which the oncogenes relay instead of the oncogenes themselves. A shRNA- 
screening, using cells carrying a mutated form of RAS, reveled a multiple 
synthetic lethal phenotype (Luo, Emanuele et al. 2009). These genes were not 
previously suspected to be involved in cancer, more interestingly; the 
functional categories that these genes showed overlap with the functional 
annotation of our list of genes, representing ribosome biogenesis, protein 
modification and splicing a major fraction. Similarly, comparing the data of a 
cancer genes census (Puente, Velasco et al. 2006), and the most 
representative GO categories of the candidate genes here described, showed a 
highly similar but not identical picture, wherein all the GO categories are 
represented, although at an altered relative abundance (Figure 7). 
 
Table 4. Pairs of orthologous genes between plants and humans that have conserved 
E2F-cis-regulatory elements for both orthologues. Analysis based on Bracken, 2004 
and Jensen 2005. 
Functional Category Associated Genes 
Cell division control CDC6(AT1G07270), CDC7(AT4G16970), CDC45(AT3G25100) and RB(AT3G12280) 
DNA replication MCM2(AT1G44900), MCM3(AT5G46280), MCM4(AT2G16440), MCM5(AT2G07690), 
MCM7(AT4G02060), ORC1L(AT2G29680), ORC3L(AT5G16690), 
ORC6L(AT1G26840), POLA1(AT5G67100), POLA2(AT1G67630), 
POLD1(AT5G63960), RFC4(AT1G21690) and PCNA(AT1G07370) 
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DNA repair RAD50(AT2G31970), RAD51C(AT2G45280), RAD54B(AT3G19210), 
MLH1(AT4G09140) and FANCD2(AT4G14970)  
Chromosome structure NCAPD2(AT3G57060) and NCAPG(AT5G37630) 
Oncogenes BARD1(AT1G04010) and BRIP1(AT1G20720 
Unknown function PSMC3IP(AT1G13330), PPP5C(AT2G42810), TRMT6(AT2G45730), 
NUP35(AT3G16310), USP5(AT3G20630), OSGEPL1(AT4G22720), 
KRR1(AT5G08420), RQCD1(AT5G12980) and TIMELESS(AT5G52910) 
In parenthesis, the Arabidopsis orthologue (AGI code) of the human gene that is 
specified. 
 
In the following chapters, our goal will be to demonstrate that some of the 
genes detected by our integrative approach, which have not been related 
before either with cell cycle-related processes or with carcinogenic events, are 
indeed involved with DNA replication or DNA repair mechanisms. For doing so, 
we developed also and experimental strategy based on the analysis of T-DNA 
insertion mutant lines in Arabidopsis and in the analysis of specific cell lines 
subjected to siRNA procedures in human cell cultures. The results that will be 
described in the following chapters show that the systemic approach described 
here is useful in order to capture and retain relevant new conserved molecules 
that might play a fundamental role during carcinogenic events. 
 
 
Figure 7. Comparison between the data of a cancer genes census, reported by 
Puente, et al and the most representative GO categories of the candidate genes 
described in the present study. Strikingly, a highly similar but not identical picture can 
be appreciated, in which all the GO categories described by Puente are represented in 
our study, although in some cases the proportion of genes within the specific category 
is not the same. 
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2.4. Materials and Methods 
Arabidopsis microarray expression data analysis and clustering 
Microarray data were retrieved from the NASC transcriptomics service 
(Craigon, James et al. 2004). Based on the Affymetrix ATH1 array, 20,777 
Arabidopsis thaliana genes were analyzed using 213 microarray CEL files 
covering different tissues and under different experimental conditions 
(Appendix D). Raw data were background corrected and normalized using RMA 
(Irizarry, Hobbs et al. 2003) and a custom-made CDF. This high-quality CDF 
file was built using selected reporter probes that have perfect sequence 
identity with a single target transcript (Casneuf, De Bodt et al. 2006). 
Reporters that hybridized with one mismatch to another gene’s transcript were 
filtered out, as well as reverse complementary matching reporters and 
reporters that hybridized multiple times on the genomic sequence. The mean 
intensity value was calculated for the replicated slides. 
 
To detect coexpressed genes, all 20,777 Arabidopsis genes were used as seed 
to detect coexpression neighbourhoods using the complete expression 
compendium. The Pearson correlation coefficient (PCC) was calculated for each 
pair of genes within the data set, generating a 20,777 X 20,777 data matrix.  
For all the pair-wise comparisons, a significance value of coexpression 
between the compared genes was established. This threshold was calculated 
as follows: based on the similarity between expression profiles for 1,000 
random genes a PCC threshold of 0.56 corresponding with the 95th percentile 
of this random distribution was used to detect coexpressed genes. 
 
Gene Ontology associations 
Gene Ontology associations for Arabidopsis proteins were retrieved from TAIR 
(Poole 2007) and for human proteins were retrieved from AmiGO (Carbon, 
Ireland et al. 2009). The assignments of genes to the original GO categories 
were extended to include parental terms (i.e. a gene assigned to a given 
category was automatically assigned to all the parent categories as well). 
Enrichment values for the GO terms “DNA repair” (GO0006281) and DNA 
“replication” (GO0006260) for both Arabidopsis and Homo sapiens were 
calculated as the ratio of the relative occurrence in a set of genes 
(coexpression neighbourhood) to the relative occurrence in the genome. The 
statistical significance of the functional enrichment within sets of genes was 
evaluated using the hypergeometric distribution adjusted by the Bonferroni 
correction for multiple hypotheses testing. Corrected P-values smaller than 
0.05 were considered as significant. 
 
Cis-regulatory elements detection 
One-Kb promoter regions of the set of genes significantly enriched for the 
terms DNA repair and/or DNA replication were scanned for the presence of an 
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E2F binding site using a Positional Weight Matrix with as consensus sequence 
TTTssCGC (based on a set of E2F-upregulated genes (Vandepoele, Vlieghe et 
al. 2005)). E2F motif instances were identified with MotifLocator using a 
threshold of 0.95 (Thijs, Marchal et al. 2002). 
 
Detection of orthologous genes 
Orthologous genes between Arabidopsis and Homo sapiens were identified 
using the OrthoMCL-DB (Chen, Mackey et al. 2006), a comparative genomics 
resource hosting orthologous families based on protein clustering. Starting 
from the selected Arabidopsis genes, the corresponding orthologous gene 
families were retrieved and evaluated using phylogenetic inference. For each 
family protein sequences were aligned using MUSCLE (Edgar 2004) and a 
Neighbor-Joining phylogenetic tree was constructed using TREECON (Van de 
Peer and De Wachter 1994) with the Poisson Correction for evolutionary 
distance calculation. Highly supported nodes (bootstrap support >90%) 
indicating the speciation between plants and mammals were used to identify 
orthologous genes and copy numbers. 
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2.5. Supplementary information 
 
Figure S1. Some of the phylogenetic trees that were constructed in order to validate 
the orthology relationships that were found by means of OrthoMCL database 
comparisons. Highlighted in green the Arabidopsis gene and in blue the corresponding 
human orthologue. 
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3.1. Introduction 
For vegetative plant cells, two different cell cycle forms can be distinguished. 
One is the canonical mitotic cell cycle that encompasses the duplication and 
subsequent distribution of chromosomes between two daughter cells. The 
other is known as the endoreduplication cycle or the endocycle, and occurs in 
response to a variety of physiological signals and developmental cues. The 
endocycle involves repetitive chromosomal DNA replication without intervening 
mitosis or cytokinesis, leading to an increment in the ploidy level (Brodsky and 
Uryvaeva 1977) (Figure 8A). Endoreduplication is the most common mode of 
polyploidization in plants and can be found in many cell types, often being 
tightly linked with cells undergoing differentiation and expansion processes, 
suggesting, that this alternative cell cycle is developmentally regulated 
(Joubes and Chevalier 2000). 
 
As the leaf grows, its cells progressively shift from a dividing mode to a phase 
during which they exit their cell cycle program and start expanding and 
differentiating (Figure 8B). In Arabidopsis this differentiation phase is 
correlated with the onset of endoreduplication (De Veylder, Beeckman et al. 
2002; Boudolf, Vlieghe et al. 2004; Vlieghe, Boudolf et al. 2005). The 
molecular switch to go from normal replication cycles into the endocycle has 
started to be understood; as expected, key cell cycle regulators are involved. 
Some examples of this cell cycle regulators with a specific role during 
endoreduplication onset are the RB protein (Park, Ahn et al. 2005), some E2F-
DP transcription factors (De Veylder, Beeckman et al. 2002; del Pozo, Diaz-
Trivino et al. 2006) and the CDC6 replication factor (Castellano, del Pozo et al. 
2001). But seemly one of the most important events during the endocycle’s 
activation is the reduction in the activity of mitotic CDKs. In plants this can be 
achieved by the induction of CDK inhibitors like KRP2 (De Veylder, Beeckman 
et al. 2001; Verkest, Manes et al. 2005). Interestingly, in humans, the 
differentiation process from trophoblast stem cells to mature trophoblast giant 
cells, the only cell type that in humans is undergoing endoreduplication cycles, 
is also achieved by the repression of the CDK activity by the induction of the 
orthologous gene of the Arabidopsis KRP2 gene (p57/Kip2)(Ullah, Kohn et al. 
2008). 
 
Given that mutations on cell cycle regulators directly affect the balance 
between replication and endoreduplication, it is logically expected that novel 
genes directly implicated in the control and regulation of cell cycle, affect the 
normal developmental scheme of the plant, temporally translocating the 
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replication-endoreduplication balance. Thus, mutations that affect the 
endoreduplication index (EI), being the mean number of endoreduplication 
cycles of the leaf, are indicative for a change in the timing of differentiation, 
with a decreased or an increased EI reflecting a delayed or premature cell 
cycle exit, respectively. These phenotypic changes can be addressed by using 
flow cytometric techniques in specific days during leaf development. Similarly, 
it has been suggested that a direct link exist between the activation of the 
endocycle and the cell size. It has been shown that endoreduplication 
frequently correlates with an increased cell size (Melaragno, Mehrotra et al. 
1993). Therefore, changes in the DNA content due to an altered timing of 
endocycle induction and cell differentiation should affect the total leaf cell 
number and cell size distribution, and consequently, a delayed or premature 
onset of cell differentiation, often correlates with smaller or bigger cells, 
respectively. 
 
Regarding DNA damage, as our screening method involved a selection of 
genes displaying a significant enrichment of molecules involved in DNA repair 
among its coexpressed neighbors (see chapter II), the experimental validation 
of our integrative approach should involve appropriate experiments in order to 
link some of our target genes with specific DNA-stress responses. For doing 
so, Arabidopsis plants were tested for hypersensitivity towards DNA replication 
inhibiting stress treatments, including UV-B (UV) radiation and hydroxyurea 
(HU) treatment. UV-B radiation results into dimerization of adjacent 
pyrimidine bases, inhibiting replication and transcription, eventually causing a 
growth delay. Similarly, HU treatment blocks replication forks due to the 
generation of double strands breaks that in turn activate the DNA-damage 
checkpoints, halting the progression through the cell cycle, causing a severe 
growth inhibition (Culligan, Tissier et al. 2004). 
 
With the experimental approach that is described in this chapter, we want to 
prove, that some of the novel plant genes selected by means of the previously 
described integrative approach are associated with specific Arabidopsis cell 
cycle events, having a direct influence in the replication-endoreduplication 
balance of the plant, and because of this, having a direct influence in the 
amount of cells and cell sizes of the developing leaf. Similarly, the DNA-stress 
response experiments are aiming to detect new molecules associated with this 
process in Arabidopsis. 
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Figure 8. A. Schematic representation of the mitotic cell cycle and the commonly 
diversified in plants alternative cycle, the endocycle. Note that as a consequence of 
skipping M-phase during the endocycle, cells become polyploidy. This has a direct 
effect on both nuclear size and cellular size (Modified from Gutierrez, 2009). B. As the 
leaf grows during time, its cells progressively shift from a dividing mode to a phase 
during which they exit their cell cycle program and start to expand, this cell expansion 
phase is developmentally regulated and correlates with the onset of endoreduplication 
(Modified from Boudolf, 2004). 
 
3.2. Results 
To experimentally validate in Arabidopsis thaliana a subset of the previously 
identified novel cell cycle regulators (Appendix C), we screened for potential 
Arabidopsis knock-out lines in the available T-DNA insertion collections 
(http://signal.salk.edu/cgi-bin/tdnaexpress). A total of 40 genes were selected 
according to the availability of T-DNA insertion lines, harboring the 
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corresponding T-DNA insertion in-between the translational start and stop 
codons, either in an intron or in an exon (Table 5). Afterwards, homozygous 
lines were selected for all the mutant lines (see materials and methods in this 
section) and their respective transcripts were quantified using Q-PCR (Figure 
9).  
 
Table 5. List of genes selected for downstream experimental validation. 
Arabidopsis Line TAIR Annotation SALK Line HUGO 
AT1G01940 F22M8.7 061120.53.75.X-Intronic PPIL3 
AT1G03110 TRM82 025857.27.50.X-Exonic WDR4 
AT1G03530 ATNAF1 013589.53.50.X-Exonic NAF1 
AT1G04020 ATBARD1 031862.53.75.X-Exonic BARD1 
AT1G06590 F12K11.7 024997.29.40.X-Intronic ANAPC5 
AT1G08410 T27G7.9 119395.38.15.X-Exonic LSG1 
AT1G10490 T10O24.10 070262.56.00.X-Intronic NAT10 
AT1G13330 AHP2 136002.41.85.X-Exonic PSMC3IP 
AT1G49540 ATELP2 106485.50.75.X-Intronic ELP2-STATIP1 
AT1G72320 APUM23 052992.53.50.X-Intronic C14ORF21 
AT1G74150 F9E11.8 088010.26.55.X-Exonic KHLDC3 
AT1G76260 DWA2 143341.50.65.X-Exonic TSSC1 
AT2G15790 CYCLOPHILIN 40 033511.51.20.X-Intronic PPID 
AT2G19430 ATTHO6 051022.41.15.X-Exonic THOC6 
AT2G28450 T1B3.3 039998.52.40.X-Exonic TRMT2A 
AT2G40550 ETG1 145460.18.05.X-Exonic MCMBP 
AT2G34260 F13P17.10 063054.55.75.X-Intronic WDR55 
AT3G02220 F14P3.13 028532.34.35.X-Exonic C9ORF85 
AT3G07050 F17A9.21 099852.47.75.X-Exonic GNL3 
AT3G26410 ATTRM11 122158.32.05.X-Exonic TRMT11 
AT3G42660 T12K4.110 052512.12.95.X-Exonic WDHD1 
AT3G49990 F3A4.70 090801.18.60.X-Exonic LTV1 
AT3G55160 T26I12.40 006621.56.00.X-Exonic THADA 
AT3G56990 EDA7 098429.45.45.X-Exonic NOL10 
AT3G60660 T4C21.70 041743.49.40.X-Exonic C18ORF24-SKA1 
AT4G00850 GIF3 052744.30.10.X-Exonic SS18 
AT4G01270 F2N1.19 056467.55.00.X-Exonic TRAIP 
AT4G07410 F28D6.14 022607.45.25.X-Exonic CIRH1A 
AT4G15890 DL3985W 094776.23.50.X-Intronic NCAPD3 
AT4G20350 F9F13.6 138864.18.85.X-Exonic ALKBH6 
AT4G22970 AESP 037016.52.60.X-Intronic ESPL1 
AT4G35910 T19K4.40 030197.20.30.X-Intronic CTU2 
AT4G38120 F20D10.240 066582.56.00.X-Exonic HEATR6 
AT5G05660 ATNFXL2 017558.18.75.X-Exonic NFXL1 
AT5G11240 F2I11.130 052897.39.70.X-Exonic WDR43 
AT5G14600 T15N1.90 024680.34.10.X-Exonic TRMT61B 
AT5G22370 EMB1705 059852.56.00.X-Intronic GPN2 
AT5G40530 MNF13.4 102154.30.95.X-Intronic RRP8 
AT5G49110 K20J1.8 055483.52.00.X-Exonic FANCI 
AT5G61770 PAN-LIKE 088929.56.00.X-Exonic PPAN 
HUGO: Gene nomenclature, Homo sapiens official symbol. 
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Figure 9. Q-PCR transcripts quantification of the T-DNA insertion mutant lines 
described in the present chapter. Expression values are given as a relative 
measurement in comparison with wild-type Col-0 set up as one for all the measured 
transcripts. The values represent three biological repeats; each one conformed by 
three technical repeats. Error bars, represent the SD. +/- represents hemizygous 
lines. 
 
Homozygous T-DNA insertion lines could be identified for all, except for three 
genes (AT1G06590, AT4G07410 and AT5G22370), indicating that their 
deficiency was embryonically lethal. Indeed, when the siliques of the 
hemizygous lines were analyzed in detail, one quarter of the embryos were 
found to be aborted, indicative for an embryo lethal phenotype (P-value < 
0.01 according to the statistical χ2 test), and suggesting that the proteins that 
these three genes encode are essential for embryogenesis (Figure 10). 
 
For the available homozygous insertion lines, cell division and DNA replication 
parameters were determined for the first developed leaf pair harvested at 
maturity (three weeks after sowing). As was mentioned previously, the first 
leaf serves as an excellent model system for studying cell division and DNA 
replication parameters. 
 
Endoreduplication index measurements (EI) indicated a shift in DNA ploidy 
distribution for 15 of the 40 knock-out lines (37 homozygous knock-outs and 
the 3 hemizygous mutants) (Figure 12A). Due to a decrease in their 8C and 
16C DNA content the EI in five mutant lines was lower than that in wild-type 
plants, whereas for 10 knockout lines it was higher (Table 6 and Figure S2). 
Interestingly, although the mutant line AT1G72320 (APUM23) showed an EI 
being almost identical to that of the control plants, it displayed a totally 
different DNA ploidy distribution (Figure 13), which indicates that proliferation 
in this line was both stimulated and inhibited. 
Chapter III 
 
52 
 
 
Figure 10. Siliques of the analyzed hemizygous T-DNA insertion lines (+/-). Aborted 
seeds are indicated by arrowheads and compared with control seeds (Col-0). The 
number of aborted seeds was correlated with the proportion of expected homozygous 
seeds, being significant according to the χ2 statistical test. 
 
Table 6. Analyses of endoreduplication index (EI), pavement cell size, cell number 
and cell density in the first developed leaf pair of the studied T-DNA insertion mutants. 
Line EI 
Average leaf 
area (mm2) 
Average cell 
size (µm2) 
Leaf cell 
density 
Pavement cell 
per leaf 
Col-0 129.6 28.2 1,976 320 9,040 
AT1G06590+/- 101.1 23.0 1,380 559 12,864 
AT1G49540 113.9 38.7 1,537 332 12,850 
AT1G72320 131.8 17.9 2,409 258 4,626 
AT1G74150 124.3 20.1 1,643 347 6,987 
AT2G19430 144.9 27.0 2,252 270 7,289 
AT2G40550 141.6 21.5 2,819 309 6,651 
AT3G02220 138.9 40.0 2,165 223 8,937 
AT3G26410 142.9 33.0 2,816 241 7,939 
AT3G49990 143.9 26.4 2,419 208 5,499 
AT3G55160 138.7 29.9 2,569 204 6,110 
AT3G60660 149.6 26.6 2,651 165 4,376 
AT4G07410+/- 115.6 18.3 1,524 398 7,286 
AT4G38120 137.0 30.1 2,020 377 11,359 
AT5G22370+/- 110.4 29.1 1,387 550 16,016 
AT5G49110 151.4 26.2 2,498 203 5,320 
+/- Hemizygous lines. 
Leaf cell density: Number of cells per mm2 
 
As was stated in the introduction of the present chapter, changes in the DNA 
content due to an altered timing of cell differentiation and endocyle induction 
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should affect the total leaf cell number and cell size distribution. Therefore, a 
cell number and cell size distribution analysis was performed for the leaf 
epidermal cells of the studied T-DNA lines (Figure 11). When the average cell 
numbers and cell sizes were plotted, two main subgroups of mutants could be 
recognized: one characterized by more but smaller cells and one with less but 
larger cells, than those of the wild-type plants (Figure 12B). According to the 
flow cytometric measurements, a subgroup of mutant lines in the first group 
had a reduced EI (green dots), showing that the differences at the DNA ploidy 
level were originated from enhanced cell proliferation or delayed cell 
differentiation. Conversely, the other subgroup of mutants comprised plants 
displaying an increased DNA ploidy content (red dots), indicative for 
premature cell cycle exit. The data were substantiated by cell size distribution 
analysis, with those mutants showing a decreased EI exhibiting an increased 
subpopulation of small cells, in comparison with controls. Reversely, those 
mutants that displayed an increased EI showed enrichment for enlarged cells 
(Figure 13). The mutant line AT1G72320 showed both an increase in the 
population of small and large cells, hinting again at a dual effect of this gene 
on cell proliferation. 
 
Figure 11. The figure shows leaf epidermal images from three of the mutants that 
were associated experimentally with specific cell cycle events in comparison with wild-
type plants. At the bottom side of each picture the average cell number per mm2 is 
shown; next to it, between parentheses the average cell size in µm2 is depicted. These 
measurements were used for the cell number and cell size distribution analysis 
described in the present chapter. As is mentioned in the text, the mutant line 
AT1G49540 has more and smaller cells than the control. Contrastingly, in comparison 
with Columbia, the mutant line AT3G26410 has less and bigger cells. The mutant line 
AT1G72320 has severe growth and developmental problems, which are representative 
of a highly deregulated cell cycle, producing the aberrant cells that can be seen in the 
figure. 
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Figure 12. A. Endoreduplication Index (EI) of T-DNA insertion lines in comparison 
with controls (*Statistical different from the control (Col-0) plants according to the t-
Test P-value < 0.05 (n=10); +/- represents hemizygous mutants). B. Scatter plot of 
the analyzed mutants.  Mutants were plotted according to their respective number of 
cells and cell size. Mutant lines are color-coded according to their DNA ploidy content 
phenotype. Green and red dots represent mutants with a reduced and increased EI, 
respectively.  Dotted in black are the control (Col-0) and the mutant line AT1G72320 
in which both processes, replication and endoreduplication are enhanced. 
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Figure 13. Cell size distributions of pavement cells in Col-0 and the analyzed T-DNA 
insertion lines. S, M, L and XL cells represent cells with a surface between 1 and 200 
µm2, 201 and 700 µm2, 701 to 3000 µm2 and 3001 to 10000 µm2 respectively. 
 
In order to select genes with a putative function on DNA-stress response, the 
knock-out lines were tested for hypersensitivity towards DNA replication 
inhibiting stress treatments, including UV-B (UV) radiation and hydroxyurea 
(HU) treatment. DNA damage was measured by comparing root growth under 
control and DNA-damaging growth conditions (see materials and methods in 
this section). Without any DNA stress treatment, the mutants ATG06590+/-, 
AT1G49540 (ATELP2), AT1G72320 (APUM23), AT2G40550 (ETG1), 
AT3G55160, and AT3G60660, showed a significant root growth reduction (P-
value < 0.01 according to Student’s t-Test), when compared to wild type Col-0 
plants, displaying at 7 days after germination 35%, 46%, 67%, 23%, 33% 
and 44% of growth reduction, respectively. Conversely, the mutants 
AT4G07410+/- and AT5G22370+/- showed a significant increase in root 
growth (Figure 14A). Wild-type plants were not hypersensitive towards UV-B 
(1.9 W/m2). By contrast, for the lines AT1G01940 and AT1G04020, a clear 
growth inhibition was observed 72 hours after the treatment (Figure 14B). 
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Similarly, these two mutants displayed a root growth inhibition stronger than 
that observed for the wild-type plants when treated with 1 mM HU for 7 days 
(Figure 14C). 
 
 
Figure 14. A. Root length under standard growth conditions for the analyzed T-DNA 
insertion lines. Root growth was monitored and measured after seven days on vertical 
MS plates. B and C. Mutants displaying a differential root growth response upon UV 
irradiation (B) or in the presence of 1mM HU (C) (*Statistical different form the 
control (Col-0) plants according to the t-Test P-value <0.05 (n=30); +/- represents 
hemizygous mutants). 
 
3.3. Discussion 
In this study, we have compiled different information sources (coexpression 
networks, GO enrichment analysis, cis-regulatory elements and phylogenetic 
analysis) in order to create a reliable platform for the detection of novel-
conserved cell cycle regulators for plants and humans. To determine the 
success rate of our integrative approach, we randomly selected 11 T-DNA 
insertion lines as negative controls. Subsequently, homozygous lines were 
selected and flow cytometry experiments were carried out. For only one line 
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(AT5G46160) the DNA ploidy distribution profile differed significantly from the 
control (Figure 15), generating an identification rate of mutants possibly 
involved in replication events of 9%. In contrast, out of 40 plant candidate 
genes selected for downstream functional analysis, 15 were experimentally 
proven to affect cell proliferation, two could be related with DNA stress-
response, and three genes interfered with embryogenesis. Overall, 20 out of 
40 analyzed mutants displayed a cell proliferation or a DNA damage associated 
phenotype, representing a success rate being 5.5-fold higher compared to the 
random approach.This means that our systemic strategy is highly efficient 
retaining genes involved in specific cell cycle processes and suggests that the 
mutants here described are indeed, new cell cycle regulators for plants, 
although, further experimental investigation is necessary in order to identify 
the molecular function that these genes are carrying out in Arabidopsis cells, 
and in order to clarify how are these putative molecular functions linked with 
cell cycle progression.  
 
 
Figure 15. Flow cytometry DNA profiles of Col-0 and 11 randomly selected T-DNA 
insertion lines. No significant changes were observed when compared to control plants 
(Col-0), with exception for the T-DNA insertion line of the AT5G46160 gene. 
 
Another argument to validate the list of genes presented here as novel cell 
cycle regulators, is that besides the functional GO enrichment for DNA 
replication and/or DNA repair, there are also some other GO categories related 
with cell cycle progression and development for which our genes are enriched; 
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strikingly, some of these categories are evolutionarily conserved between 
Arabidopsis and humans (Table 7). 
 
Table 7. According to their respective coexpression neighborhoods, the candidate 
genes that experimentally displayed specific cell cycle-related phenotypes are also 
enriched for different GO categories associated with cell cycle control. In some cases 
these enrichments are evolutionarily conserved for their respective orthologous genes 
in humans. 
Line GO Category 
GO 
Enrichment 
Human 
Orthologue 
GO Category 
Go 
Enrichment 
AT1G01940 
Response to 
stress  
6.0XE-3 PPIL3 Translation 4.4XE-11 
AT1G04020 Cell cycle control 3.8XE-10 BARD1 Cell cycle control 6.7 XE-65 
AT1G06590+/- Cell cycle control 9.4XE-12 APC5 Cell cycle control 8.3XE-6 
AT1G49540 RNA processing 2.4XE-4 STATIP1 RNA processing 6.4XE-4 
AT1G72320 
Ribosome 
biogenesis 
1.8XE-6 C14ORF21 tRNA processing 7.24XE-4 
AT1G74150 Cell cycle control 1.4XE-4 KLHDC3 M-phase control 4.5XE-3 
AT2G19430 Cell cycle control 1.4XE-4 THOC6 Cell cycle control 1.5XE-3 
AT2G40550 Cell cycle control 5.5XE-7 MCMBP Cell cycle control 2.7XE-7 
AT3G02220 
Transcription 
regulation 
4.9XE-18 C9ORF85 G-Protein signaling 1.3XE-4 
AT3G26410 RNA processing 6.2XE-6 TRMT11 RNA processing 7.6XE-12 
AT3G49990 
Ribosome 
assembly 
3.4XE-18 LTV1 Ribosome assembly 1.2XE-26 
AT3G55160 
Response to 
stress 
1.9XE-4 THADA Response to stress 0.055 
AT3G60660 
Chromatin 
modeling 
2.8XE-7 SKA1 
Chromosome 
segregation 
1.8XE-22 
AT4G07410+/- 
Ribosome 
biogenesis 
2.3XE-12 CIRH1A RNA processing 5.5XE-12 
AT4G38120 
Transcription 
regulation 
1.5XE-5 HEATR6 
Transcription 
regulation 
1.2XE-8 
AT5G22370+/- 
Ribosome 
biogenesis 
3.2XE-20 GPN2 RNA processing 2.3XE-65 
AT5G49110 Ubiquitination 9.2XE-4 FANCI 
DNA damage stress 
response 
4.1XE-30 
GO enrichments are defined by significant P-values obtained by the calculation of 
thehypergeometric distribution. 
 
According to TAIR website (Huala, Dickerman et al. 2001), most of the 
Arabidopsis genes here reported, lack a functional annotation, which makes of 
this study the first research providing functional evidence that these genes are 
related with cell cycle processes. Nevertheless, in some cases, during the 
progression of this study some reports appeared, linking some of these genes 
with specific molecular functions. Next, some examples are given connecting 
the newly inferred molecular function of those genes with their possible 
relation with cell cycle progression.  
 
The AT1G49540 (ELP2)gene, which is part of the hexameric Elongator complex 
in both Arabidopsis and human, controls the recruitment of the RNA 
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polymerase II (RNAPII) enzyme during transcription initiation and its passage 
along the template during transcription elongation. The Elongator complex has 
been implicated in a wide range of phenomena: RNAPII transcriptional 
elongation, polarized exocytosis and histone-acetyl-transferase activity among 
others (Versees, De Groeve et al. 2010). It has been shown that some elo-
knocked-down mutants (ELO1, ELO2 and ELO3) are characterized by narrow 
leaves and reduced root growth that results from a decreased cell division rate 
(Nelissen, Fleury et al. 2005). Contrastingly, here we showed that a knock-
down of the ELP2 gene produces an enhanced cell proliferation, which in turn, 
as a consequence, produces plants with more cells than control plants (Table 6 
and Figure 11). This observation suggests that ELP2 might function as a 
repressor subunit of the complex and due to this, a deregulated ELP2 can 
trigger the early induction of the complex, generating plants with much more 
cells. This observation is in agreement with the phenotype observed by flow 
cytometry in plants overexpressing ELP2, in which a higher endureduplication 
activity is observed (Figure 16). 
 
 
Figure 16. Flow cytometry profiles of the mutant line AT1G49540-ELP2. One knock-
down line (KD) and two overexpressing lines (OE1 and OE2) are compared with Col-0. 
The numbers above each peak represent the percentage of cells that belong to the 
specified ploidy class. According to the profiles, in the knock-down mutant, normal 
replication cycles are enhanced as the percentage of cells with 4C DNA content is 
higher in comparison with control plants. Contrastingly, in both overexpressing lines, 
the endoreduplication cycles are increased given that the percentages of cell with 16C 
and 32C DNA content are higher than in the control Col-0. Values presented are the 
mean of two biological repeats, each of them formed by three technical repeats. 
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In all domains of life, transfer RNA (tRNA) molecules contain modified 
nucleosides. Modifications to tRNAs affect their coding capacity and influence 
codon-anticodon interactions. Nucleoside modification deficiencies have a 
diverse range of effects, from decreased virulence in bacteria, neural system 
disease in human, and gene expression and stress response changes in plants 
(de Crecy-Lagard 2007). The gene AT3G26410 (ATTRM11) codifies a tRNA-
modifying-enzyme and upon mutation, the knocked-down plants exhibited an 
early-flowering phenotype. Interestingly the knock-down of a different gene 
involved in tRNA modification (ATELP1), produced plants with narrow leaves 
and reduced root growth (Chen, Jager et al. 2010). This suggests that a 
deregulation in the pathway that originates tRNA molecules can have serious 
implication on cell cycle progression and plant development. Similarly, the 
gene AT2G19430 (ATTHO6) encodes a component of the putative Arabidopsis 
THO/TREX complex. In animals, this complex has been implicated in the 
transport of mRNA precursors. In Arabidopsis, mutants of THO6 accumulate 
reduced amounts of small interfering RNA (siRNA), suggesting a role of the 
Arabidopsis THO/TREX complex in siRNA biosynthesis (Yelina, Smith et al. 
2010). Given that siRNAs have a major role during plant development and cell 
cycle progression (Chen 2009), a disruption into the siRNA biosynthetic 
pathway can explain why our Arabidopsis THO6 mutants have and altered 
developmental balance between replication and endoreduplication cycles. 
 
It has been shown, that the APC/C complex is one of the most important units 
regulating the transition from the normal replication cycles to the endocycle. 
The APC targets mitotic cyclins for ubiquitin-dependent degradation, reducing 
their levels and driving the cells into the endoreduplication cycle (Marrocco, 
Bergdoll et al. 2010).  The results presented here showed that the nullizygous 
mutants for the subunit 5 of the APC (AT1G06590 mutant) are lethal, 
illustrating the importance of this complex for plant survival. Similarly, 
heterozygous plants, showed a 50% reduction in the transcript of the gene 
(Figure 9). Nevertheless, in AT1G06590+/- plants, there is an induction of a 
hyper-proliferative state as a consequence of a delay in the endocycle 
induction, probably due to a poor degradation of the mitotic cyclins by the 
APC. These results confirm the fundamental role of the APC in the endocycle 
onset.  
 
Regarding the DNA damage experiments described here, two genes were 
detected as new elements in the DNA-damage-response pathway. The first 
one is the AT1G04020 (ATBARD1) gene, which is the plant orthologue of the 
well-studied mammalian Breast-Cancer-Protein Associated RING Domain 
Protein 1 gene (BARD1), involved in DNA repair. Recently, it was 
demonstrated that this gene control DNA repair in plants as well (Reidt, Wurz 
et al. 2006). Whereas it was established that this gene is essential for 
responding to the DNA cross-linking agent mitomycin, our results revealed 
that BARD1 knocked-down plants are sensitive towards UV irradiation and HU, 
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confirming the role of this gene in DNA-repair processes.  The second one is 
the AT1G01940 (PPIL3) gene. This geneis a member of the cyclophilin family 
of peptidyl-prolyl-cis-transisomerases (PPI), which molecular function is the 
peptidyl bond flipping from cis to trans. In humans, cyclophilins are known to 
be involved in mitochondrial cell death response, HIV progression and 
inflammation (Leone, Lattanzi et al. 2009). Interestingly, in yeast some 
members of the cyclophilin family are involved in the stability and targeting of 
WEE1 to the nucleus (Goes and Martin 2001). If the same mechanism is 
conserved, in Arabidopsis PPIL3 could prevent the activity of WEE1, which 
would lead to growth defects, given that the cells would be unable of halting 
their cell cycle progression upon DNA damage. Cells would continue through 
the cell cycle with unrepaired DNA damage, probably explaining the observed 
growth phenotypes. 
 
3.4 Materials and methods 
Plant growth conditions and homozygous lines detection 
Arabidopsis thaliana ecotype Columbia-0 and the mutant plants were grown 
under long-day conditions (16 h/8 h light/darkness) at 22oC on half-strength 
Murashige and Skoog (MS) agar plates. All the insertion T-DNA lines were 
obtained from the European Arabidopsis Stock Centre (NASC). To screen for 
homozygous insertion alleles, primers were designed following the instructions 
of the Salk institute genomic analysis laboratory 
(http://signal.salk.edu/tdnaprimers.2.html). The complete list of the used 
primers for the selection of homozygous lines and for the respective Q-PCR 
transcript quantitation is detailed in the Appendix D. 
 
Characterization of embryo-lethal mutants 
Hemizygous lines for the T-DNA insertion lines AT1G06590 
(SALK_024997.29.40.X), AT4G07410 (SALK_022607.45.25.X) and 
AT5G22370 (SALK_059852.56.00.X) were identified as describe above.  At 
least 10 different plants from each hemizygous line were grown in soil until 
flowering under greenhouse conditions. Independent siliques (>10) from 
different plants were harvested and dissected. Pictures were taken using a 
Leica MZ16 stereoscope using a 5X magnification factor. The number of 
aborted seeds was correlated with the proportion of expected homozygous 
seeds; the significance of this correlation was tested using the χ2 statistical 
test. 
 
Arabidopsis flow cytometry and EI determination 
The analysed mutant lines were germinated and grown in round 12-cm Petri 
dishes filled with 100 ml of half-strength MS medium (Duchefa, Haarlem, The 
Netherlands) and 0.7% plant tissue culture agar (Lab M, Bury, UK). After 
three weeks of growing, the first developed leaf was chopped with a razor 
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blade in 200 µl of nucleus extraction solution, supplemented with 800 µl of 
staining solution (http://www.partec.com). The homogenate was filtered 
through a 30 µm mesh. The nuclei were analysed using a CyFlow cytometer 
and FloMax software (http://www.partec.com). The EI was calculated from the 
number of nuclei of each represented ploidy level multiplied by the number of 
endoreduplication cycles necessary to reach the corresponding ploidy level. 
The sum of the resulting products was divided by the total number of nuclei. 
 
Arabidopsis cell number and cell sizes analysis 
Plants were germinated and grown in round 12-cm Petri dishes filled with 100 
ml of half-strength MS medium (Duchefa, Haarlem, The Netherlands) and 
0.7% plant tissue culture agar (Lab M, Bury, UK). Three-week-old plants were 
harvested, cleared overnight in 100% ethanol, and subsequently stored in 
lactic acid for microscopy. The leaf primordia were observed under a 
microscope fitted with differential interference contrast optics (DMLB; Leica, 
Wetzlar, Germany). The total (blade) area of the first leaves of each seedling 
was determined from drawing-tube images with the public domain image 
analysis program ImageJ (version 1.30v; http://rsb.info.nih.gov/ij/). The 
primordia were digitized directly with a charge-coupled device camera 
mounted on a binocular (Stemi SV11; Zeiss, Jena, Germany). Cell density was 
determined from scanned drawing-tube images of outlines of at least 100 cells 
of the abaxial epidermis located 25% and 75% from the distance between the 
tip and the base of the leaf primordium, halfway between the midrib and the 
leaf margin. The following parameters were automatically generated by using 
in-house developed software for imaging analysis: total area of each cell in the 
drawing, total number of cells, number of guard cells and cell area of the 
guard cells. 
 
Root growth analysis and DNA damage assays 
For root growth experiments, seedlings of the different T-DNA mutant lines 
and the control plants were grown in square plates in vertical position in half-
strength MS medium containing 10 g/L plant tissue culture agar. Root growth 
was marked every 24 h during seven days on plates that were photographed. 
Root growth was determined with ImageJ software by calculating the distance 
between successive marks along the root axis. For the hydroxyurea (HU) 
treatment, the same set-up described for root growth in vertical plates was 
used, but HU was added to the MS medium to obtain a final concentration of 
1mM.  For the UV treatment T-DNA mutant lines and the control plants were 
grown in square plates in vertical position in half-strength MS medium during 
three days, the position of the root tip was marked and then plants were 
subjected to a UV treatment of 10 minutes with an intensity of 1.9 W/m2.  
Plates were wrapped and protected from the light to avoid the action of 
photolyases and after two days the root growth was measured using the 
ImageJ software. 
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Gene Ontology associations 
Gene ontology associations for the terms described in this section were 
obtained as described in chapter II. Gene Ontology associations for 
Arabidopsis proteins were retrieved from TAIR (Huala, Dickerman et al. 
2001)and for human proteins were retrieved from AmiGO (Carbon, Ireland et 
al. 2009). 
 
 
3.5. Supplementary information 
 
 
Figure S2. Flow cytometry DNA profiles of Col-0 and the analysed T-DNA insertion 
mutants. 
 
 
 
 
Chapter III 
 
64 
 
3.6. References 
 
Boudolf, V., K. Vlieghe, et al. (2004). "The plant-specific cyclin-dependent kinase 
CDKB1;1 and transcription factor E2Fa-DPa control the balance of mitotically 
dividing and endoreduplicating cells in Arabidopsis." Plant Cell16(10): 2683-
2692. 
Brodsky, W. Y. and I. V. Uryvaeva (1977). "Cell polyploidy: its relation to tissue 
growth and function." Int Rev Cytol50: 275-332. 
Carbon, S., A. Ireland, et al. (2009). "AmiGO: online access to ontology and 
annotation data." Bioinformatics25(2): 288-289. 
Castellano, M. M., J. C. del Pozo, et al. (2001). "Expression and stability of Arabidopsis 
CDC6 are associated with endoreplication." Plant Cell13(12): 2671-2686. 
Culligan, K., A. Tissier, et al. (2004). "ATR regulates a G2-phase cell-cycle checkpoint 
in Arabidopsis thaliana." Plant Cell16(5): 1091-1104. 
Chen, P., G. Jager, et al. (2010). "Transfer RNA modifications and genes for modifying 
enzymes in Arabidopsis thaliana." BMC Plant Biol10: 201. 
Chen, X. (2009). "Small RNAs and their roles in plant development." Annu Rev Cell 
Dev Biol25: 21-44. 
de Crecy-Lagard, V. (2007). "Identification of genes encoding tRNA modification 
enzymes by comparative genomics." Methods Enzymol425: 153-183. 
De Veylder, L., T. Beeckman, et al. (2002). "Control of proliferation, endoreduplication 
and differentiation by the Arabidopsis E2Fa-DPa transcription factor." Embo 
J21(6): 1360-1368. 
De Veylder, L., T. Beeckman, et al. (2001). "Functional analysis of cyclin-dependent 
kinase inhibitors of Arabidopsis." Plant Cell13(7): 1653-1668. 
del Pozo, J. C., S. Diaz-Trivino, et al. (2006). "The balance between cell division and 
endoreplication depends on E2FC-DPB, transcription factors regulated by the 
ubiquitin-SCFSKP2A pathway in Arabidopsis." Plant Cell18(9): 2224-2235. 
Goes, F. S. and J. Martin (2001). "Hsp90 chaperone complexes are required for the 
activity and stability of yeast protein kinases Mik1, Wee1 and Swe1." Eur J 
Biochem268(8): 2281-2289. 
Huala, E., A. W. Dickerman, et al. (2001). "The Arabidopsis Information Resource 
(TAIR): a comprehensive database and web-based information retrieval, 
analysis, and visualization system for a model plant." Nucleic Acids Res29(1): 
102-105. 
Joubes, J. and C. Chevalier (2000). "Endoreduplication in higher plants." Plant Mol 
Biol43(5-6): 735-745. 
Leone, V., G. Lattanzi, et al. (2009). "Mechanism of action of cyclophilin a explored by 
metadynamics simulations." PLoS Comput Biol5(3): 13. 
Marrocco, K., M. Bergdoll, et al. (2010). "Selective proteolysis sets the tempo of the 
cell cycle." Curr Opin Plant Biol13(6): 631-639. 
Melaragno, J. E., B. Mehrotra, et al. (1993). "Relationship between Endopolyploidy and 
Cell Size in Epidermal Tissue of Arabidopsis." Plant Cell5(11): 1661-1668. 
Nelissen, H., D. Fleury, et al. (2005). "The elongata mutants identify a functional 
Elongator complex in plants with a role in cell proliferation during organ 
growth." Proc Natl Acad Sci U S A102(21): 7754-7759. 
Park, J. A., J. W. Ahn, et al. (2005). "Retinoblastoma protein regulates cell 
proliferation, differentiation, and endoreduplication in plants." Plant J42(2): 
153-163. 
Reidt, W., R. Wurz, et al. (2006). "A homologue of the breast cancer-associated gene 
BARD1 is involved in DNA repair in plants." Embo J25(18): 4326-4337. 
Ullah, Z., M. J. Kohn, et al. (2008). "Differentiation of trophoblast stem cells into giant 
cells is triggered by p57/Kip2 inhibition of CDK1 activity." Genes Dev22(21): 
3024-3036. 
Verkest, A., C. L. Manes, et al. (2005). "The cyclin-dependent kinase inhibitor KRP2 
controls the onset of the endoreduplication cycle during Arabidopsis leaf 
Validation of new cell cycle regulators using Arabidopsis 
 
65 
 
development through inhibition of mitotic CDKA;1 kinase complexes." Plant 
Cell17(6): 1723-1736. 
Versees, W., S. De Groeve, et al. (2010). "Elongator, a conserved multitasking 
complex?" Mol Microbiol76(5): 1065-1069. 
Vlieghe, K., V. Boudolf, et al. (2005). "The DP-E2F-like gene DEL1 controls the 
endocycle in Arabidopsis thaliana." Curr Biol15(1): 59-63. 
Yelina, N. E., L. M. Smith, et al. (2010). "Putative Arabidopsis THO/TREX mRNA export 
complex is involved in transgene and endogenous siRNA biosynthesis." Proc 
Natl Acad Sci U S A107(31): 13948-13953. 
 
 
 
MAURICIO QUIMBAYA 
Chapter IV 
Validation of new cell cycle regulators 
in the human model 
 
How to prove it? 
 
 
 
  
 
Validation of new cell cycle regulators in the human model 
 
69 
 
  
 
4.1. Introduction 
During the last decade, the systematic study of cancer has allowed the 
identification of the “cancer hallmarks”. These cancer trademarks structure an 
organizing principle that provides a logical framework for explaining the 
different steps that are followed by the disease. To evolve progressively to a 
neoplastic state, cells must acquire in a logic and causal fashion these 
hallmarks in a multistep process that enables them to become tumorigenic 
and ultimately malignant. It has been stated that the hallmarks of cancer 
comprise six biological capabilities acquired progressively during the process 
that structures a cancer tumor. They include the constant production of 
proliferative signals, the evasion of growth suppressors, the resistance to cell 
death, the acquisition of immortal properties, the induction of angiogenesis, 
and the activation of pathways that allow those cells to invade and 
metastasize (Hanahan and Weinberg 2000). Recently some other carcinogenic 
processes have been added to this list of cancer hallmarks, including a 
deregulation in the energetic balance of the cell, genome instability, the 
avoidance of immune destruction, and the induction of an inflammatory 
response (Colotta, Allavena et al. 2009; Tennant, Duran et al. 2009; Pietras 
and Ostman 2010; Hanahan and Weinberg 2011). 
 
The identification and characterization of the previously mentioned cancer 
trademarks has been possible due to the important technological advances 
that have been produced during the last twenty years. The application of 
genome-wide technologies like microarrays has revolutionized cancer 
diagnosis and therapy (Alizadeh, Ross et al. 2001; Rhodes, Yu et al. 2004; 
Miller and Liu 2007). Additionally, the integration of different techniques and 
perspectives (proteomics, transcriptomics and metabolomics) has allowed the 
identification of key carcinogenic events from a systemic perspective 
(Goodarzi, Elemento et al. 2009; McGary, Park et al. 2010). Nevertheless, not 
all the elements and molecular components that structure and regulate the 
different cancer hallmarks have been identified. The identification of new 
missing elements is fundamental for cancer research, given that each new 
molecular component of the network can provide us with vital information 
necessary to understand the carcinogenic process as a whole. Even what is 
more important, the discovery of new elements in the puzzle can help us to 
explain the great variability of genomic alterations that exist in cancer and 
furthermore, those elements can emerge as new tools for cancer diagnosis 
and/or treatment (Mehta, Jain et al. 2011). 
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The challenge for the coming years is to identify these new elements that can 
play a preponderant role in the regulation of the different cancer hallmarks. 
These new elements can be specific genes solely or particular patterns of gene 
expression produced by different genes (metagenes). Recently, it has been 
shown that the integration of different data sources is a powerful way to 
identify specific molecules or metagenes that can have a strong influence on 
cancer progression. The combination of clinical data derived from different 
pathological studies (analysis based on the clinical information compiled from 
different tumors and patients) with detailed transcriptional profiles obtained 
via microarray experiments is emerging as a powerful technique to identify 
new molecular elements that can have a direct influence on the different 
cancer hallmarks. In this way, particular tumor properties like tumor´s size, 
histological properties, tumor´s grade of development, presence of 
metastasis; or specific information about the patience like age, sex, survival 
time or cancer recurrence (relapse), can be associated with the transcriptional 
profile obtained after the analysis of such tumors via microarray experiments. 
Therefore, specific associations can be obtained, for instance, it is possible to 
determine, which genes are overexpressed in the most aggressive tumors or 
reciprocally it is possible to know whether a particular gene that is 
overexpressed in a subset of tumors has an important effect on the relapse 
risk of a group of patients (Tan, Iravani et al. 2011; Zhao, Rodland et al. 
2011).  
 
To determine the significance of a particular association between gene 
expression and a clinical parameter, specific statistical methods exist. One of 
the most commonly used is the Cox regression analysis. A Cox model is a 
statistical technique for exploring the relationship between a dependent 
variable, for example the survival of a patient or the relapse risk, and several 
explanatory variables, for instance changes in gene expression for a particular 
gene or group of genes. A cox model provides an estimate of the treatment 
effect on survival during time. In addition it allows to estimate the hazard (or 
risk) of death and/or survival probability for an individual, given the measured 
variables (in our case, differential gene expression). To do this, the Cox model 
determines the relationship that exists between the dependent variable 
(relapse risk or patient´s survival) with the explanatory variables (gene 
expression changes) by a regression analysis. A positive regression coefficient 
for a particular variable means that the hazard is higher and thus the 
prognosis is worst, contrastingly, a negative correlation means the opposite 
(Lee, Yoshizawa et al. 1992; Ghali, Quan et al. 2001). 
 
On the present chapter we will address the role of our candidate genes as 
important cell cycle molecules that might have key functions in the origin or 
progression of some of the cancer hallmarks, especially in those ones related 
with abnormal cell proliferation. 
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4.2. Results 
To asses the potential correlation between the phenotypes of the plant genes 
selected by means of our integrative approach with the phenotype of those of 
their corresponding human orthologues, we created a database of 
transcriptional profiles of breast cancer samples obtained with the Affymetrix 
U133A or 133plus2 platforms associated with well-annotated clinical 
information including relapse events and time to relapse (see material and 
methods in this section). To determine the significance of the association 
between gene expression changes for a particular gene and the here studied 
clinical parameter relapse risk, Cox regression analyses were performed 
(Figure 17). 
 
In our analysis, only 223 probe sets corresponding to 167 human orthologues 
(see Appendix F) out of the 339 selected Arabidopsis genes fulfilled our 
reliability criteria (see materials and methods in this section). Association of 
each selected probe set with increased or decreased risk of relapse was 
evaluated at the 0.01 level of significance by the Cox survival analysis. As the 
range of raw gene expression values varied between probe sets, raw 
expression intensity values were stratified in dichotomic categories or in 
quarters categories (see materials and methods in this section) to generate 
more comparable hazard ratios provided by the Cox survival analyses. The “all 
ways category” (Table 8) gives the most reproducible associations because 
they represent significant associations with relapse risk through whatever 
method (raw data, quarter categories, or dichotomic categories) to stratify the 
data, whereas, the “any way category” provides associations that are 
significant only in one (or two) of the methods used to categorize the data. 
Albeit weaker, they can still represent clinically important relapse risk 
associations. 
 
In the generated database, 1,173 probe sets were not significantly associated 
with relapse risk in any of the ways to categorize the data; out of the 9,976 
probe sets 993 or 3,077 were associated with decreased risk of relapse 
independently of the way they were categorized (“All ways”) or in at least one 
way of categorizing the data (“Any way”) respectively. In contrast, 3,724 or 
5,819 probe sets were associated with increased risk of relapse independently 
of the way they were stratified (“All ways”) or in at least one way of stratifying 
the data (“Any way”), respectively. In the list of candidate genes, out of the 
223 probe sets, only 3 or 16 probe sets were associated with decreased risk of 
relapse independently of the way they were categorized (“All ways”) or in at 
least one way of categorizing the data (“Any way”), respectively. In contrast 
to, 143 or 188 probe sets were associated with increased risk of relapse 
independently of the way they were stratified (“All ways”) or in at least one 
way of stratifying the data (“Any way”), respectively. Finally, 19 probe sets 
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were not significantly associated with relapse risk in any of the ways to stratify 
the data. 
 
 
Figure 17. Methodology that was followed to establish correlations between changes 
in gene expression of candidate cell cycle genes identified through our integrative 
approach and clinical parameters derived from tumors, for our study relapse time. The 
significances of such associations were obtained by using Cox survival analysis. 
 
Compared to the 9,976 probes present in the database, the 223 probe sets 
corresponding to human orthologues of the 339 selected Arabidopsis genes 
were enriched in probes associated with increased risk of relapse in either one 
or all of the ways to categorize the data. On the other hand the frequency of 
association of these 223 probes with a decreased risk of relapse was lower 
than that in the whole database. These alterations of the data distribution and 
respective association with relapse risk were highly significant (P value = 5.85 
10-23 according to the χ2 test).  
 
Interestingly, among the 15 analyzed Arabidopsis mutant lines that displayed 
a leaf growth phenotype upon mutation (Table 6), six were associated with an 
increased risk of relapse independently of the way to stratify the data. 
Moreover, the Cox survival curves for these lines showed a clear association 
between altered gene expression levels and a diminished probability of 
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survival, indicating that they were apparently putative good markers to predict 
disease outcome in human breast cancer (Figure 18). 
 
Table 8. Alteration in the data distribution given the respective associations of the 
reliable probe set in the final list of candidate genes (339 genes) with increased or 
decreased risk of relapse, in relation with the same type of probes that are present in 
the whole array. 
Analyzed probe sets All Ways Any Way 
 Probes in the database associated with a decreased relapse risk 993 3077 
 Probes in the database associated with an increased relapse risk 3724 5819 
 Probes in the database not significantly associated with relapse risk  1173 
 Probes in the gene list associated with a decreased relapse risk 3 16 
 Probes in the gene list associated with an increased relapse risk 143 188 
 Probes in the list of genes not significantly associated with relapse risk  19 
Alterations in the distribution of the data (Χ2 Test) 5.85E-23 
 
 
 
Figure 18. Examples of Cox-survival plots for a selected number of the human 
orthologues of Arabidopsis genes with a direct influence on cell proliferation are given, 
illustrating a clear association between increased gene expression levels and a 
diminished probability of survival. (RRC: Relative Risk Coefficient; * represents 
statistically significant differences in the survival probability P <0.01). 
 
Strikingly, out of the 143 human genes that in our data set are related with a 
significantly increased relapse risk when overexpressed, 52 Arabidopsis 
orthologues are expressed in the leaf when it is actively proliferating (Table 9). 
This correlation is highly significant (P-value< 0.01 according to the 
hypergeometric distribution). 
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Table 9. Sets of orthologous genes related with an increased risk of relapse in 
humans and positively associated with cell proliferation in Arabidopsis leaves according 
to microarray experiments.   
Arabidopsis line 
Human 
orthologue 
Hazard ratioa Arabidopsis line 
Human 
orthologue 
Hazard ratioa 
AT1G02970* WEE1 1.50 AT3G12380* ACTR5 1.51 
AT1G07270* CDC6 1.88 AT3G12530* GINS2 2.14 
AT1G08410* LSG1 1.64 AT3G13940* POLR1E 2.21 
AT1G13330* PSMC3IP 2.01 AT3G18524* MSH2 4.2 
AT1G16280* DDX49 1.71 AT3G18630* UNG 1.86 
AT1G21690* RFC4 2.26 AT3G46940* DUT 1.36 
AT1G44900* MCM2 2.14 AT3G57000* EMG1 1.75 
AT1G64350* SEH1L 1.87 AT3G60360* UTP11L 3.32 
AT1G65650* UCHL5 3.85 AT3G61620* EXOSC4 1.92 
AT1G66740* ASF1A 2.70 AT4G14110* COPS8 1.76 
AT1G76120* PUS1 2.84 AT4G25630* FBL 1.75 
AT1G78650* POLD3 1.95 AT4G26430* COPS6 1.66 
AT1G80190* GINS1 2.25 AT4G26720* PPP4C 1.69 
AT2G03820* NMD3 2.14 AT5G01230* FTSJ1 1.92 
AT2G16440* MCM4 2.17 AT5G06000* EIF3G 1.39 
AT2G19430* THOC6 2.03 AT5G12980* RQCD1 3.54 
AT2G20980* MCM10 2.20 AT5G19680* PPP1R7 2.48 
AT2G29680* ORC1L 2.59 AT5G20890* CCT2 2.62 
AT2G37560* ORC2L 2.03 AT5G22330* RUVBL1 1.98 
AT2G41500* PRPF4 1.94 AT5G27740* RFC3 2.26 
AT2G45280* RAD51C 1.67 AT5G42970* COPS4 1.92 
AT2G46470* OXA1L 1.97 AT5G45140* POLR2B 1.98 
AT3G03600* MRPS2 1.89 AT5G46840* RBM34 1.80 
AT3G06530* HEATR1 2.11 AT5G56740* HAT1 2.05 
AT3G07590* SNRPD1 1.55 AT5G60730* ASNA1 1.49 
AT3G12270* PRMT3 1.61 AT5G61220* LYRM4 1.45 
*Represents genes significantly down-regulated (P<0.01) in microarray experiments 
of growing leaves in the transition from day 9 to day 11, thus, represents genes 
associated with the proliferative status of the leaf. 
a The hazard radio represents a significantly increased relapse risk probability. E.g., 
when WEE1 is expressed above the threshold in tumor samples, the probability of 
relapse is 1.50 times higher that when the gene is expressed below that threshold. In 
other words, when WEE1 is highly expressed the probability of cancer recurrence is 
50% higher.  
 
To test whether the obtained gene list had a predictive power for oncogenes, 
three human genes that, to our knowledge, had not been implicated in cancer 
origin or progression, were silenced in breast epithelial cancer cell cultures 
(MCF7 cells), Including the orthologues of AT1G49540 (STATIP1), AT4G38120 
(HEATR6), and AT1G72320 (C14ORF21). In Arabidopsis, knock-out of the 
AT1G49540 gene resulted into an enhanced cell division phenotype, the 
knock-out of the AT4G38120 gene caused an early induction of the 
differentiation processes, whereas the knock-out of the AT1G72320 gene was 
responsible for a dual phenotype. Similarly to its plant counterpart, the 
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coexpression neighborhood of HEATR6 was enriched for the GO term “DNA 
repair” (P-value < 0.01 according to the hypergeometric distribution) (Table 
10). This was not the case for STATIP1 and C14ORF21. 
 
After transient knock-down of STATIP1, C14ORF21, and HEATR6 through 
specific siRNA pools, cell culture growth was monitored by the colorimetric 
MTT assay ((3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide)(Cory, Owen et al. 1991). In comparison with controls (untransfected 
cells [WT] and cells transfected with si-control [NT]), knock-down of 
C14ORF21 and HEATR6 clearly affected growth (Figure 19A). The reduced 
number of cells might be caused by a cell cycle arrest. To corroborate this 
possibility, flow cytometric experiments revealed a larger number of G2/M 
cells in the knock-down cultures of the C14Orf21 and HEATR6 genes than that 
in the controls (Figure 19B), indicative for a transient G2 arrest. In agreement 
with these results, the transcripts of the G2/M marker genes CDK1, CyclinB1, 
and CyclinB2 were up-regulated upon knock-down of C14ORF21 and HEATR6 
(Figure 19C). 
 
Table 10. GO enrichments for the terms “DNA repair” and “DNA replication” were 
calculated for the Arabidopsis mutants that showed a cell cycle-related phenotype 
(chapter III) and for their respective orthologous genes in humans. Enrichment for 
each GO class in both Arabidopsis thaliana and Homo sapiens are given. 
Statistical significance according to the hypergeometric distribution: * P-value <0.01, 
** P-value <0.05, - no significant enrichment. 
 
 
 
Arabidopsis fold enrichments Homo sapiens fold enrichments 
AGI code DNA replication  DNA repair  HUGO DNA replication  DNA repair  
AT1G01940 3.86* 2.92* PPIL3 4.26* 2.59** 
AT1G04020 6.31* 3.07** BARD1 22.23* 12.59* 
AT1G06590 5.07* 3.89* APC5 1.89- 1.85- 
AT1G49540 3.73* 2.59* STATIP1 0.00- 1.11- 
AT1G72320 5.04* 2.98* C14Orf21 0.95- 1.85- 
AT1G74150 4.98* 3.68* KLHDC3 0.95- 1.11- 
AT2G19430 4.38* 3.02* THOC6 7.09* 4.07* 
AT2G40550 5.18* 3.03* MCMBP 3.31* 5.93* 
AT3G02220 3.95* 0.00- C9Orf85 0.00- 0.00- 
AT3G26410 4.31* 2.91* TRMT11 3.31* 3.33* 
AT3G49990 3.95* 0.00- LTV1 3.31* 1.85- 
AT3G55160 3.58* 2.72* THADA 0.47- 0.00- 
AT3G60660 3.88* 2.69* C18Orf24 23.65* 13.7* 
AT4G07410 4.06* 2.57* CIRH1A 6.15* 2.22** 
AT4G38120 5.46* 2.76* HEATR6 1.42- 3.33* 
AT5G22370 4.04* 2.69* GPN2 0.95- 1.85- 
AT5G49110 3.94* 2.81* FANCI 23.18* 14.07* 
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Figure 19. A. Growth curves of the siRNA knocked-down MCF7 cultures. B. Ploidy 
distributions of the STATIP1, C14ORF21, and HEATR6 knocked-down cultures in 
comparison with controls. Significant differences were observed for C14ORF21 and 
HEATR6 (P-value <0.05 (n =9) according to a t-Test). C. Expression levels of cell cycle 
phase makers measured by Q-PCR. 
 
4.3. Discussion 
Despite the 1.6 billion years of divergence between the animal and plant 
clades; commonly shared pathways and cascades inherited from their last 
common ancestor still persist (Jones, Chory et al. 2008).  Such pathways must 
be of great importance for both plants and animals, given their retention 
throughout evolution. Nevertheless, only some of these conserved pathways 
might have a direct effect in any or some of the archetypical cancer hallmarks 
defined by Hanahan and Weinberg. Interestingly, here we showed that by 
selecting genes in the Arabidopsis genome functionally related with replication 
processes (given their tightly coexpression pattern with replication genes and 
the presence of E2F-binding sides on their promoter regions) it is possible to 
retain human orthologues associated with particular cancer events, in our 
study, an increased relapse risk probability. These results clearly exemplify 
and support the currently existing evidence suggesting that the alteration in 
the cellular machinery that regulates and controls cell proliferation is a 
decisive trademark for cancer onset. Reciprocally, those novel genes 
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associated with the control of cell proliferation emerge as interesting target 
genes for cancer therapy (Mirza, Mirza et al. 2002; Soerjomataram, Louwman 
et al. 2008). Strikingly, given that a significant amount of human genes that 
confer growth advantage to tumors, hold Arabidopsis orthologues implicated in 
cell proliferation, we can suggest that the basic molecular toolkit necessary for 
controlling cell replication in multicellular organisms has been conserved for 
more than 1.6 billion years, sharing important control mechanisms and thus, 
this highlights the importance of cell replication control for multicellular 
organisms. 
 
In the second chapter of this work, we mentioned several known cell cycle 
regulators and oncogenes that were detected by means of our systemic 
strategy that can be considered as positive controls (Table 3), suggesting that 
the rest of genes here retained (or a least a majority of them), should be 
novel molecules related with cell cycle processes.  Here we show that 143 of 
our candidate genes have a significant prognosis value, predicting specific 
clinical outcomes when deregulated. This means that almost half of our genes 
are important cancer predictors, representing highly significant cancer 
associations (P-value <0.01 according to the hypergeometric distribution), 
validating also in the human model our computational prediction based on an 
integrative model for gene selection. 
 
Besides the results here described, different facts argue in favor of our list of 
cell cycle regulators to hold important elements in the mammalian cell cycle as 
cancer predictors. Recently it has been shown that the FANC pathway, in 
which the gene FANCI is one of the central players, is involved in rescuing 
abnormal anaphase and telophase cells, limiting aneuploidy and reducing 
chromosome instability (Chan, Palmai-Pallag et al. 2009; Naim and Rosselli 
2009). Similarly, it has been suggested that the DNA-repair gene MSH2 has an 
important prognosis value in specific types of cancer (Dong, Li et al. 2011; 
Mukherjee, Rennert et al. 2011). According to our analysis, both genes are 
important predictors of relapse risk in breast carcinomas (Figure 18 and table 
9), supporting the value of these molecules as cancer markers. Interestingly, 
genome instability caused by errors during DNA-repair process has been 
proposed recently as a new cancer hallmark (Hanahan and Weinberg 2011). 
 
Here, we found that the knock-down of the genes C14ORF21 and HEATR6, 
have an inhibitory effect on cell proliferation given that their depletion results 
into an increase in the population of cells with a 4C DNA content, which is 
supported by an up-regulation of G2/M cell cycle marker genes. Interestingly, 
HEATR6 lays on one of the most commonly amplified fragments in breast 
cancer (Wu, Sinclair et al. 2001), and accordingly, its transcript is significantly 
overexpressed in gastric, brain and breast carcinomas. Similarly, the 
C14ORF21 transcript is up-regulated in colorectal, gastric and prostate cancers 
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(Figure 20). Our results also suggest that HEATR6 has an important predictive 
value as a cancer marker (Figure 18). 
 
 
Figure 20. A. Examples taken from Oncomine (www.oncomine.org) of carcinomas in 
which HEATR6 transcript is significantly up-regulated (P-value<0.05) and B. 
Malignancies in the which C14ORF21 gene is transcriptionally up-regulated (P-
value<0.05). For all the given examples, light blue boxes represent normal tissues 
while dark blue boxes, represent specific carcinomas. 
 
Another example of interest is the E2F TARGET GENE 1 (ETG1) protein that 
was identified recently as a novel evolutionarily conserved replisome factor. 
ETG1 is associated with the minichromosome maintenance complex (MCM) 
being crucial for efficient DNA replication (Takahashi, Lammens et al. 2008). 
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Additionally, depletion of ETG1 or its human orthologous MCM-BP results in a 
stringent late G2 cell cycle arrest that correlates with a partial loss of sister 
chromatids cohesion (Takahashi, Quimbaya et al. 2010), suggesting an 
equally important developmental role for this molecule in plants and 
mammals. In the following chapters the role of ETG1 and its human 
orthologue MCM-BP will be scrutinized in detail, showing the importance of this 
novel molecule for cell cycle progression in both genomes. 
 
The data presented argue in favor of an applied integrative approach as a 
powerful strategy to discover new conserved cell cycle regulators. 
Nevertheless, this strategy suffers from restrictions, especially because it is 
based on gene coexpression, and thus, cannot provide a full perspective of 
molecular interactions, such as protein-protein interactions, as exemplified by 
the Arabidopsis gene AT1G49540 and its human orthologue STATIP1. Although 
the knock-down of the Arabidopsis gene triggered cell proliferation, the knock-
down of STATIP1 did not. In contrast to the plant gene, the coexpression 
neighborhood of STATIP1 is not enriched for DNA replication or DNA repair 
(Table 10), indicating that despite their orthologous relationship both 
molecules may have diverged functionally during evolution. The contrasting 
phenotypic effects between these two orthologous genes illustrate that not 
only the components belonging to a specific network are important, but also 
their wiring. Alternatively, in the human genome, STATP1 is located in close 
proximity with LIV1 and they share the same regulatory region, and probably 
the same regulatory mechanisms (Yamashita, Miyagi et al. 2004). Knock-down 
of LIV1 suppresses apoptosis in malignant cells, although a negligible effect is 
observed in cell proliferation (Ma, Ma et al. 2009). This observation can 
explain also why STATIP1 which must be controlled in a similar fashion as 
LIV1, has a minimal effect on cell proliferation. 
 
To understand the origin and progression of the carcinogenic process, and to 
shed light onto the complex mechanisms that lead to tumorigenesis and 
cancer, different model organisms have been used. Some of them, like Mus 
musculus, are relatively closely related with humans and several mouse 
models are currently used in cancer research (White, Kurpios et al. 2004; 
Pearson, Greiner et al. 2008; Vucur, Roderburg et al. 2010), whereas some 
others, like Drosphila melanogaster or Saccharomyces cerevisiae, are distantly 
related. Nevertheless they have also extensively contributed to the 
understanding of the disease (Rosengard, Krutzsch et al. 1989; Hartwell 1992; 
Caussinus and Gonzalez 2005). With this study, we demonstrate that by 
searching for proliferation genes in the Arabidopsis genome it is possible to 
retain human orthologues of which the misexpression might contribute to 
cancer progression, represented in clinical hallmarks as the increment in 
relapse risk. Reciprocally, genes that confer growing advantages to tumors 
coincide with orthologous genes implicated on cell proliferation in Arabidopsis, 
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suggesting that Arabidopsis might represent a tempting new model organism 
for cancer research. 
 
4.4. Materials and methods 
Human microarray data analysis 
We downloaded the CEL files of studies performed on Affymetrix array 
platforms compatible with our mRNA expression data (HG133A or 
HG133plus2). We selected studies involving t tumor samples (Appendix G) 
published before September 2009 in the GEO or Array Express databases. 
Data were extracted, background-subtracted, normalized and summarized 
(median polish option) using frozen RMA, the new summarization bioconductor 
package developed by Dr. Irizarry's group (McCall, Bolstad et al. 2010). This 
package estimates and corrects probe-specific effects and variance on the 
basis of a common defined vector using all data obtained with the same 
platform as the one used to generate the analyzed data published in GEO. 
Data expressed by default in a log scale by the fRMA script were converted 
back to signal intensity values. Data from the nine selected studies were 
merged in a pooled dataset. To avoid over-fitting, data corresponding to the 
same patient analyzed in different studies were included only once in the 
pooled dataset containing 1400 patients. R scripts used to extract, process, 
analyze and display data are available on request. 
 
Probe sets of good reliability were selected based on the consistency between 
their annotation and the similarity of the probes with their target sequence as 
reported in the Geneannot (Ferrari, Bortoluzzi et al. 2007) or PLANdbAffy 
(Nurtdinov, Vasiliev et al. 2010) databases and on the reproducibility of the 
expression values corresponding to common breast cancer cell lines described 
in the studies GSE10890, GSE12777 and GSE16795. A probe set was 
considered as reliable when the corresponding Geneannot annotation quality 
markers and the specificity and sensitivity indexes were equal to one. A probe 
set was considered as reliable when more than 63% of the probes from the 
probe sets are flagged as green (perfect match) or yellow (perfect match but 
with sequence in non-coding RNA) in the PLANdbAffy database. To evaluate 
reproducibility, the expression values for each probe set observed in the 
common cell lines in one study were linearly correlated to the corresponding 
values described in the two other studies. A probe set was considered as 
reliable if the averaged Pearson correlation coefficient obtained in this way was 
above 0.5. To compare, within one study, the cell line expression values 
corresponding to different probes, the intensity values for each probe set and 
cell line were normalized by removing the minimal intensity value considered 
as background and dividing this difference by the range of intensities.  
To enhance the statistical power of our analysis, we merged the data from the 
nine studies into a single pooled database. This was made possible because 
the same expression values for each probe are obtained for the same patient 
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when fRMA summarized expression data are considered. By comparing the 
patient names, we realized that several patients were shared between two or 
more studies. The identity of these patients was confirmed if the clinical 
parameters and the expression data were the same in the different studies. To 
avoid over-fitting, those patients were included only once in the pooled 
database. Patients with unknown values for relapse event or time were 
removed from the pooled database.  
 
Cox survival analyses were performed in R with the Survival package using 
raw expression intensity values or intensity data stratified in quarters or in 
dichotomic categories. For stratification in quarters, the range of expression 
values was divided into four equal intervals before each expression intensity 
value was assigned a value of 1, 2, 3 or 4 according to the interval in which it 
fell. Dichotomic categories are defined as 0 or 1, depending on whether or not 
the expression value is above a threshold value leading to the highest Chi-
square value in a training Cox survival analysis. To this end, the range of 
expression values for each probe sets was divided in 50 threshold values 
before a Cox analysis was run for each threshold with the data converted to 0 
or 1 according to whether the expression value is below or above the 
considered threshold. 
 
Gene Ontology associations 
Gene ontology associations for the terms described in this section were 
obtained as described in chapter II. Gene Ontology associations for 
Arabidopsis proteins were retrieved from TAIR (Huala, Dickerman et al. 2001) 
and for human proteins were retrieved from AmiGO (Carbon, Ireland et al. 
2009). 
 
MCF7 cell culture and transfection 
MCF7 cell cultures were grown in complete medium (Dulbecco’s modified MEM 
Eagle medium with 5% fetal calf serum, suplemented with L-Gln, NaPy, NEAA 
and 6ng/ml bovine insulin) at 37oC and 5% CO2. The following siRNA 
sequences (DharmaFECT, Thermo Fisher Scientific, Waltham, MA, USA), were 
used for the specific transfections: human HEATR6 (SMARTpool; J-015921-09, 
J-015921-10. J-015921-11, J-015921-12), human STATIP1 (SMARTpool; J-
021064-05, J-021064-06, J-021064-07, J-021064-08), human C14ORF21 
(SMARTpool; J-017798-09, J-017798-10, J-017798-11, J-017798-12) and 
control (SMARTpool non-targeting pool). 
 
Growth curves 
MCF7 cells (10,000 cells approximately) were seed in 250 µl of MCF7 medium 
without antibiotics in a 96-well plate format and grown in the previously 
described conditions. STATIP1, C14ORF21, HEATR6 and control siRNAs were 
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transfected in quadruplicates into the cells according to the manufacturer’s 
instructions (DharmaFECT, Thermo Fisher Scientific, Waltham, MA, USA).  The 
final concentrations of each siRNA were 30 nM. Cell growth and viability was 
followed every 24 hours during five days using MTT assays ((3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), briefly, 20 µl of 
5mg/ml MTT substrate were added into the cells, after two hours of incubation 
at  37oC, the medium was removed and cells were resuspended in 200 µl  of 
DMSO.  The absorbance at 595 nm was measured using a Benchmark® 
microplate reader spectrophotometer (Bio-Rad). 
 
Homo sapiens siRNAs flow cytometry 
MCF7 cells (250,000 cells approximately) were seed in 5 ml of MCF7 medium 
without antibiotics in a 6-well plate format and grown in the previously 
described conditions. STATIP1, C14ORF21, HEATR6 and control siRNAs were 
transfected in triplicates into the cells according to the manufacturer’s 
instructions (DharmaFECT, Thermo Fisher Scientific, Waltham, MA, USA). The 
final concentrations of each siRNA were 30 nM.  48 hours after transfection, 
cells were trypsinized, pelleted (110 g for 5 min), and resuspended in 800 µl 
of staining solution (http://www.partec.com). The cells were filtered through a 
30 µm mesh and the nuclei were analysed using a CyFlow cytometer and 
FloMax software (http://www.partec.com). 
 
Homo sapiens siRNAs QPCR analysis 
MCF7 cells (250,000 cells approximately) were seed in 5 ml of MCF7 medium 
without antibiotics in a 6-well plate format and grown in the previously 
described conditions. STATIP1, C14ORF21, HEATR6 and control siRNAs were 
transfected into the cells according to the manufacturer’s instructions 
(DharmaFECT, Thermo Fisher Scientific, Waltham, MA, USA). The final 
concentrations of each siRNA were 30 nM. Cells were collected 48 h after 
transfection with a rubber policeman. RNA was extracted with an RNeasy 
animal Mini Kit (Qiagen) and cDNA was prepared with the cDNA synthesis 
system according to manufacturer’s instructions (Roche Diagnostics, 
Indianapolis, USA). For quantitative PCR, a Light-Cycler 480 SYBR Green I 
Master (Roche Diagnostics) was used with 100 nM primers and 0.1 mg of 
reverse transcription reaction product. Reactions were run and analysed on 
the LightCycler 480 Real Time PCR System according to manufacturer’s 
instructions (Roche Diagnostics). All quantifications were normalized to the 
TATA Binding Protein (TBP) and Ubiquitin C (UBC) expression levels. 
Quantitative reactions were done in triplicate and averaged. 
Primers used were 5’CGTGGTTGCAGTAGGATTGGAGTG 3’ and 
5’GCACCTTCTGCTTCCTTCTGTTCA 3’ for STATIP1; 
5’GGAGGAGGAGGATGGAAAGGATG 3’ and 5’TTACATTCCTGAGCTGGGGTCTTC 
3’ for C14ORF21; 5’GCTTCATTTTCTGCAACCCTCTCA 3’ and 5’ 
TCACGACCGATGTCAGGGCA 3’ for HEATR6; 5’ GCCCGAGGTCCCGATGCTT 3’ 
Validation of new cell cycle regulators in the human model 
 
83 
 
and 5’ CAGTCAGGGAGTGCTTTCTTTCCA 3’ for Cyclin A1; 5’ 
TGAGCCAGTGCCAGAGCCAGA 3’ and 5’ GCTCCATCTTCTGCATCCACATC 3’ for 
Cyclin B1; 5’ CCAAAGTTCCAGTTCAACCCACC 3’ and 5’ 
CAATCCACTAGGATGGCACGCA3’ for Cyclin B2; 5’ 
CCTTGCCAGAGCTTTTGGAATACC 3’ and 5’ CACACTTCATTATTGGGAGTGCCC 3’ 
for CDK1; 5’CGGCTGTTTAACTTCGCTTC3’ and 5’CACACGCCAAGAAACAGTGA3’ 
for TBP, and 5’ATTTGGGTCGCGGTTCTTG3’ and 
5’TGCCTTGACATTCTCGATGGT3’ for UBC. 
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In this chapter the experiments and respective results regarding ETG1 and its function 
in plant cohesion were performed by Naoki Takahashi and collaborators. All the 
experiments and respective results regarding MCMBP and its function in sister 
chromatid cohesion in human cell lines were performed by Mauricio Quimbaya. In 
order to illustrate the conserved role for both orthologues in cohesion, it is important 
to have a general overview of their function in both models and because of that, the 
results obtained by studying ETG1 in plants are included. Naoki Takahashi is 
completely aware that these results are included in the present thesis.  
  
5.1. Introduction 
For one single cell to generate two daughter cells, numerous events must be 
coordinated, in particular, faithful DNA replication and partitioning of the sister 
chromatids to each of the newly originated cells. It is of utmost importance to 
ensure the error-free duplication of the replicated DNA during each cell cycle, 
preventing the transmission of potentially harmful mutations to the daughter 
cells, which otherwise might result in developmental defects or even cancer. 
DNA damage and replication errors generally originate from DNA stress 
provoked by either exogenous (such as UV-B light) or endogenous (such as 
metabolic byproducts) sources. The latter include the replication process itself 
that necessitates the cooperation of many different proteins in a highly 
complex manner. Different mechanisms have evolved in order to cope with 
DNA damage, one of those mechanisms is homologous recombination. In this 
DNA-repair process, by using the undamaged DNA copy of one of the sister 
chromatids as a template, it is possible to repair the other damaged one. This 
action is facilitated by keeping the two sister chromatids in close proximity 
after the replication process by the action of a molecular glue, called cohesin 
(Bernard, Maure et al. 2001; Gartenberg 2009). 
 
Cohesin is a member of a large family of DNA-associated complexes based on 
SMC (structural maintenance of chromosome) proteins, which are a group of 
proteins that are evolutionarily conserved, predating the trifurcation of 
eukaryotes, archaea, and prokaryotes (Woese, Kandler et al. 1990). All SMC 
proteins use intramolecular coiled-coil interactions to fold on themselves, 
producing rod-shaped molecules with an ATPase ‘‘head’’ domain and 
dimerizing ‘‘hinge’’ at either end (Hirano 2006). In the case of cohesin, the 
ATPase heads of the Smc1–Smc3 heterodimer are bridged by the non-SMC 
subunit Scc1 to form a closed ring (Arumugam, Nishino et al. 2006; Hu, Itoh 
et al. 2011), while a fourth non-SMC subunit (Scc3 in yeast or stromalin 
Chapter V 
 
88 
 
antigen isoforms 1 and 2 [SA1 and SA2] in vertebrates) interacts directly with 
Scc1 (Losada, Yokochi et al. 2000). Recent evidence supports the notion that 
the cohesin ring holds sister chromatids together topologically (Nasmyth and 
Haering 2009), with DNA entering the ring via ATP-dependent opening of the 
Smc1–Smc3 hinge interface (Gruber, Arumugam et al. 2006). Whereas 
cohesion loading occurs before S phase, the process of cohesion establishment 
is intimately connected with DNA replication. In Xenopus, Scc2–Scc4 complex 
binds chromatin through specific interactions with the pre-replication complex 
via the S-phase kinase Cdc7 (Sherwood, Takahashi et al. 2010) (Figure 21). 
 
 
Figure 21. SSC2-SS4 cohesin-loading complex structure. The ATPase heads of the 
Smc1–Smc3 heterodimer are bridged by the non-SMC subunit Scc1 to form a closed 
ring, while a fourth non-SMC subunit SS3 (SA1/2) interacts directly with Scc1. In 
Xenopus egg extracts, the Scc2–Scc4 complex binds chromatin through specific 
interactions with pre-RCs via the S-phase kinase Cdc7. Contrastingly, in Yeast it is not 
clear whether this interaction is mediated by the replication machinery. (Taken from 
Sherwood, 2011). 
 
It has been suggested that genomic instability underlies the characteristic 
cancer hallmarks (briefly described in the previous chapter)(Hanahan and 
Weinberg 2011). Similarly, it has been shown that sister chromatid cohesion 
defects greatly contribute to this genome instability (Barber, McManus et al. 
2008; Lee, Endesfelder et al. 2011). For some types of cancers, including 
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colorectal carcinomas, chromosome instability due to loss of sister chromatid 
cohesion is the most distinctive characteristic (Soreide 2007; Worthley and 
Leggett 2010; Bacolod and Barany 2011), clearly exemplifying that defects on 
sister chromatid cohesion can progress to tumorigenesis and cancer. 
 
As it has been mentioned before, the E2F transcription factors control the 
expression of many genes involved in DNA replication and DNA repair. 
Recently, by studying putative Arabidopsis thaliana E2F target genes, 
Takahashi and collaborators have previously identified the E2F TARGET GENE 
1 (ETG1-AT2G40550) as a novel evolutionarily conserved replisome factor. 
ETG1 binds with the mini chromosome maintenance (MCM) complex and is 
crucial for efficient DNA replication (Takahashi, Lammens et al. 2008). 
Similarly, it has been shown that the human orthologue of ETG1, the MCMBP 
protein, binds to replication origins as part of the MCM complex as well 
(Sakwe, Nguyen et al. 2007). 
 
Plants lacking the ETG1 gene display serrated leaves due to inhibition of their 
cell cycle. This inhibition is triggered by the DNA replication checkpoint, as 
illustrated by the transcriptional induction of DNA stress checkpoint genes 
(Takahashi, Lammens et al. 2008). In the present study we showed that in 
ETG1 knock-down mutants the population of cells with an 8C and 16C DNA 
ploidy level is increased (see Figure 12B and Table 6), clearly indicating that 
the loss of the ETG1 transcript induces an endoreduplication phenotype. 
Additionally, when the first mature leaf pair from wild type and ETG1-deficient 
plants is compared, the average abaxial pavement cell area is increased 
significantly in the mutant plants, being correlated with a decrease in the 
number of cells (Table 6). 
 
Given that the ETG1 gene and its human orthologue MCMBP were detected in 
our selected list of candidate genes, and furthermore, given that the 
evolutionary conservation between ETG1 and its human orthologue MCMBP is 
extended to their coexpression neighborhood (Figure 22), we decided to study 
in detail the molecular function of them in both models Arabidopsis thaliana 
and Homo sapiens. Additionally, specific experiments were carried out in order 
to assess the putative role of MCMBP during carcinogenesis onset. 
Interestingly, according to our Cox analyses, MCMBP is a good predictor of 
cancer relapse on breast carcinomas (Figure 18). 
 
5.2. Results 
ETG1-deficient plants suffer from endogenous DNA stress and display a 
transient cell cycle arrest (Takahashi, Lammens et al. 2008). To explore the 
reasons for this defective cell cycle, the transcript levels of 22,750 genes were 
measured by using Affymetrix ATH1GeneChip arrays, comparing proliferating 
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first leaves (harvested from9-day-old plants) from ETG1 knock-out with 
control (Col-0) plants. Statistical analysis identified a total of 219 genes 
differentially expressed between wild-type and ETG1-deficient plants (P-
value<0.01). Among these genes 89% corresponded to up-regulated 
transcripts, while 11% of the genes were down-regulated. Strikingly, out of 
the 195 up-regulated genes, 103 (53%) showed an expression peak during 
mitosis. Transcription of genes expressed specifically during mitosis is 
regulated by a common upstream cis-acting element (ynCAACGG), designated 
mitosis-specific activator (MSA). In total, 82 up-regulated genes in ETG1 
knocked-down plants possessed an MSA element within the first 1 kb region 
upstream of the translation start codon. 
 
 
Figure 22. Fraction of the evolutionarily conserved coexpression neighborhood 
between sets of orthologous genes in Arabidopsis and humans. If a pair of orthologous 
genes in plants and humans is functionally conserved, it is expected that the 
overlapping set of coexpressed genes that have been evolutionarily conserved for both 
organisms was significantly higher in comparison with pairs of orthologues which 
function have diverged. The blue line represents this threshold of significance (see 
materials and methods). Arrow pinpoints that this conservation is significant for the 
ETG1-MCMBP coexpression neighborhoods. 
 
To identify the biological processes that might be affected in the ETG1 
deficient plants, the up- and down-regulated genes were analyzed for gene 
ontology (GO) enrichment (Maere, Heymans et al. 2005). Among the up-
regulated genes, regulation of progression through cell cycle, mitotic cell cycle, 
and microtubule-based movement genes were significantly overrepresented 
(Figure 23), indicating that lack of ETG1 resulted in mitotic defects. This is a 
surprising result given that ETG1 is an E2F-dependent target gene expressed 
during the S phase and its gene product is required for DNA replication. 
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Additionally, ETG1-deficient plants had been found to interact synergistically 
with the wee1 and atr1 replication checkpoint mutants and to suffer from DNA 
replication stress (Takahashi, Lammens et al. 2008), which is anticipated to 
arrest the cell cycle during S phase. 
 
 
 
Figure 23. BINGO (GO enrichment) analysis of the 196 up-regulated genes in the first 
leaves of ETG1-deficient plants. The yellow-to-orange color of the circles correspond to 
the level of significance of the overrepresented GO category (P-value<0.01 according 
to a multiple t test with false discovery rate–corrected). The size of the circle is 
proportional to the number of genes in the category. A clear overrepresentation of GO 
terms associated with M-phase processes can be observed. Similarly, specific 
processes related with chromosome-segregation events as “microtubule-based 
process” or “microtubule-based movement” are depicted. 
 
 
Due to the conserved coexpression neighborhood between ETG1 and its 
human orthologue MCMBP, it was tested whether the coexpression 
neighborhood of MCMBP is functionally enriched in GO categories related with 
M-phase progression. Strikingly, the MCMBP coexpression neighborhood was 
found to be significantly enriched (P-value <0.01 according to a multiple t test 
with false discovery rate–corrected) in processes related with chromosome 
segregation and sister chromatid cohesion (Figure 24 and Table 11). 
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Figure 24. BINGO (GO enrichment) analysis of the top 300 genes coexpressed with 
MCMBP. The yellow-to-orange color of the circles correspond to the level of 
significance of the overrepresented GO category (P-value<0.01 according to a multiple 
t test with false discovery rate–corrected). The size of the circle is proportional to the 
number of genes in the category. A clear overrepresentation of GO terms associated 
with M-phase processes and sister chromatid cohesion can be observed. 
 
 
Table 11. List of genes significantly associate with the GO term “Sister chromatid 
cohesion” (P- value <0.01), that are present in the MCMBP coexpression neighborhood 
(top 50).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To establish a direct link between ETG1 function and sister chromatid 
cohesion, we analyzed by fluorescent in situ hybridization (FISH) whether the 
Official symbol Functional annotation  
CTCF CCCTC-binding factor (zinc finger protein) 
MAD2 MAD2 mitotic arrest deficient-like 1 (yeast) 
SEH1L SEH1-like (S. cerevisiae) 
SRPK1 SFRS protein kinase 1 
BUB3 Budding uninhibited by benzimidazoles 3 homolog (yeast) 
CDC23 Cell division cycle 23 homolog (S. cerevisiae) 
NUP37 Nucleoporin 37kDa 
STAG1 Stromal antigen 1 
SMC1A Structural maintenance of chromosomes 1A 
SMC2 Structural maintenance of chromosomes 2 
SMC3 Structural maintenance of chromosomes 3 
SMC4 Structural maintenance of chromosomes 4 
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cell cycle arrest in ETG1 knocked-down plants might be linked with a loss of 
cohesion. The two adjacent overlapping bacterial artificial chromosomes 
(BACs) T2P11 and T7N9 that label the upper mid-arm position of chromosome 
1 were used for FISH analysis on flow-sorted 4C leaf nuclei to compare the 
frequency of sister arm alignment between the wild-type and ETG1 knocked-
down mutants. The number of FISH signals indicates whether sister 
chromatids are linked at different positions: one (pairing of both homologs) or 
two FISH signals mark the positionalalignment of sister chromatids at the 
corresponding region, whereas and three or four signals indicate sister 
chromatid separation at one or both homologous chromosomes, respectively 
(Figure 25B–D). When compared to the wild-type nuclei, the ETG1-defecien 
nuclei showed a significant increase (P-value <0.01) in sister chromatid 
separation (Figure 25A and 25E). Positional sister chromatid separation 
occurred in 28.1% of the homologs in 4C wild-type leaf nuclei, whereas ETG1 
knocked-down nuclei displayed 42.7% sister chromatid separation per 
homolog (Figure 25A). By contrast, FISH applied to the 178-bp centromere-
specific sequence (pAL) revealed 4–12 signals in both the wild-type and the 
ETG1 knocked-down mutant 4C nuclei (Figure 25A and 25F). These findings 
suggest that ETG1 is required for correct establishment of sister chromatid 
cohesion along chromosome arms. 
 
 
 
Figure 25. A. Percentage of positional separation frequencies per homologous 
chromosome (number of investigated nuclei in parentheses) analyzed in wild-type 
(Col-0) and ETG1 mutant plants after FISH with the labeled T2P11 or T7N9 BACs from 
chromosome 1. The FISH probe pAL detects the centromeric 178-bp repeats. B–D 
Structural arrangement of FISH signal positions in 4C nuclei counterstained with DAPI. 
B. Positional alignment (T2P11) at both chromosome 1 homologs. Two of 10 
centromeric signals associated (arrow). C. Positional sister chromatid separation at 
both homologs. D. Positional association of both homologs. E. Percentage of sister 
chromatid alignment/separation frequencies analyzed in wild-type (Col-0) and ETG1.F. 
Identical frequencies of centromere-specific FISH signals in wild-type and ETG1nuclei. 
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A role for MCMBP, the human ETG1 orthologue, in sister chromatid cohesion 
was assessed with the RNA interference technique by means of pooled short 
interference RNAs (siRNAs). In human embryonic kidney 293T (HEK-293T) 
cells transfected with siRNAs that targeted MCMBP, the MCMBP expression was 
much lower than that of untransfected or transfected control cells (Figure26A). 
Protein gel blotting with a specific antibody confirmed that the decrease in 
transcription was accompanied by a reduced MCMBP protein abundance 
(Figure 26B). No change in protein level was seen for MCM4, MCM6, and 
MCM7, which are the most conserved and core subunits of the MCM complex, 
demonstrating that the siRNAs targeted specifically MCMBP without affecting 
the abundance of other proteins of the MCM complex. As seen inmitotic 
spreads (Figure 26C–26F), depletion of MCMBP strongly affected sister 
chromatid cohesion, resulting in a higher proportion of nuclei with completely 
separated sister chromatids (38% versus 2% or 3% in untransfected or 
transfected control cells, respectively). Thus, as observed for its plant 
counterpart, MCMBP seems to be important for sister chromatid cohesion. 
 
 
Figure 26. A. MCMBP transcript levels in siRNA transfected HEK-293T cells versus 
untransfected and transfected control cells. Samples were harvested 48 h after 
transfection. All values were normalized against the expression level of the TBP and 
UBC genes. B. MCM-BP, MCM4, MCM6, and MCM7 protein levels in samples as 
described in A. C. Quantification of nuclei showing totally separated sister chromatids 
The asterisk marks a significant difference by Student’s t-test (P-value <0.05). C–E. 
Representative images of mitotic spread of untransformed (D), control transfected (E), 
and MCMBP siRNA-transfected HEK-293T cells (F). Insets show higher magnification 
images of single sister chromatid pairs. 
MCMBP and its function in sister chromatid cohesion 
95 
 
To address whether the effect on sister chromatid cohesion seen upon MCMBP 
knock-down is cell-line-specific, MCMBP transcript was knocked-down in 
different breast cancer cell lines. A transient knock-down was generated for 
the epithelial-like MCF10A cell line by means of the previously used pooled 
short interference RNAs; while in the case of the epithelial-like MCF7 cell line 
and for the mesenchymal-like MDA-MB231 cell line, cellular lines with a stable 
MCMBP knock-down were produced using specific lentiviral constructs (see 
material and methods in this section). Upon MCMBP knock-down an effect on 
sister chromatid cohesion was observed for the different studied cell lines, 
suggesting that the effect observed on sister chromatid cohesion upon MCMBP 
deregulation is a general phenotype (Figure 27). 
 
 
Figure 27. Knock-down of the MCMBP transcript has a direct effect on sister 
chromatid cohesion in different breast cancer cell lines. A. Examples of metaphases 
where the sister chromatids become to be separated when MCMBP transcript is 
deregulated, either transiently (MCF10A cell line) or in a stable manner (MDA231 cell 
line). Insets show higher magnification images of single sister chromatid pairs. For the 
MDA231 cells, control refers to the empty vector used for the lentiviral transfection, 
while in the case of the MCF10A cells, control refers to a control pool of siRNAs 
designed to do not target any gen in the human genome. B.Quantification of disrupted 
metaphases for the analyzed lines. Disrupted metaphases refers to metaphases in 
which at least 70% of the chromosomes presented totally separated sister chromatids. 
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In the case of the Arabidopsis model no plant overexpressing ETG1 could be 
obtained, suggesting thathigh ETG1 levels interfere with the regeneration 
process. Therefore, we tested the effects of transiently overexpressing MCMBP 
in HEK293T cells. Again, effects on sister chromatid cohesion were observed. 
When the metaphases of cells overexpressing MCMBP were examined in detail, 
close to 70% of the metaphases were found to be disrupted, illustrating than 
in human cells, next to depletion, also the overexpression of MCMBP, has a 
direct effect in sister chromatid cohesion (Figure 28). 
 
 
 
Figure 28. The overexpression of MCMBP has a direct effect on sister chromatid 
cohesion in HEK293T cells. A. Examples of metaphases in which the sister chromatids 
become separated when MCMBP transcript is up-regulated. Insets show higher 
magnification images of single sister chromatid pairs. B. QPCR showing that the 
MCMBP transcript is up-regulated 200-fold in the overexpressing cell line. 
C.Quantitation of the phenotype, almost 70 % of the metaphases are disrupted when 
MCMBP is overexpressed. 
 
Previously, we have demonstrated that ETG1-deficient plants suffer from 
replication stress, resulting in transcriptional induction of DNA repair genes 
and activation of the DNA replication checkpoint (Takahashi, Lammens et al. 
2008). To examine the relation between the loss of sister chromatid cohesion 
and specific DNA-repair processes, the level of DNA damage in control and 
ETG1 knocked-down 8-day-old seedlings treated with 50 mg/ml bleomycin for 
1 hour, was assayed by comet assay. ETG1 knocked-down mutants, exhibited 
significant DNA damage in comparison with control plants (Figure 29A and 
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29B). In Arabidopsis, the S phase-established cohesion is a prerequisite for 
double-strand break (DSB)-dependently enforced cohesion that, in turn, is 
required for homologous recombination repair between sister chromatids 
(Watanabe, Pacher et al. 2009). Therefore, the DSB repair kinetics of ETG1-
deficient and wild-type plants were compared during the recovery from 
bleomycin treatment by calculating the extent of the remaining DNA damage 
from the percentage of DNA in the comet tails. Whereas in wild-type seedlings 
almost 80% of all DSBs was repaired within 1 hour, in ETG1-deficient plants, it 
was significantly delayed (Figure 29C). These data substantiate a role for 
ETG1 in sister chromatid cohesion and support the idea that cohesion might be 
important for homologous recombination repair. 
 
 
Figure 29. Inefficient DNA repair upon loss of sister chromatid cohesion.A. Examples 
of comets from plant nuclei with undamaged (top) or damaged (bottom) DNA. B. 
Analysis of a comet assay. The average % values of DNA in tails of nuclei of 7-day-old 
wild-type (Col-0) and ETG1-deficient seedlings. Error bars indicate SD.C. Kinetics of 
DSB repair in wild-type versus etg1mutant plants. Fractions of remaining DSB were 
calculated for 0, 5, 10, 20, and 60 min recovery time after treatment with 50 mg/ml 
bleomycin for 1 hour. Maximum damage was normalized as 100% at t = 0. 
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As demonstrated above, ETG1 knock-down in Arabidopsis induces the 
activation of the DNA replication checkpoint, triggered by an inefficient repair 
of DNA damages by homologous recombination. Because of this, it was tested 
in the human model whether the knock-down of the MCMBP transcript also 
triggered the response of DNA stress genes. Histone H2A.X is a single-copy 
gene that is located outside of the histones cluster in high eukaryotes. Its 
transcription is differently regulated from the typical gene expression of the 
rest of histones and it is rapidly phosphorylated by the ATM kinase on serine 
139 in response to DNA double-strand breaks and replication stress, providing 
a binding site for DNA repairing proteins (Bin and Zheng 2007; Pinto and Flaus 
2010). Immunolocalizations of the phosphorylated H2A.X histone using a 
specific antibody were carried out in MCF7 cultures. Phosphorylation of histone 
H2A.X was rarely observed in wild type MCF7 cells or in the empty vector 
control. In contrast, histone H2A.X phosphorylation was enhanced in the 
MCMBP knocked-down cells (Figure30). These results suggest that the 
absence of a functional MCMBP protein triggers the DNA stress response in 
MCF7cells. 
 
 
Figure 30. A. Immunostainings of phosphorylated histone H2A.X in MCF7 cells. Upon 
MCMBP knock-down, the DNA-stress-response checkpoint is activated, exemplified by 
the enhanced phosphorylation of the histone H2A.X. B. QPCR analysis of the different 
MCF7 lines used in the experiment, 80% of the MCMBP transcript is reduced in the 
stable knocked-down MCF7 line used in the experiment.C.Quantitation of the histone 
H2A.X foci that were observed in the control’s nuclei in comparison with the MCMBP 
knocked-down cells. 
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5.3. Discussion 
It has been shown that ETG1 protein binds to replisome components being 
required for efficient DNA replication, and its absence causes DNA replication 
stress (Takahashi, Lammens et al. 2008). Here, we showed that ETG1 plays 
an additional role in sister chromatid cohesion, suggesting that the DNA 
replication stress that exist in ETG1-deficient plants must be a causal effect 
derived from the altered DNA-repair efficiency exhibited in the knocked-down 
mutants. In both, plants and animals, external environmental cues, genotoxic 
stresses and the replication process itself, constantly challenge the cell DNA-
repair machinery. In order to cope with these challenges the cell has evolved 
different strategies to repair damaged DNA. In the particular case of double-
strand-brakes, the only way to repair them is by homologous recombination 
and thus, during the replication process sister chromatids must be held in 
close proximity in order to allow crossovers to occur. This implies that the 
processes of DNA replication, DNA repair, and sister chromatid cohesion must 
be tightly regulated at the same time and at the same place in order to assure 
an efficient and error-free cell cycle progression. 
 
Several observations suggest that the cohesion establishment is coupled to 
the replication process and occurs in close vicinity to the replisome. Cohesion 
is initiated by the acetyl transferase ECO1/CTF7 that travels along the DNA 
together with replication forks (Lengronne, McIntyre et al. 2006). 
Furthermore, in yeasts, the depletion or mutation of several nonessential 
components of the replisome, such as the replication factor CTF18, causes 
cohesion defects (Hanna, Kroll et al. 2001; Mayer, Pot et al. 2004). Through its 
association with MCM proteins, ETG1 is very likely a component of the 
replisome, and according to the results presented here, plays a role in 
establishing cohesion during the replication process.This model is supported by 
co-regulated expression of ETG1 and other genes involved in cohesion 
establishment, such as CTF7, CHL1, and CTF18 that are expressed during S 
phase and interestingly, are transcriptionally up-regulated in E2Fa-DPa 
overexpressing plants (Vandepoele, Vlieghe et al. 2005). Similarly, in this 
study we showed that the coexpression neighborhood from ETG1 and its 
human orthologue MCMBP is highly conserved (Figure 22). Moreover, similarly 
to its Arabidopsis homolog, MCMBP is highly coexpressed with genes related 
with sister chromatid cohesion such as MAD2, BUB3, and the members of the 
SMC complex (Table 11). 
 
When down-regulated in different human cell lines, MCMBP produced drastic 
phenotypic effects regarding sister chromatid cohesion. Nevertheless, the 
penetrance of the phenotype was different. When MCMBP was knocked-down 
in MDA-MB231 cells, a highly dedifferentiated-mesenchymal-like cell line, the 
percentage of totally disrupted metaphases was close to 70%. Similarly a high 
proportion of altered metaphases (35%) were found in the control cultures. 
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Opposing these results, in the MCF10A cells, an epithelial-like cell line, the 
amount of disrupted metaphases in the knocked-down cultures was only 7% 
and the presence of such altered metaphases was negligible in the control 
cultures (Figure 27). These differences can be explained by the different 
genetic background of the studied cell lines. The MDA-MB231 cells resemble 
the cellular conditions that can be found in terminal aggressive carcinomas; 
they are highly metastatic and invasive. This cell line contains dramatic 
genomic alterations and therefore, the phenotypic effect on sister chromatid 
cohesion is not only produced by MCMBP knock-down, but by the accumulation 
of different mutations on the replication machinery that have an additive effect 
on the observed phenotype. Contrastingly in the MCF10A cells, which resemble 
a normal epithelium, the archetypical DNA repair and DNA replication 
checkpoints should be active, controlling the cells in which MCMBP is knocked-
out targeting them probably to undergo apoptotic events. Experimentally, this 
was observed by a high proportion of dead cells in the MCMBP knocked-down 
cultures (data not shown). Similarly on MCF7 cells, another type of epithelial-
like cells, after the generation of a cell line with a constitutive MCMBP knock-
down, a constant diminishing in the knock-down status of the cell line during 
time was observed (Figure S3), hinting again, that given the importance of 
MCMBP, the cells having a good knocked-down of the MCMBP transcript are in 
some way controlled by the different replication checkpoints that are active in 
these types of cells. 
 
Similarly to its plant orthologue, upon MCMBP knock-down the activation of 
DNA-stress-response pathways were induced. This was evidenced by the 
phosphorylation of the histone H2A.X, suggesting that also in human cells the 
lack of cohesion between the sister chromatids has important effects on the 
efficient repair of DNA damages. Taken together, these results suggest that 
ETG1 and MCMBP have a conserved function during S phase for cohesion 
establishment, representing a novel important link between DNA replication 
and sister chromatid cohesion. 
 
As mentioned in the introductory chapter of this thesis, many oncogenes 
and/or tumor suppressors are involved in the G1-S cell cycle transition. 
Nevertheless, some spindle checkpoint regulators, such as the BUB kinases or 
MAD2, protect cells from aberrant chromosome segregation and may therefore 
function as suppressors of malignant transformation. Interestingly, MAD2 are 
either up- or down-regulated depending on the tumor type, and in both cases, 
these alterations result in chromosomal imbalances and tumor development 
(Perez de Castro, de Carcer et al. 2007; Pinto, Soares et al. 2007). Some 
other genes related with cohesion and chromosome segregation processes 
behave like MAD2, being overexpressed in certain types of carcinomas and 
down-regulated in others, having on either cases, a similar phenotypic 
outcome regarding chromosome structure. For example, this is the case of the 
Aurora kinases (Baldini, Arlot-Bonnemains et al. 2010; Wang, Xiang et al. 
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2010; Wu, Ma et al. 2011) or the Polo Like Kinase 1 (PLK1) (Grinshtein, Datti 
et al. 2011; Nihal, Stutz et al. 2011). Interestingly either, the down-regulation 
or overexpression of MCMBP on HEK293T cells produced similar effects on 
sister chromatids cohesion, suggesting that for the molecules involved in this 
process must be tightly controlled in order to avoid DNA replication and DNA 
repair problems that can result into carcinogenic events. 
 
Cohesion is essential for diverse biological processes, including chromosome 
segregation and gene expression (Watrin and Peters 2006). The importance of 
cohesion is illustrated by the observations that defects in cohesion factors 
associate with human genetic disorders, including colorectal cancer and 
developmental diseases, such as the Cornelia de Lange syndrome (Dorsett 
2007). Studies from a number of organisms have shown that defects in sister 
chromatid cohesion lead to chromosome missegregation, with aneuploidy, a 
hallmark of cancer progression, as a consequence (Barber, McManus et al. 
2008; Skibbens 2008). The depletion of the human MCMBP protein caused 
chromatid cohesion defects, suggesting that aberrant MCMBP expression might 
result in chromosome instability that increases the organism’s risk of 
neoplastic transformation. Therefore, in the next chapter, we will specifically 
address the role of MCMBP in cancer progression. 
 
5.4. Materials and methods 
Plant growth conditions and homozygous lines detection 
Arabidopsis thaliana ecotype Columbia-0 and ETG1 mutant plants were grown 
under long-day conditions (16 h/8 h light/darkness) at 22oC on half-strength 
Murashige and Skoog (MS) agar plates. ETG1 T-DNA lines were obtained from 
the European Arabidopsis Stock Centre (NASC). To screen for homozygous 
insertion alleles, primers were designed following the instructions of the Salk 
institute genomic analysis laboratory 
(http://signal.salk.edu/tdnaprimers.2.html). The complete list of the used 
primers for the selection of homozygous lines is detailed in the Appendix D. 
 
Microarray and GO analyses 
For the microarray experiment, RNA was extracted from 9-day-old Arabidopsis 
leaf primordia with the RNeasy Plant Mini Kit (Qiagen). The microarray 
experiment was done by the VIB MicroArrays Facility (Leuven, Belgium; 
http://www.microarrays.be/) with the ATH1 GeneChip array (Affymetrix, 
Santa Clara, CA, USA) of 23,800 probe sets designed for Arabidopsis. The 
experimental design comprised three replicates of each genotype, with one 
replicate corresponding to one RNA extraction from an independent pool of 
plants. Raw data obtained by microarray were analyzed as described in 
(Lammens, Boudolf et al. 2008). To determine significantly overrepresented 
GO categories among up- and down-regulated genes, we used the BiNGO 
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plugin for Cytoscape (http://www.psb.ugent.be/cbd/papers/BiNGO/)(Maere, 
Heymans et al. 2005). Promoter motif enrichment was calculated with the 
hypergeometric distribution based on MSA motif instances as reported 
(Vandepoele, Casneuf et al. 2006). 
 
Calculation of the evolutionary conservation of the ETG1-MCMBP 
coexpression neighborhood 
The top 300 coexpressed genes for ETG1 were retrieved from the ATTED-II 
database (Obayashi, Kinoshita et al. 2007) and for MCMBP from COXPRESdb 
(Obayashi and Kinoshita 2011). The percentage of orthologous genes present 
in the list of coexpressed genes for both species, was determined looking for 
overlapping sets of orthologues using Microsoft Access®. To establish the 
threshold of significance, 100 random Arabidopsis genes with human 
orthologues were selected and the lists of coexpressed genes were retrieved 
from the previously mentioned databases. On these random lists 95% of the 
orthologous-sets selected, had less than 9% of shared orthologous genes. This 
value corresponds to the significance threshold. 
 
FISH analysis, microscopic evaluation, image processing, and 
statistics 
Preparation of nuclei, probe labeling, and fluorescent in situ hybridization 
(FISH) were as described in (Schubert, Kim et al. 2008). FISH signals were 
analyzed with an epifluorescence microscope Axiophot (Zeiss) with a 
100x/1.45 a-plan-fluar objective and a 3-chip color camera (DXC-950P; Sony, 
Tokyo, Japan). The microscope was integrated into a Digital Optical 3D 
Microscope system (SchwertnerGbR, Jena, Germany) to check signal 
separation/distances along x-, y-, and z-axes. Images were captured 
separately for each fluorochrome with appropriate excitation and emission 
filters. The images were merged with Adobe Photoshop 6.0 software (Adobe 
Systems, San Jose, CA, USA). FISH signals indicating positional sister 
chromatid separation were compared against those of the Col-0 wild-type by 
the one-sided Fisher’s exact test. 
 
Comet assay for DNA damage measurement 
DNA damage was detected by comet using a CometAssay kit (Trevigen, 
Gaithersburg, MD, USA). Samples were prepared as described in (Wang and 
Liu 2006). The percentage of DNA in each comet tail was evaluated with 
Comet Score software (http://www.autocomet.com). DNA damage was 
calculated by averaging the values for the percentage of DNA in tails from 
three individual slides, scoring 80 comets per slide. The percentage of the 
remaining damage after a given post-treatment recovery time is defined as: % 
of DSB remaining = (mean % tail-DNA (tx) - mean % tail-DNA (control))/ 
(mean % tail-DNA (t0) - mean % tail-DNA (control)) X 100. 
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HEK-293T cell culture and transfection 
HEK-293T cell cultures were grown in 5 ml of complete medium (Dulbecco’s 
modified Eagle medium with 10% fetal calf serum; Invitrogen) at 37⁰C and 
5% CO2. siRNAs were transfected into HEK-293T cells grown in 6-well plates 
according to the manufacturer’s instructions (DharmaFECT, Thermo Fisher 
Scientific, Waltham, MA, USA). Final concentrations of each siRNA were 30 nM. 
The following siRNA sequences were used: human MCMBP (C10ORF119) 
(SMARTpool; J-014474-09, J-014474- 10, J-014474-11, and J-014474-12) 
and control (SMARTpoolnon-targeting pool). For the overexpression of MCMBP, 
a lentiviral construct containing the complete ORF of the MCMBP gene 
(C10ORF110) was purchased to Open-Biosystems® (MHS1011-58896) and 
cloned into the pDWPITetoMCMBPv5His vector. For the transfection 
experiments the previously prepared lentiviral vector was used in a final 
concentration of 1µg/µl.The transfection of the HEK cells to transiently 
overexpressed MCMBP was done as follows: 250 µl of BS/Hepes were put into 
an eppendorf tube.  In a different eppendorf tube 50 µl of CaCl2/Hepes, 197 µl 
of TE and 3 µl of the lentivaral construct containing MCMBP were mixed. This 
mix was added drop-wise onto the 250 µl of BS/Hepes. This final mixed was 
gently shook in a vortex for one minute and incubated at 37⁰C for 10 minutes. 
After incubation, the mix was added drop-wise to 1.0X106 HEK cells, contained 
into a T25 Flask. After 6h, the medium was refreshed. 
 
Protein gel blotting 
Protein extracts were prepared from 2-day-old transfected HEK293T cells. 
Protein gel blotting was carried out according to standard procedures with 
primary anti-MCM4 (ab4459), anti- MCM6 (ab4458), and anti-MCF7 (ab52489) 
antibodies (Abcam, Cambridge, UK) at a dilution of 1:2,000, 1:2,000, and 
1:10,000, respectively. The MCMBP antibody (Sakwe, Nguyen et al. 2007) was 
used at a 1:1,000 dilution and a horseradish peroxidase–conjugated donkey 
anti-rabbit (GE-Healthcare) diluted 1:10,000 as a secondary antibody. Proteins 
were detected with Western Lightning Plus-ECL luminol reagent (Perkin Elmer, 
Massachusetts, USA) according to the manufacturer’s instructions. 
 
Chromosome spreads and DAPI staining 
Sub-confluent HEK cells were treated 48h after transfection with 
KaryoMAXcolcemid (Invitrogen) to enrich for mitotic chromosomes. The 
complete medium was replaced by 2 ml of medium at a final concentration of 
KaryoMAX of 0.6 mg/ml. Cells were incubated at 37⁰C with 5% CO2 for 5h 
before harvesting, trypsinized, pelleted (110 g for 5 min), and resuspended in 
1 ml of a hypotonic solution of KCl at a final concentration of 60 mM for 30 
min at room temperature. After incubation, HEK cells were twice pelleted (110 
g for 5 min) and resuspended in freshly made methanol:glacial acetic acid 
(3:1) added drop-wise. Two or 3 drops of suspended cells were applied to pre-
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cleaned smear glass slides (Menzel-Glazer, Braunschweig, Germany) and 
chromosomes were counterstained with Vecta- Shield (Vector Laboratories, 
Burlingame, CA, USA) containing DAPI. A minimum of 200 mitotic spreads 
were imaged for each control or siRNA-treated cell population with the DAPI 
channel of a BX61 Olympus epifluorescence microscope equipped with a 
1006/1.30 UPlan FLN objective coupled to a U-C MAD 3 imaging system with a 
Cell-M imaging software (Olympus, Tokyo, Japan). A minimum of 200 
metaphases were evaluated per construct and those metaphases containing 
more than 70% of chromosomes with separated sister chromatids were scored 
as positives. 
 
Quantitative PCR analysis of MCMBP knocked-down cells 
Cells were collected 48h after transfection with a rubber policeman. RNA was 
extracted with an RNeasy animal Mini Kit (Qiagen) and cDNA was prepared 
with the cDNA Synthesis System according to manufacturer’s instructions 
(Roche Diagnostics, Indianapolis, USA). For quantitative PCR, a Light-Cycler 
480 SYBR Green I Master (Roche Diagnostics) was used with 100 nM primers 
and 0.1 mg of reverse transcription reaction product. Reactions were run and 
analyzed on the LightCycler 480 Real-Time PCR System according to 
manufacturer’s instructions (Roche Diagnostics). All quantifications were 
normalized to the TATA Binding Protein (TBP) and Ubiquitin C (UBC) 
expression levels. Quantitative reactions were done in triplicate and averaged. 
Primers used were 5’ACTCTCCACGAAATACCACTTTG3’and 
5’GTAGGATGTTGAGGGACTGACTCG3’ for MCMBP, 
5’CGGCTGTTTAACTTCGCTTC3’ and 5’CACACGCCAAGAAACAGTGA3’for TBP, 
and 5’ATTTGGGTCGCGGTTCTTG3’and 5’TGCCTTGACATTCTCGATGGT3’ for 
UBC. 
 
Generation of stable MDA-MB231 and MCF7 lines with a constitutive 
knock-down of MCMBP 
Lentiviral construct V2HS-158067 (Catalog number: RHS4430-99167940) to 
knock-down MCMBP (C10ORF119) was purchased to Open-Biosystems®. 
Protocol to obtain 100 µl of V2HS-158067 construct at 1 µg/ µl necessary to 
transfect HEK-293 cells to produce viral particles was followed according to the 
manufacturer's instructions using Qiagen midi-preps extraction kid®. 
 
Three different constructs were used to produce the final DNA mix prior-to 
transfect HEK-293 cells.  3 µl of the construct pCMVD8-9-MCO23, 1.5 µl of the 
construct pMG-MCO22 and 3 µl of the construct V2HS-158067 each one with a 
concentration of 1 µg/µl were mixed with 1 µl of 1M Sodium Acetate, 3 µl of 
absolute ethanol and 8.5 µl of bi-distillated water to obtain a final mix of 20 µl. 
The mix was gently mixed by pipetting and was put at -70oC for 30 minutes, 
after this, the mix was centrifuged at maximum speed during 30 minutes at 
4oC.  Supernatant was removed and the pellet was washed with 250 µl of 70% 
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Ethanol.  The mix was again centrifuged at maximum speed during 5 minutes 
at 4oC after of which, the supernatant was removed and the pellet was dried 
at room temperature; afterwards the pellet was resuspended in 10 µl of bi-
distillated water.HEK cells were grown in 25 cm2 Flasks in 5 ml of complete 
medium (DMEM 10% FACS) at 37⁰C and 5% CO2.  Two days before 
transfection, HEK cells were trypsinized and split into 6-well plates containing 
4 ml of fresh culture media.  Afterwards cells were incubated at 37⁰C and 5% 
CO2 during two days until the moment of transfection in which cells were still 
sub-confluent. 
 
A calcium phosphate precipitate suspension was prepared in two 5 ml tubes. 
In one of these tubes 250 µl of HEPES buffered saline solution (16.4 g NaCl, 
11.9 g HEPES acid and 0.21 g Na2HPO4, per liter, pH 7.05) were put. In the 
other tube a solution containing 10 µl of the lentiviral mix , 190 µl of TE Buffer 
and 50 µl of CaCl2 (2.5 M) was prepared.This DNA mix was added drop-wise 
to the tube containing the HEPES buffered, afterwards, the solution was mixed 
well using gently vortex for 30 seconds. The mixed solution was kept for 10 
min at 37⁰C in order to form the calcium phosphate precipitates. After the 
incubation, 4µl of 25mM Chlorocaine were added to the mix. Sub-confluent 
HEK cells were transfected by adding 250 µl of the DNA mix to the culture 
cells. HEK cells were grown during 8 hours at 37⁰C and 5% CO2, after this 
period of time, the culture medium was refreshed. Finally HEK cells were 
grown during 2 days to produce viral particles.After 2 days of incubation, HEK 
cells were trypsinized, collected in 15 ml tubes and filtered, using a syringe 
and a 0.45 µm filter.  The filtered suspension was recovered and viral particle 
aliquots of 1ml were collected in 1.5 ml centrifuge tubes. Viral particles 
suspension was storage at -80⁰C. 
 
MCF7 (or MDA-MB231) cells were grown in 25 cm2 flasks in 5 ml of medium 
(10% bovine calf serum and 10 mM HEPES) at 37⁰C and 5% CO2. Before 
infecting MCF7 cells with the viral particles cells were trypsinized and counted 
making aliquots of 4 ml cells (70000-80000 cells/ml) in 15 ml tubes. MCF7 
cells were precipitated by centrifugation at 2000 rpm during 5 minutes.  
Supernatant was removed and cells were gently resuspended in 600 µl of viral 
particles suspension.  The mix was divided in triplicates of 200 µl into 96 well-
plates. The mix was centrifuged at 2000 rpm during 90 minutes at 32⁰C, after 
centrifugation, plates were placed at 37⁰C and 5% CO2 during two days to let 
the viruses infecting the MCF7 cells.  After 2 days of incubation the triplicates 
of cells were stopped and merged into a single well using 12 well-plates; in the 
same way after two days of incubation cells were transferred from 12 well-
plates to 6 well-plates and incubated during 4 weeks at 37⁰C and 5% CO2in a 
quarantine period, the MCF7 medium was replaced twice a week.  After one 
month a stable MCMBP knocked-down MCF7 (or MDA-MB231)cell line was 
obtained. 
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Immunofluorescence analysis of histone H2A.X 
MCF7  parental, empty vector control, and MCMBP knocked-down cells were 
grown in 25 cm2 Flasks in 5 ml of MCF7 medium at 37⁰C and 5% CO2. Two 
days before the experiment, cells were trypsinized and resuspended into 4.5 
ml of fresh medium. Small coverslips were placed inside 18 well-plates and 
1ml of the cell suspension was added to each one of the coverslips.  Cells were 
grown at 37⁰C and 5% CO2 during two days.  Afterwards, cells were washed 
with 1ml of PBS three times and fixed with 500 µl of methanol.  After 
methanol fixation cells were incubated at -20⁰C during 10 minutes.  After, 
methanol was removed from the coverslips and cells were washed three times 
with 1 ml of PBS buffer.  Subsequently, 200 µl of 0.02% gelatin in PBS 
solution were added to the coverslips and cells were incubated during 1 hour 
at room temperature. A solution of 200 µl of gelatin in PBS buffer and 1 µl of 
primary antibody (0.05 µg/ml Anti-phospho-Histone H2A.X-ser-139 antibody, 
Millipore® catalog number 05-636) was made. Gelatin was removed from the 
coverslips and 200µl of primary antibody solution was added to the cells 
incubating during 1 hour at room temperature.  After incubation, the excess of 
primary antibody was removed from the cells by washing the cells three times 
with 1 ml of PBS buffer. A solution of 200 µl of gelatin in PBS buffer and 0.5 µl 
of secondary antibody (2mg/ml Alexafluor® 488 goat-anti-mouse antibody, 
Invitrogen®) was made and 200µl of secondary antibody solution were added 
to the cells incubating during 1 hour at room temperature in the dark.  After 
incubation, the excess of secondary antibody was removed from the cells by 
washing the cells three times with 1 ml of PBS buffer.  Coverslips were 
mounted on microscopic glass slides andcounterstained with Vecta-Shield 
(Vector Laboratories, Burlingame, CA, USA) containing DAPI. Cells were 
imaged using the green channel of a BX61 Olympus epifluorescence 
microscope equipped with a 1006/1.30 UPlan FLN objective coupled to a U-C 
MAD 3 imaging system with a Cell-M imaging software (Olympus, Tokyo, 
Japan). A minimum of 100 nuclei per construct were selected and in each 
nucleus the histone H2A.X foci were counted. 
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5.5. Supplementary information 
 
 
Figure S3. Counter-selection against the MCMBP knocked-down cells. The MCMBP 
knock-down of the MCF7 cell line with a constitutive MCMBP knock-down is diminishing 
during time. 
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6.1. Introduction 
Most current methods for the detection and characterization of abnormally 
proliferating cells on biopsied samples are limited to a small number of 
proliferation markers. For some of these markers very little is known about its 
biology and cell cycle-related function, while for others, their activity is not 
only limited to proliferation processes.  Because of this, molecular marker 
identification for early cancer detection on biopsied samples holds promise for 
refining our ability to establish early diagnosis, and prognosis, and to predict 
response to therapy.  One of the most important advantages in the 
development of new molecular markers is based on the knowledge about the 
molecular biology of the marker itself; the more that we know about the 
molecular function of the marker, the more that we can expect about its 
potential use in the cancer diagnosis and treatment (Ransohoff 2004). 
 
Nevertheless, the complex molecular alterations and inherited abnormalities 
that are present in cancer, make it extremely difficult to develop molecular 
tools that can be used as early markers for all the distinct and heterogonous 
neoplasias that exist.  A good marker for the detection of breast carcinomas it 
is not necessarily good for the detection of colorectal cancers and vice versa.  
For the generation of a useful marker with a high prognosis value in a wide 
range of carcinomas, it is necessary to aim to the core of any malignant 
transformation. As was shown in the introductory chapter of this thesis, one of 
the most distinguishable and relevant cancer characteristic that is shared 
among a great variety of neoplasias is the ability of the malignant cells to 
hyper-proliferate (Hanahan and Weinberg 2000; Evan and Vousden 2001; 
Goodarzi, Elemento et al. 2009; Hanahan and Weinberg 2011). 
 
Because of its essential role during development, it is not surprising to see 
that the molecular machinery controlling DNA replication and mitosis is highly 
conserved among organisms. All known physiologic signals and signalling 
pathways affecting cell proliferation are in some way connected to the 
regulators of the cell cycle, which is one of the most conserved mechanisms 
throughout evolution. Drastic changes over key steps within these signalling 
pathways can lead to dramatic changes in DNA replication, DNA repair 
efficiency, and rate of cell proliferation. In mammals, altered cell proliferation 
pathways are directly linked with malignant transformation processes that lead 
to tumorigenesis.  Due to this, it is expected that key molecules involved in 
the control of cell proliferation could be considered as potential good markers 
for early cancer diagnosis in a broad spectrum of malignancies. 
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The best example of a diagnostic tool is the commonly used marker for 
proliferation Ki-67, an evolutionary conserved protein which expression is 
strictly associated with cell proliferation.  The fact that the Ki-67 protein is 
present during all active phases of the cell cycle, but absent from resting G0 
cells, makes it an excellent marker for determining the growth fraction of a 
specific cell population including tumors (Scholzen and Gerdes 2000).  The 
fraction of Ki-67 positive tumor cells (the Ki-67 labelling index) is often 
correlated with the clinical course of many different types of cancers like 
sarcomas (Rudolph, Kellner et al. 1997; Huuhtanen, Blomqvist et al. 1999), 
prostate cancer (Aaltomaa, Lipponen et al. 1997; Borre, Bentzen et al. 1998) 
and breast carcinomas (Archer, Eliopoulos et al. 1995; Veronese, Maisano et 
al. 1995). Nevertheless, this molecule has two major drawbacks as the perfect 
cancer marker. Firstly, almost nothing is known about its molecular function. 
We do not know why this molecule is so tightly linked with the cell cycle.  
Clarifying the biological function of the Ki-67 protein could shed light on its 
importance in proliferation, and could explain why in some cases no 
correlation has been found between its expression and the diagnosis and 
prognosis of specific carcinomas. Secondly, Ki-67 is a marker for cell 
proliferation in general; a distinction between normal proliferating cells and 
neoplastic transformed proliferating cells cannot be made, which is crucial in 
order to differentiate normal cells from those ones that are transformed in 
early stages of the disease. 
 
Previous reports have shown that the evolutionarily conserved replisome 
MCMBP binds to chromatin in a cell cycle phase-dependent manner with the 
highest affinity for DNA during G1/S and S phases.  Even more interesting, the 
MCMBP protein was shown to be an active member of the MCM complex in 
humans (Sakwe, Nguyen et al. 2007). Additionally, our experiments were able 
to demonstrate that depletion of ETG1, the plant orthologue of MCMBP, 
resulted in a late G2 cell cycle arrest, correlated with a partial loss of sister 
chromatid cohesion. Similarly, cohesion defects were observed upon knock-
down of the MCMBP gene in human cell cultures, suggesting an equally 
important developmental role for this evolutionarily conserved protein 
(Takahashi, Quimbaya et al. 2010). As stipulated above, molecules directly 
involved in the process of DNA replication can be considered as potential 
markers for early cancer detection. Given that MCMBP is novel member of the 
MCM complex, it might represent a new marker for cancer diagnosis, 
prognosis, and perhaps also treatment. The fact that MCMBP expression must 
be continued from G1 to mitosis due to its function on DNA replication and 
sister chromatid cohesion, being associated only with replicating cells, 
suggests that this protein can have an extraordinary value as a cancer marker. 
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6.2. Results 
To address the role of the novel replisome factor MCMBP in carcinogenesis, the 
effects of knocking-down or overexpressing MCMBP were studied at 
transcriptional and protein level. For doing so, the previously generated MCF7 
and MDA-MB231 cells lines constitutively overexpressing or silencing the 
MCMBP gene were used. Concomitantly, to study MCMBP at the protein level, 
a high-quality antibody against the MCMBP protein was generated. The full-
length protein was purified and injected as antigen into rabbits to produce a 
polyclonal antibody. The anti-serum obtained was further immune-purified 
using the antigen (Figure 31A). Western-blot analysis showed that the 
antibody recognizes specifically the MCMBP protein with almost no 
background. The antibody specifically recognized MCMBP in different cell lines 
and appeared sensitive enough to detect the small fraction of the protein that 
remains expressed in knocked-down cultures (Figure 31B). 
Immunofluorescence analyses on cell cultures using the specific antibody 
showed that the MCMBP protein localized in the nuclei (excluding the nucleoli) 
of the cells, in accordance with its predicted molecular function as replication 
factor (Figure 31C).  In MCMBP knocked-down cultures, the protein is barely 
detectable (Figure 31D), whereas in overexpressing cultures harboring a 
tagged version of MCMBP (V5-tag), a perfect co-localization is observed when 
using an antibody against the tag and the MCMBP antibody (Figure 31E), 
indicating that the generated antibody is specific and sensitive. 
 
MCMBP  knocked-down cultures were studied at cellular level. Flow cytometric 
analysis of knocked-down cultures displayed a shoulder on the ploidy profile, 
characterized by the presence of a sub-population of cells with a DNA content 
higher than 4C (Figure 32A). This cell population was correlated with particular 
changes in the cellular morphology of some cells. These changes appeared as 
multi-nucleated and/or giant cells that were completely negative for the 
MCMBP protein (Figure 32B). The number of multi-nucleated cells was almost 
five-fold higher in the knocked-down cultures, in comparison with controls 
(Figure 32C). This phenotype was accompanied by the transcriptional up-
regulation of specific cell cycle markers such as cyclin-B1, cyclin-B2 and CDK1 
(Figure 32E). Similarly, in MCF7 cultures overexpressing MCMBP, 
multinucleated cells were observed, as well as cell with micronuclei (Figure 
33A). A four-fold increment in the number of multi-nucleated cells in 
comparison with controls could be observed (Figure 33B). Also here, cell cycle 
marker genes were transcriptional up-regulated (Figure 33C). 
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Figure 31. Generation of an antibody against the MCMBP protein. A. Elisa reactions 
testing antibody specificity and sensitivity. One µg of proteins per well (plant extracts 
and MCMBP purified protein) was used. 1. Arabidopsis protein extracts (negative 
control), 2. Pre-immunization control, 3. First bleeding, 4. Second bleeding and 5. Last 
bleeding. Ratio’s at right indicate serum dilutions. B. Western-blot analysis of the 
purified MCMBP antibody in two different cell lines. 1. MCF7-WT, 2. MCF7-Empty 
Vector, 3. MFC7-MCMBP-KD, 4. MCF7-MCMBP-OE (V5-tagged), 5. MDA-MB231-WT, 6. 
MDA-MB231-Empty Vector, 7. MDA-MB231-MCMBP-KD, 8. MCMBP purified protein. C. 
Nuclear localization of the MCMBP protein in MCF7 cells. D. MCF7 culture where the 
MCMBP transcript has been constitutively knocked-down. Note the strong reduction in 
MCMBP signal. E. Localization of the MCMBP protein in overexpressing MCF7 cultures.  
MCMBP protein was detected using two different antibodies, the V5-tag antibody that 
detects the tagged version of MCMBP, and the generated MCMBP antibody. A perfect 
colocalization is observed in the merged image. 
 
 
As was shown in chapter-IV, according to the performed Cox analyses, MCMBP 
expression levels represent a good marker for predicting particular cancer 
outcomes, specifically relapse risk in breast carcinomas. Given this 
association, a cohort of 56 breast tumor samples was studied at transcriptional 
level. By examining this cohort of tumors, it was evident that a high 
proportion of tumors expressing MCMBP were also estrogen receptor negative 
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(ER-), a cancer hallmark that accounts for poor prognosis and difficult 
treatment (Figure 34).   
 
 
Figure 32. Cellular analysis of of MCMBP knocked-down MCF7 cells. A. Flow 
cytometry profiles of MCMBP-knocked down cells in comparison with controls. Upon 
knock-down a sub-population of cells with DNA content higher than 4C appeared in 
the culture. B. A correlation exists, between multinucleation and a reduction or 
absence of MCMBP protein expression in those types of cells, both in control and 
knocked-down cultures C. Quantification of the multinucleated cells present in the 
different analyzed cultures. D. Up-regulation of specific cell cycle markers upon 
MCMBP knock-down. 
 
In order to validate MCMBP as a novel cancer marker with a prognostic value, 
we extended our Cox analyses to different types of carcinomas, to detect 
whether in these neoplasias a change in MCMBP gene expression is associated 
with changes on relapse risk probability. Figure 35 shows, that for different 
carcinomas, either a high or reduced MCMBP gene expression is significantly 
associated with cancer relapse events. 
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Figure 33. Cellular analysis of MCMBP overexpressing MCF7 cells. A. Upon MCMBP 
overexpression multinucleated cells and micronuclei (arrows) can be observed. B. 
Quantification of the multinucleated cells that are present in the different analyzed 
cultures and C. Up-regulation of specific cell cycle markers upon MCMBP 
overexpression.  
 
 
Figure 34. A. MCMBP transcript levels in a series of 56 primary human breast 
cancers, showing a broad variation in expression. B. The 56 breast tumors were 
divided in quartiles according to MCMBP expression level. In those tumors in which 
MCMBP is highly expressed (Q3 and Q4 quartiles), the ER status is negative, a cancer 
hallmark that accounts for poor prognosis and difficult treatment in breast cancers. 
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Figure 35. Examples of Cox-survival plots for specific carcinomas. For colon, head 
and neck carcinomas, and leukemia, a clear association between an increased MCMBP 
gene expression level and a diminished probability of survival is illustrated. Contrary 
for lung carcinoma, when MCMBP is lowly expressed the relapse-free survival 
probability is reduced. (RRC: Relative Risk Coefficient; * represents statistically 
significant differences in the survival probability P <0.05 and n is the number of 
patients taken into account for the construction of the survival plots). 
 
To study further the role of MCMBP in carcinogenesis, different tumor samples 
were studied at protein level by immunohistochemistry. To determine whether 
MCMBP protein accumulation is associated with proliferation, normal tissues 
and tumor sections were analyzed and compared with samples stained with 
the Ki-67 antibody.  The immunostainings revealed a high correlation between 
MCMBP and Ki-67 accumulation. In this way, Ki-67 positive samples stained 
strongly positive for MCMBP and vice versa; samples negative for MCMBP, 
scored also negatively for Ki-67 (Figure 36).  Interestingly, in breast cancer 
xenografts, Ki-67 identified proliferating cells from the tumor and also from 
the surrounding skin, whereas the MCMBP antibody identified proliferating 
cells from the tumor but its staining was weak for the proliferating cells from 
the normal skin, suggesting that MCMBP predominantly identifies cells that are 
malignantly proliferating. This potential ability to identify malignantly 
transformed cells over normal proliferating cells suggests that the MCMBP 
antibody might be useful for early detection of cancer (Figure 37). 
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Figure 36. Immunohistochemistry analysis of different tumor sections showing a high 
correlation between Ki-67 and MCMBP accumulation. Mouse tumors highly positive for 
Ki-67 are also positive for MCMBP and vice versa. 
 
 
Figure 37. Breast cancer xenograft stained for Ki-67 and MCMBP. Ki-67 identifies 
proliferating cells from the tumor and also from the skin. Contrastingly, MCMBP 
identifies proliferating cells from the tumor, but its staining is weak for the 
proliferating cells of the normal skin, suggesting that MCMBP detects preferentially 
malignantly transformed cells. 
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In order to establish a direct link between MCMBP levels and cancer 
progression, and in order to validate the potential use of the MCMBP antibody 
in cancer diagnosis and prognosis, the immunohistochemical analysis was 
extended to a series of human tumors. A cohort of 20 human colon 
adenocarcinoma sections was analyzed in detail. Particularly we selected 
tumor samples that contained normal colon epithelium tissue within the same 
sample, making possible direct comparisons between the tumoral and the 
normal tissue. In addition this cohort contained tumors with different degrees 
of progression, ranging from well differentiated colon adenocarcinomas to 
poorly differentiated carcinomas.  The reason to study colon carcinomas was 
based on the fact that according to our data, MCMBP has a fundamental role in 
sister chromatid cohesion, whereas recent evidence suggests that cohesion is 
a key deregulated process particularly in colorectal cancers (Dorsett 2007; 
Barber, McManus et al. 2008; Barbero 2011).  
 
The pathological analysis of the samples, revealed that normal epithelium, 
showed week to moderate staining of MCMBP at the base of the crypts, this 
region corresponds to the proliferative compartment from where regeneration 
happens. Contrastingly, MCMBP positivity disappeared towards the surface of 
the crypt at the site of the lumen, where cell division is not active and cells are 
differentiated (Figure 38B). Interestingly, in some other structures MCMBP 
protein abundance was associated with proliferating cells in normal tissue. This 
was the case of the lymph nodules in peripheral lymph tissue in which the 
germinal centers, structures that contain B-cells that proliferate and mutate 
via somatic hypermutation, were moderately stained with the MCMBP antibody 
(Figure 38C). Similarly in the mucinous adenocarcinoma, the mucinous cancer 
cells, which are more differentiated structures stained week for MCMBP in 
comparison with less differentiated cancer cells (Figure 38D). Strikingly, in the 
majority of the tumors there was a clear stronger expression of MCMBP in 
comparison with the normal mucosa. Only in a few tumor samples, the 
staining for MCMBP was a little bit weaker but still stronger in comparison with 
the normal tissue. In the tumoral fractions of the different types of analyzed 
carcinomas, the MCMBP abundance is remarkably strong in the nuclei of the 
cells and in a lesser extend the positivity can also be detected in the 
cytoplasm (Table 12 and figure 39). Finally, at the invasion front of the tumors 
there is no clear change in MCMBP expression in comparison with the rest of 
the tumor-mass. 
 
The data above described, hints again the ability of MCMBP antibody for 
detecting specifically replicating cells, concomitantly, its capability of strongly 
mark abnormally proliferating cells, suggest that the use of the MCMBP 
antibody might have important clinical applications for cancer detection in 
biopsied samples. 
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Figure 38. MCMBP protein levels in normal replicating cells. A. In general, normal 
epithelium, showed week to moderate staining of MCMBP. B. At the base of the 
normal crypts (in proximity to the muscularis mucosae, light blue bar on top of the 
picture), corresponding to the proliferative stem and transient amplifying cell 
compartment from where regeneration happens, MCMBP protein is well expressed 
(arrow). Contrastingly, MCMBP positivity disappears towards the surface of the crypt 
at the site of the lumen, where cell division is not active and cells are strongly 
differentiated (dark blue bar on top of the picture). C. In lymphoid follicles the 
germinal centers (arrow), sites that contain actively replicating B-cells, MCMBP is 
detected. D. In the mucinous adenocarcinoma type, the mucinous cancer cells, which 
are more differentiated and responsible for the abnormal mucus production (red 
arrows), stained weaker for MCMBP in comparison with the highly MCMBP positive 
cancer cells (light blue bar on top of the picture). 
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Figure 39. In the majority of the tumors there was a clear stronger expression of 
MCMBP in comparison with the normal mucosa. MCMBP is highly present in the nuclei 
of tumor Cells, A. Well-differentiated adenocarcinoma, B.  Moderate-differentiated 
adenocarcinoma and C. poorly differentiated adenocarcinoma. D.  Quantification of 
MCMBP positive cells in the tumor mass of the different analyzed carcinomas in 
comparison with the normal tissue.  
 
Table 12. Detailed pathological analysis of the colorectal adenocarcinoma samples. 
Tumor information MCMBP staining 
Tumor ID Tumor type 
Nuclear 
intensity 
Cytoplasmic 
intensity 
%  of MCMBP positive 
cells in the tumor 
1586472 MD adenocarcinoma after RCT Strong Strong > 90 
1588283 WD to MD adenocarcinoma Strong Strong > 90 
1586788 MD adenocarcinoma after RCT Moderate Light 70 
1587630 MD adenocarcinoma Strong Strong > 90 
1587605 WD to MD adenocarcinoma Strong Strong 70 
1588382 MD adenocarcinoma Strong Strong > 90 
1588619 MD tot PD adenocarcinoma Strong Strong 70 
1588677 MD adenocarcinoma Moderate Light > 90 
1586813 MD adenocarcinoma Moderate Strong 80 
1588204 WD adenocarcinoma Strong Strong > 90 
1589162 PD adenocarcinoma Light Moderate 80 
1588915 MD adenocarcinoma Strong Strong > 90 
1321831 MD adenocarcinoma Moderate Light 60 
1324028 MD adenocarcinoma Strong Light 70 
1324038 MD adenocarcinoma Moderate Moderate > 90 
1324941 MD adenocarcinoma Strong Strong > 90 
1328264 MD + PD adenocarcinoma Strong Strong > 90 
1325706 PD adenocarcinoma (mucineus type) Strong Strong > 90 
1335290 MD adenocarcinoma Strong Moderate > 90 
1321369 MD adenocarcinoma Moderate Light 50 
WD, MD and PD: Well, moderate and poorly differentiated carcinomas respectively. 
RCT: Radio-Chemo Therapy.  
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6.3. Discussion 
Cancer is considered as a group of diseases for which the tumor of origin, 
gives the common distinctive characteristics of a particular cancer type. More 
than one hundred of human cancers have been classified, making extremely 
difficult the comprehensive understanding of all the molecular signals and 
altered transductional cascades that lead to the neoplastic transformation.  A 
potential complementary tool for unraveling the complex genotype-phenotype 
relationships that occur during cancer progression, is the use of systems 
biology approaches and integrative studies (Goodarzi, Elemento et al. 2009; 
Ficklin, Luo et al. 2010). 
 
In this research, by using and integrative strategy compiling different 
structural and genomic data the E2F TARGET GENE 1 (ETG1) was identified as 
a novel evolutionarily conserved replisome factor. We were able to 
demonstrate, that in plants ETG1 is associated with the minichromosome 
maintenance complex (MCM), being crucial for efficient DNA replication 
(Takahashi, Lammens et al. 2008).  Additionally, we were able to show that 
depletion of ETG1 in Arabidopsis results in a late G2 cell cycle arrest that 
correlates with a partial loss of sister chromatid cohesion. Reciprocally, 
cohesion defects observed upon knock-down or overexpression of the human 
orthologue of the ETG1 gene, the MCMBP molecule, in human cell cultures 
suggest an equally important developmental role for this evolutionarily 
conserved novel protein. 
 
When the consequences of having a MCMBP knock-down in MCF7 human 
cultures were analyzed, one of the first observations was the accumulation of 
a subpopulation of cells that are multinucleated with polylobed nuclei. This cell 
population was characterized by flow cytometry, representing between 7% 
and 8% of the cultured cells (Figure 32A).  Interestingly, when we addressed 
the depletion of the MCMBP protein by using a specific antibody against 
MCMBP, we observed that the multinucleated cells in the MCMBP knocked-
down cultures were MCMBP negative. Strikingly, also in MCF7 cell cultures 
overexpressing the MCMBP transcript an increase in the number of 
multinucleated cells was observed, together with the appearance of 
micronuclei (Figure 33). In the previous chapter, it was shown that MCMBP 
misexpression has a significant negative effect on sister chromatids cohesion. 
Interestingly, recently it has been shown that a clear correlation exists 
between sister chromatid cohesion phenotypes, chromosome-segregation 
problems, and the appearance of multinucleated-polylobed cells. Nguyen and 
collaborators showed that when the Aurora-B protein is misregulated, there is 
a clear accumulation of multinucleated cells, which are able to promote 
tumorigenesis (Nguyen, Makitalo et al. 2009). Similarly, in a genome-wide 
screening searching for cell division-related genes, Neumann and colleagues 
were able to show that genes that are necessary for the proper separation of 
the chromosomes, can be clustered according to specific phenotypes that have 
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in common the production of multinucleated cells (Neumann, Walter et al. 
2010). Chromosomal missegregation and its direct consequence, the 
production of aneuploid cells, is a hallmark of the neoplastic transformation 
(Hanahan and Weinberg 2011). Aneuploid cells are prompted to become 
cancer cells due to the generation of an imbalanced genome, which amplifies 
oncogenes in some cells and restrain tumor suppressors in others (Draviam, 
Xie et al. 2004; Fang and Zhang 2011). We can postulate that the MCMBP 
gene acts as a putative oncogene. MCMBP protein participates in the 
oncogenic transformation by the generation of aneuploid multinucleated cells. 
Its misregulation can be regarded as a driver mutation in the oncogenic 
process. This is stressed by the fact that even in MCF7 control cells, a small 
proportion of multinucleated cells can be observed in which MCMBP is poorly 
present (Figure 32). It is possible that these cells arise specifically because of 
MCMBP deregulation, given that in control-multinucleated MCF7 cells other 
proteins belonging to the MCM complex are well expressed (Figure 40). 
 
Figure 40. In multinucleated cells, the cells are expressing MCM4 and MCM7 proteins, 
two of the core elements in the MCM complex. Contrastingly, MCMBP is poorly 
expressed in the same type of cells, suggesting that multinucleation emerges as a 
direct consequence of MCMBP down-regulation, pinpointing a particular function for 
MCMBP in the MCM complex. 
 
It has been shown that oncogenes that control the proper chromosome 
segregation, when deregulated, are able to generate specific types of cancers 
like colorectal carcinomas (Barber, McManus et al. 2008; Baker and van 
Deursen 2010; Pino and Chung 2010) or prostatic carcinomas (Taylor, Schultz 
et al. 2010). Interestingly, according to our Cox survival analyses MCMBP 
altered expression has a significant prognostic value in different types of 
cancers. Furthermore, in the case of breast carcinomas, its overexpression is 
directly linked with the estrogen receptor negative status. All together 
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suggesting that misregulated MCMBP behaves like an oncogene in a wide 
spectrum of malignancies.  
 
Its role in cohesion might not be the only factor that accounts for cancer 
progression when MCMBP is misregulated (Figure 40). Recently, it was shown 
that MCMBP regulates the unloading of the MCM complex during the late S 
phase. In Xenopus egg extracts, MCMBP can destabilize and disassemble the 
MCM2-7 complex and might function as an unloader of the MCMs from 
chromatin (Nishiyama, Frappier et al. 2011). Interestingly, it has been proven 
that specific mutations that destabilize the MCM complex have direct 
implications in cancer origin. 
 
It is known that an excessive amount of MCM2-7 complex is loaded onto the 
origins of replication before the replication process starts (Bowers, Randell et 
al. 2004). Although a huge number of potential origins exist throughout the 
genome, only a fraction of them is sufficient for DNA replication (Woodward, 
Gohler et al. 2006). Nevertheless, upon replicative stress, resulting from 
external sources or coming from the DNA replication process itself, many 
replication forks are stalled and for the continuation of the replication process, 
dormant origins licensed by excess MCM2-7 complexes are used as backups 
for this emergency situations, increasing the number of replication forks and 
promoting the completion of DNA replication (Kawabata, Luebben et al. 2011). 
Reduced levels of MCM2-7 proteins causes spontaneous tumors in mice with 
complete penetrance (Kunnev, Rusiniak et al. 2010), suggesting that dormant 
origins play an important role in such conditions. These mouse models 
exhibited a high level of spontaneous micronuclei a distinctive phenotype for 
chromosome instability. Similarly, the MCM4chaos3 allele encodes a point 
mutation that compromises the stability of the MCM complex, and leads to a 
reduced number of dormant origins. This loss of dormant origins results in an 
accumulation of stalled replication forks, and furthermore, despite the 
activation of multiple DNA repair pathways, a significant fraction of stalled 
replication forks persist into M phase interfering with chromosome segregation 
(Shima, Alcaraz et al. 2007; Kawabata, Luebben et al. 2011). Given that 
MCMBP is important for the destabilization and disassembling of the complex, 
the overexpression of MCMBP could lead to a premature destabilization of the 
complex, having a direct influence in the rescue of the stalled replication forks, 
compromising DNA replication and chromosome stability (Figure 41). In 
accordance with this model, micronuclei formation can be observed upon 
MCMBP overexpression (Figure 33A). 
 
The additive effect of a defective stalled-replication-fork-rescue mechanism, 
combined with the emerging cohesion defects upon MCMBP overexpression, 
might have a strong effect on chromosomal stability. Due to this, is not 
unexpected to see that in the analyzed colorectal adenocarcinoma tumor 
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samples, which are the archetypical examples of carcinomas derived from 
chromosomal instability processes, MCMBP is highly overexpressed.  
 
 
Figure 41. A model for chromosome instability caused by MCMBP misregulation. Both  
MCMBP down regulation and overexpression result into loss of sister chromatid 
cohesion, causing chromosomes missegregation and the formation of polylobed 
aneuploid nuclei. When MCMBP is overexpressed an additional mechanism for 
aneuploidization might exists, caused by the destabilization of the MCM complex, 
generating problems when stalled replication forks occur. The presence of unreplicated 
DNA can cause the nondisjunction of the sister chromatids in metaphase, producing 
cells with micronuclei that can give rise to malignant cells. Still is not known whether 
the stabilization of the MCM complex by MCMBP down-regulation can have a direct 
consequence in the correct function of the replication machinery. The different 
mechanisms that emerge when MCMBP is up or down-regulated can explain why both 
the overexpression and the knock-down of MCMBP can originate different carcinomas.  
 
Scientific evidence is accumulating towards the tight relationship between 
different members of the MCM complex and cancer. MCM2 was found to be a 
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strong prognostic marker in breast cancer (Gonzalez, Pinder et al. 2003) and 
is also used for detection of colorectal cancers (Davies, Freeman et al. 2002). 
Similarly, MCMs proteins were considered as pre-cancer markers in 
esophageal cancers (Alison, Hunt et al. 2002) and MCM2 and MCM4 were 
found to be independent predictors of survival in patients with non–small-cell 
lung cancer (Ramnath, Hernandez et al. 2001). Furthermore, Cytosystems is 
an UK-based company using antibodies against members of the MCM complex 
for detecting cell turnover in bladder and prostate carcinomas, claiming that 
their antibodies have a high degree of sensitivity and a good degree of 
specificity to detect malignantly transformed cells in early phases of the 
disease (www.cytosystems.com). Here, we have given consistent evidence 
illustrating that the novel replisome factor MCMBP can be considered as a 
useful marker for cancer research. Its demonstrated prognosis value and the 
known mechanism of its action expedite the way for its use in cancer diagnosis 
and maybe treatment.  
 
6.4. Materials and methods 
MCMBP antibody generation 
Anti-human MCMBP anti sera were obtained by immunizing rabbits with full-
length MCMBP expressed in E.coli and purified by SDS-PAGE. Antisera were 
further affinity-purified with the MCMBP protein immobilized onto a 
nitrocellulose membrane. 
 
Generation of stable MDA-MB231 and MCF7 lines with a constitutive 
MCMBP knock-down or MCMBP overexpression 
The complete procedure for the generation of the cell lines was already 
detailed on chapter V. 
 
Elisa’s reactions 
Elisa 96-well plates (NuncTM) were activated by coating each well with 50µl 
0.5% glutaraldehyde during 30 minutes at room temperature. Glutaraldehyde 
was washed away by rinsing the wells two times with TBS. Afterwards; each 
well used in the assay was coated with 1µg of purified MCMBP protein, 
dissolved in 50µl of TBS. The wells coated with the antigen were incubated at 
4⁰C overnight. The excess of antigen was removed by washing two times with 
TBS. Wells were blocked with 50µl of 2% TBS-milk during 30 minutes at 37⁰C. 
Specific anti-sera were diluted in the specified proportions with TBS and 50µl 
of the dilutions were added to the wells. The antibody was incubated with the 
antigen during 2 hours at 37⁰C. The excess of antibody was removed by 
washing two times with TBS. As secondary antibody, an anti-rabbit-AP-
conjugated antibody was used in a 1:5,000 dilution in TBS-milk. 250 µl of the 
secondary antibody were incubated in the wells during one hour at 37⁰C. The 
excess of secondary antibody was removed by washing two times with TBS. 
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50µl of substrate reaction mix (one tablet of Sigma p-nitrophenylphosphate 
diluted in 5 ml of reaction buffer [10% diethanolamide+0.01% MgCL2-pH 9.8]) 
were added to the wells. After 15 minutes of incubation at room temperature a 
positive reaction can be seen characterized by a yellowish coloration. The 
colorimetric reaction can be quantified by reading absorbance at 405 nm.  
 
Protein gel blotting 
Protein extracts were prepared from 2-day-old stable transformed MCF7 and 
MDA-MB231 cells. Protein gel blotting was carried out according to standard 
procedures with primary anti-MCMBP purified antibody at a dilution of 1:1,000, 
and a horseradish peroxidase–conjugated donkey anti-rabbit (GE-Healthcare) 
diluted 1:10,000 as a secondary antibody. Proteins were detected with 
Western Lightning Plus-ECL luminol reagent (Perkin Elmer, Massachusetts, 
USA) according to the manufacturer’s instructions. 
 
 
Quantitative PCR analysis of MCMBP expression and cell cycle analyses 
Cells were collected 48h after transfection with a rubber policeman. RNA was 
extracted with an RNeasy animal Mini Kit (Qiagen) and cDNA was prepared 
with the cDNA Synthesis System according to manufacturer’s instructions 
(Roche Diagnostics, Indianapolis, USA). For quantitative PCR, a Light-Cycler 
480 SYBR Green I Master (Roche Diagnostics) was used with 100 nM primers 
and 0.1 mg of reverse transcription reaction product. Reactions were run and 
analyzed on the LightCycler 480 Real-Time PCR System according to 
manufacturer’s instructions (Roche Diagnostics). All quantifications were 
normalized to the TATA Binding Protein (TBP) and Ubiquitin C (UBC) 
expression levels. Quantitative reactions were done in triplicate and averaged. 
Primers used were 5’ACTCTCCACGAAATACCACTTTG3’ and 
5’GTAGGATGTTGAGGGACTGACTCG3’ for MCMBP; 5’ 
TGAGCCAGTGCCAGAGCCAGA 3’ and 5’ GCTCCATCTTCTGCATCCACATC 3’ for 
Cyclin B1; 5’ CCAAAGTTCCAGTTCAACCCACC 3’ and 5’ 
CAATCCACTAGGATGGCACGCA3’ for Cyclin B2; 5’ 
CCTTGCCAGAGCTTTTGGAATACC 3’ and 5’ CACACTTCATTATTGGGAGTGCCC 3’ 
for CDK1; 5’GTGGAGTGTTGGCTGTATCTTTGC3’ and 
5’GCTCCCGACTCCTCCATCTCAG3’ for CDK4; 5’TGCCGCTCTCCACCATCCG3’ and 
5’GGTTTCAGTGGGCACTCCAGG3’ for CDK6; 5’CGGCTGTTTAACTTCGCTTC3’ and 
5’CACACGCCAAGAAACAGTGA3’ for TBP, and 5’ATTTGGGTCGCGGTTCTTG3’ and 
5’TGCCTTGACATTCTCGATGGT3’ for UBC. 
 
Quantitative PCR analysis for tumor samples 
Tumor’s RNA was extracted with an RNeasy animal Mini Kit (Qiagen) and cDNA 
was prepared with the cDNA Synthesis System according to manufacturer’s 
instructions (Roche Diagnostics, Indianapolis, USA). For quantitative PCR, a 
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Light-Cycler 480 SYBR Green I Master (Roche Diagnostics) was used with 100 
nM primers and 0.1 mg of reverse transcription reaction product. Reactions 
were run and analyzed on the LightCycler 480 Real-Time PCR System 
according to manufacturer’s instructions (Roche Diagnostics). All 
quantifications were normalized to the TATA Binding Protein (TBP) and 
Ubiquitin C (UBC) expression levels. Quantitative reactions were done in 
triplicate and averaged. 
Primers used were 5’ACTCTCCACGAAATACCACTTTG3’ and 
5’GTAGGATGTTGAGGGACTGACTCG3’ for MCMBP; 
5’CGGCTGTTTAACTTCGCTTC3’ and 5’CACACGCCAAGAAACAGTGA3’ for TBP, 
and 5’ATTTGGGTCGCGGTTCTTG3’ and 5’TGCCTTGACATTCTCGATGGT3’ for 
UBC. 
 
Flow cytomety experiments 
MCF7 cells (250,000 cells approximately) were seed in 5 ml of MCF7 medium 
in a 6-well plate. Cells were grown in 25 cm2 flasks in 5 ml of medium (10% 
bovine calf serum and 10 mM HEPES) at 37⁰C and 5% CO2. Each cell line 
(MCF7-control, empty vector and MCMBP knock-down) were seed in 
triplicates. After 48 hours of transfection, cells were trypsinized, pelleted (110 
g for 5 min), and resuspended in 800 µl of staining solution 
(http://www.partec.com). The cells were filtered through a 30 µm mesh and 
the nuclei were analyzed using a CyFlow cytometer and FloMax software 
(http://www.partec.com). 
 
Immunofluorescence analysis 
MCF7  parental, empty vector control, and MCMBP knocked-down cells were 
grown in 25 cm2 Flasks in 5 ml of MCF7 medium at 37⁰C and 5% CO2. Two 
days before the experiment, cells were trypsinized and resuspended into 4.5 
ml of fresh medium. Small coverslips were placed inside 18 well-plates and 
1ml of the cell suspension was added to each one of the coverslips.  Cells were 
grown at 37⁰C and 5% CO2 during two days.  Afterwards, cells were washed 
with 1ml of PBS three times and fixed in paraformaldehyde.  Subsequently, 
200 µl of 0.02% gelatin in PBS solution were added to the coverslips and cells 
were incubated during 1 hour at room temperature. A solution of 200 µl of 
gelatin in PBS buffer and 1 µl of primary antibody anti-MCMBP, anti-MCM4 
(ab4459), anti- MCM6 (ab4458), anti-MCF7 (ab52489) antibodies (Abcam, 
Cambridge, UK) or anti-Ecadherin was made. Gelatin was removed from the 
coverslips and 200µl of primary antibody solution was added to the cells 
incubating during 1 hour at room temperature.  After incubation, the excess of 
primary antibody was removed from the cells by washing the cells three times 
with 1 ml of PBS buffer. A solution of 200 µl of gelatin in PBS buffer and 0.5 µl 
of secondary antibody , 2mg/ml Alexa fluor® 488 goat-anti-rabbit antibody, or 
2mg/ml Alexa fluor® 594 goat-anti-mouse antibody  Invitrogen® was made 
and 200µl of secondary antibody solution were added to the cells incubating 
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during 1 hour at room temperature in the dark.  After incubation, the excess 
of secondary antibody was removed from the cells by washing the cells three 
times with 1 ml of PBS buffer.  Coverslips were mounted on microscopic glass 
slides and counterstained with Vecta-Shield (Vector Laboratories, Burlingame, 
CA, USA) containing DAPI. Cells were imaged using the green channel of a 
BX61 Olympus epifluorescence microscope equipped with a 1006/1.30 UPlan 
FLN objective coupled to a U-C MAD 3 imaging system with a Cell-M imaging 
software (Olympus, Tokyo, Japan). A minimum of 200 fields per construct 
were scored and multinucleated and/or cells with micronuclei were counted. 
 
Cox survival analyses 
The survival plots were constructed as described previously in chapter IV. 
 
Immunohistochemistry for tumor samples 
Tumor sections were deparaffinized and rehydrated as follows. Sections were 
washed 2 times for 3 minutes in xylene, 2 times for 1 minute in isopropanol, 2 
times for one minute in 100% ethanol, 2 times for 1 minute in 70% ethanol 
and finally rinsed with tap-water. Afterwards, the antigens in the tumor 
sections were retrieved using a Dako® retriever. The used retrieval buffer was 
a 1X citrate buffer (Dako®). The antigen was retrieved during 2 hours. After 
the antigen-retrieving procedure, samples were cooled-down and rinsed in 
tap-water. Afterwards the tumor sections were immersed into a peroxidase-
blocking solution (a 1:9 solution H2O2:methanol) for 10 minutes. After the 
incubation time, sections were washed for 5 minutes 3 times with PBS. 
Sections were kindly dried and the tumor sample itself was circled using a 
Dako pen (Dako®). Tumor samples were blocked for 45 minutes at room 
temperature, using a blocking buffer (Dako®) enriched with 5% of goat serum. 
Afterwards, the blocking buffer was removed by aspiration and the primary 
antibody (a 1/100 dilution of MCMBP antibody in blocking buffer) was added to 
the samples. The incubation of the primary antibody was done overnight at 
4⁰C. After primary antibody incubation, tumor sections were washed for 5 
minutes 3 times with PBS. As a secondary antibody, envision anti-rabbit 
drops-HRP conjugated was used; a few drops to cover the section were added 
to the sections and were incubated for 45 minutes at room temperature. 
Slides were developed using a liquid DAB solution, incubating from 30 seconds 
to 1 minute until a positive reaction was observed, afterwards, the reaction 
was stop by immersing the slides in bi-distillated water. The slides were 
counter-stained with Hematoxylin (Mayer-Fluka) for 40 seconds. Finally the 
tumor samples were dehydrated as follows. Sections were washed 2 times for 
1 minute in 70% ethanol, 2 times for 1 minute in 100% ethanol, 2 times for 1 
minute in isopropanol, and 2 times for 3 minutes in xylen. Finally, slides were 
mounted with Depex. For each tumor-section, the normal tissue fraction and 
the tumoral fraction were identified, a minimum of 200 nuclei were selected in 
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both fractions and those nuclei with a clear nuclear staining were scored as 
positives for MCMBP expression. 
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7.1. Final remarks 
During the last 15 years, molecular sciences have experienced a deep 
revolution. Progressively, scientists have shifted from a rather reduced point of 
view, to a perspective that allows the visualization of a particular phenomenon 
from a holistic perspective. In other words, with the advent of the called 
“omics” techniques (transcriptomics, proteomics, metabolomics), nowadays 
scientist are able to understand not only why the knock-down or 
overexpression of a particular gene have a particular effect on a given 
phenotype, but rather, they can associate those changes in gene expression 
for that specific gene, with transcriptional changes in a genome-wide scale or 
with changes in the phosphoproteome of the cell. Similarly, researches can 
define how this altered gene expression is associated with changes in the 
synthesis of particular metabolites. The use of systemic approaches to explain 
multifactorial phenotypes and complex phenotype-genotype relationships are 
emerging as complementary tools to the traditionally used forward and 
reverse genetic techniques. Similarly, as consequence of the boom in available 
data, given the massive amount of information that has been produced 
through the application of this genome-wide approaches, freely available 
computational tools and detailed databases have been generated that aid 
research. 
 
The integration of structural genomic data with changes in gene expression 
and protein abundance in mathematical models that allow making predictions 
about the cellular behavior in a particular context, defines a new era in 
biology. Systems biology is evolving and growing rapidly and it is expected 
that in the coming years an avalanche of scientific breakthroughs built up 
under the scope of systems biology approaches overwhelm science in different 
fields. 
 
In this research, by using and integrative strategy compiling different 
structural and genomic data (coexpression networks, GO analyses and cis-
regulatory elements detection), and combining them with a comparative 
genomics strategy that brings over an evolutionary perspective to the 
strategy, we tried to implement a systemic approach in order to detect novel 
and conserved cell cycle-related genes for plants and for humans. In parallel 
with the implemented computational tools, an experimental strategy was 
developed aiming to validate the function of these novel genes in cell cycle 
progression events in both model organisms. The best way to evaluate the 
effectiveness of this research work is by briefly addressing the questions that 
we wanted to answer in each chapter of the presented thesis.  
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1. It is possible to find new conserved cell cycle-related genes 
between plants and humans? 
The last common ancestor of plants and animals lived 1.6 billion years ago, 
and since then, the two clades have evolved differently, generating two 
distinct types of organisms. Is evident that plants don´t look like animals and 
it is not easy to think of conserved processes between plants and humans. 
However, common fundamental pathways and shared key regulators to 
maintain the homeostasis of the organism can be found in both genomes: 
innate immunity patterns, light signaling and circadian clock regulation, DNA-
methylation and DNA-silencing mechanisms are some examples about 
fundamental processes that are shared between plants and animals.   
 
Regarding cell cycle, some mechanisms evolved differently between plants and 
animals, mainly due to some unique features intrinsically related with the 
sessile life-style of plants. Nevertheless, the evolutionary conservation of the 
machinery regulating cell cycle progress is notorious. Many cell cycle 
regulators have been evolutionarily conserved and furthermore, a big 
percentage of those conserved cell cycle regulators, when deregulated in 
humans, represent potential oncogenes and/or tumor suppressors. Likewise, 
Nearly 70% of the genes implicated in cancer have Arabidopsis orthologues. 
 
Recent scientific evidence supports abnormal cell proliferation as a 
fundamental cancer hallmark at early stages. Given the fact that the 
machinery that regulates the cell division process is highly conserved between 
plants and animals, the identification of new cell cycle regulators with a 
specific role in carcinogenesis by systematically studying the cell replication 
machinery in Arabidopsis must be possible. This view is strengthened by the 
conserved gene systems revealed by the plant-vertebrate phenologs, which 
illustrate an ancient homology between the plant and the animal clades, which 
is representative of conserved networks (McGary, Park et al. 2010). The 
existence of cancer-related phenologs between plants and humans brings 
attention to the potentially extensive molecular toolkit within the last common 
ancestor between these organisms, and even more, supports the notion of 
finding novel oncogenes by studying evolutionarily conserved molecules 
between plants and humans.  
 
2. How we did it? 
We were able to design an integrative strategy gathering different information 
sources that was able to retain a list of genes with a high chance to be 
involved in cell replication events for plants and humans. Indeed, with our 
experimental frame we were able to demonstrate that a significant subset of 
the detected genes was associated with replication processes in plants and 
with cell division processes in humans. The strength of our systemic approach 
was the coordinately and logically integration of different information sources. 
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For example, we looked for overrepresentation of the GO term DNA 
replication; because recent evidence suggests that abnormal replication events 
represent the core mechanism in the neoplastic transformation at its earliest 
stages. Similarly, we selected genes with E2F binding elements in their 
promoter region, based on the observations of Goodarzi and collaborators that 
in a broad spectrum of carcinomas a deregulated RB-E2F pathway is the 
responsible of an altered cell division process (Goodarzi, Elemento et al. 
2009). Lastly, we applied a comparative genomics approach because it has 
been extensively demonstrated that conservation of molecules and functions 
during the evolutionary process is a useful strategy to retain fundamental 
genes (or proteins) involved in the generation of a particular phenotype 
(Dimitriadi, Sleigh et al. 2010; O'Connell, Loughran et al. 2010). 
 
It is possible that by designing a different strategy (by using for example 
protein interaction networks instead of coexpression networks, or by detecting 
different cis-regulatory elements) the list of candidate genes finally retained 
would have been different. Nevertheless, given that important known cell 
replication genes and previously reported oncogenes were retained using our 
approach (Table 3), we can state that the designed strategy was powerful and 
sensitive, representing a novel systemic approach that can complement the 
more traditional tools used for the detection of cell cycle regulators and/or 
oncogenes.  
 
3. What did we prove? 
Experimentally we were able to demonstrate that: 
• 15 Arabidopsis genes previously annotated as unknown, are directly or 
indirectly involved in replication and/or endoreduplication events. 
• 2 Arabidopsis genes previously annotated as unknown, are directly or 
indirectly involved in DNA-stress responses. 
• 143 human genes detected by our integrative approach have a 
significant prognosis value, being associated with cancer relapse events 
when their expression is misregulated in breast carcinomas. 
Reciprocally, 52 Arabidopsis orthologues of these 143 genes are directly 
associated with cell proliferation, clearly illustrating that a direct relation 
exists between human genes associated with carcinogenic events and 
genes involved in plant cell proliferation. 
• The human genes HEATR6 and C14ORF21 are associated with cell 
proliferation in cell cultures and according to the oncomine database 
their up-regulation is associated with specific carcinomas. 
• The novel replisome factor ETG1 is involved in sister chromatid cohesion 
in Arabidopsis and its depletion has drastic effects in DNA-repair 
processes. 
• MCMBP, the ETG1 human orthologue, is also involved in cohesion in 
humans and its depletion has a drastic effect in DNA-repair processes. 
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• MCMBP has a significant prognosis value as a cancer marker, being 
associated with cancer relapse events in different carcinomas. 
Furthermore MCMBP protein abundance is preferentially associated with 
abnormal proliferating cells in colorectal cancers. 
•  With this study, we demonstrated that by searching for proliferation 
genes in the Arabidopsis genome, it is possible to retain human 
orthologues of which the misexpression might contribute to cancer 
progression. Reciprocally, genes that confer growing advantages to 
tumors coincide with orthologous genes implicated on cell proliferation 
in Arabidopsis, suggesting that Arabidopsis might represent a tempting 
new model organism for cancer research. 
 
4. What did we deliver to science an society 
We have identified MCMBP as a promising diagnostic marker for cancer 
detection. The fact that MCMBP expression must be continued from G1 to 
mitosis, due to its function on DNA replication and sister chromatid cohesion, 
being associated only with replicating cells, suggests that this protein can have 
an extraordinary value as a cancer marker from the earliest phases of the 
disease. MCMBP could be a better diagnostic marker than Ki-67, given that 
MCMBP is preferentially highly abundant in malignantly proliferating cells. 
Similarly, MCMBP could be better than PCNA, another commonly used 
replication marker, due to in some cases, it has been shown that PCNA is not 
exclusively involved in replication events being also associated with DNA-
repair events (Bubeck, Reijns et al. 2011; Mortusewicz, Fouquerel et al. 
2011), which is not the case for MCMBP. This evidence is supported by the 
detailed pathological report of the colorectal tumors that emphasizes the 
remarkably immuno-based accumulation pattern of MCMBP in the tumoral 
fraction of the different samples. 
 
Personally, I believe that the fundamental function of science is the generation 
of tools that can be used for the society in order to improve people´s life 
quality. The ultimate goal of a scientist must be the transformation of the 
scientific knowledge into accessible elements to the society. Those elements 
must be able of offering wellness and relief to the people in general. Still some 
work is needed, but if we were able to generate a novel cancer marker that 
could be turned into a diagnosis tool that might save lives, the mission has 
been accomplished. 
 
5. Future perspectives 
A lot of things remain undone. As was mentioned above, additional 
experiments have to be performed to prove rigorously the value of MCMBP as 
a cancer marker. For example, it would be interesting to analyze some extra 
colorectal carcinomas in which clinical information of the patients is known in 
order to establish direct associations between clinical parameters and MCMBP 
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protein abundance. Similarly it would be interesting to study the chromosomal 
aberrations that characterize the tumors where MCMBP is highly expressed. In 
order to show that MCMBP might be a better marker for abnormal DNA 
replication, specific comparisons with Ki-67 or PCNA antibodies must be 
carried out; and finally the generation of mouse models with a misregulated 
MCMBP expression would definitely demonstrate the role of MCMBP in the 
induction and progression of the carcinogenic process.   
 
Regarding Arabidopsis, with this investigation, the work has just been started. 
A long road has to be walked in order to elucidate the specific molecular 
function of the genes that were here detected. To understand why their 
depletion produces the cell cycle effects that were described, more in depth 
experiments will be required. A highly interesting candidate to study is ELP2 
(AT1G49540), a likely regulator of the elongator-complex. Several component 
of this complex have been studied in detail (Nelissen, Fleury et al. 2005; 
Versees, De Groeve et al. 2010), but currently nothing is known about the 
function of this particular gene. Similarly the gene AT1G01940 which is part of 
the cyclophilin family, is an interesting gene, given that some cyclophilin 
family members have been found to be involved in the stability and targeting 
of WEE1 to the nucleus in yeast (Leone, Lattanzi et al. 2009). Another 
motivating gene is the AT3G60660, being the plant homolog of the 
mammalian SKA1, that fulfills a critical role in coupling chromosome 
movement to microtubule dynamics at the outer kinetochore (Welburn, 
Grishchuk et al. 2009). Furthermore, similar to MCMBP, the coexpression 
neighborhoods of AT3G60660 and SKA1 are significantly conserved (Figure 
22), suggesting that SKA1 molecular function must be conserved its 
Arabidopsis counterpart. 
 
At the mammalian side, a first candidate to study would be STATIP1. Although 
the deregulation of this gene did not reveal any appreciable phenotype in the 
performed experiments, it has been shown that STATIP1 could play a 
fundamental role in cell stemness. Transcriptional profiles of mouse 
embryonic, neural, and hematopoietic stem cells were compared to define a 
genetic program for cell stemness in mouse. It was found that 230 genes are 
highly expressed in the three types of stem cells, including STATIP1 (Ivanova, 
Dimos et al. 2002). The fact that STATIP1 could be an important factor in the 
maintenance of the stem cell niche, and even more that its regulation could be 
associated with E2F transcription factors, linking cell cycle with cell stemness, 
is of great interest for future studies. Similarly, in a recent genome-wide 
screening investigation, it was shown that the knock-down of the KLHDC3 
gene induced cell death in HeLa cells (Neumann, Walter et al. 2010). In the 
same study, the authors claimed that the down-regulation of the C9ORF85 
gene slows down the cell division process, occasionally generating 
multinucleated cells. Would be worth to try whether upon gene knock-out of 
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these particular molecules, the same kind of phenotypes can be confirmed in 
different cell lines. 
 
To finalize, I would like to introduce the concept of comparable genomes. The 
global idea is that by applying the same kind of filters (same kind does not 
mean the same filters) it would be possible to compare two different genomes 
in order to find new conserved regulators for a particular process that the 
researcher is interested in (Figure 42). The selection of the proper filters would 
not be trivial as different factors must be taken into account, such as the type 
of biological problem to study, the type of genomes that are compared, the 
genomic structural information that is available, the availability of reliable 
transcriptomic arrays, etc. Nevertheless, the results presented in this 
research, indicate that this systemic approach would be powerful in order to 
detect novel gene functions. 
 
 
Figure 42. The comparable genome approach. In this example, the goal is to find 
conserved novel genes involved in the photosynthesis process. For doing so, the 
Chlamydomonas reinhardtii and Arabidopsis thaliana genomes can be compared. In a 
similar way as performed in the presented research, coexpression groups can be 
formed, followed by GO enrichment analyzes, but this time looking for the over-
representation of specific GO terms like Photosystem. Similarly specific cis-regulatory 
elements can be detected in the promoter region of the genes significantly associated 
with the analyzed GO term. In this hypothetical case, the promoter regions can be 
scanned for G-Boxes that are specific light-responsive cis-acting elements. Through a 
phylogenetic analysis it must be possible to detect orthologous genes and maybe 
orthologous phenotypes (phenologs). Novel genes can subsequently be retained for 
one or for both of the analyzed genomes to phenotypically analyze mutant alleles. 
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As a final conclusion I would like to stress out that a complete understanding 
on cancer origin is not million years away. Current science is showing that the 
myriad phenotypic complexities that exist in cancer are manifestations of a 
small fraction of underlying organizing principles that day by day we are 
approaching, deciphering, exploring and understanding. Therefore, I believe 
that cancer is a curable disease. 
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Appendix-A 
GO enrichment analysis for Arabidopsis genes 
    
AGI Code GO Label GO description pValue FE GO Label GO description pValue FE 
AT1G01370 GO:0006260 DNA Replication 1,90661E-20 7,598 GO:0006281 DNA Repair 1,70217E-09 4,811 
AT1G01530 GO:0006260 DNA Replication 3,6216E-08 3,665 GO:0006281 DNA Repair 0,000866934 2,666 
AT1G01920 GO:0006260 DNA Replication 1,08186E-16 5,4 GO:0006281 DNA Repair 3,2012E-08 3,686 
AT1G01940 GO:0006260 DNA Replication 1,77711E-10 3,855 GO:0006281 DNA Repair 8,71219E-06 2,915 
AT1G02090 GO:0006260 DNA Replication 2,36525E-10 3,919 GO:0006281 DNA Repair 7,34768E-05 2,803 
AT1G02110 GO:0006260 DNA Replication 1,86396E-12 4,978 GO:0006281 DNA Repair 0,000128509 3,135 
AT1G02250 GO:0006260 DNA Replication 0,000154518 2,777 GO:0006281 DNA Repair 0,005907308 2,355 
AT1G02370 GO:0006260 DNA Replication 2,65071E-16 5,284 GO:0006281 DNA Repair 4,97157E-07 3,435 
AT1G02670 GO:0006260 DNA Replication 3,46461E-16 6,552 GO:0006281 DNA Repair 8,77236E-13 5,448 
AT1G02690 GO:0006260 DNA Replication 4,57133E-13 4,378 GO:0006281 DNA Repair 5,14808E-07 3,202 
AT1G02730 GO:0006260 DNA Replication 6,71999E-05 4,702 GO:0006281 DNA Repair not significant not significant 
AT1G02870 GO:0006260 DNA Replication 2,76465E-10 4,482 GO:0006281 DNA Repair not significant not significant 
AT1G02970 GO:0006260 DNA Replication 1,89897E-14 4,818 GO:0006281 DNA Repair 1,59579E-07 3,429 
AT1G02980 GO:0006260 DNA Replication 1,28961E-10 4,224 GO:0006281 DNA Repair 1,59108E-06 3,283 
AT1G03110 GO:0006260 DNA Replication 9,93775E-17 5,115 GO:0006281 DNA Repair 3,5098E-07 3,332 
AT1G03150 GO:0006260 DNA Replication 2,2184E-09 4,036 GO:0006281 DNA Repair 0,001758634 2,685 
AT1G03180 GO:0006260 DNA Replication 1,13537E-16 5,034 GO:0006281 DNA Repair 1,16833E-07 3,374 
AT1G03190 GO:0006260 DNA Replication 2,28333E-09 3,751 GO:0006281 DNA Repair 1,35799E-05 2,934 
AT1G03360 GO:0006260 DNA Replication 2,20433E-15 4,699 GO:0006281 DNA Repair 5,22065E-06 3,01 
AT1G03530 GO:0006260 DNA Replication 1,31376E-11 4,153 GO:0006281 DNA Repair 0,000266207 2,713 
AT1G03620 GO:0006260 DNA Replication not significant not significant GO:0006281 DNA Repair 0,029576685 3,463 
AT1G03687 GO:0006260 DNA Replication 1,75482E-17 5,642 GO:0006281 DNA Repair 8,80976E-08 3,667 
AT1G03780 GO:0006260 DNA Replication 1,55141E-06 6,035 GO:0006281 DNA Repair not significant not significant 
AT1G03820 GO:0006260 DNA Replication 1,31941E-06 5,042 GO:0006281 DNA Repair not significant not significant 
AT1G03830 GO:0006260 DNA Replication 1,60046E-14 4,648 GO:0006281 DNA Repair 6,9421E-07 3,207 
AT1G03860 GO:0006260 DNA Replication 0,001816441 3,257 GO:0006281 DNA Repair not significant not significant 
AT1G03960 GO:0006260 DNA Replication 0,001253044 3,026 GO:0006281 DNA Repair 2,00717E-05 3,305 
AT1G03980 GO:0006260 DNA Replication 2,55885E-10 3,769 GO:0006281 DNA Repair 0,000131089 2,67 
AT1G04010 GO:0006260 DNA Replication 0,000556236 4,444 GO:0006281 DNA Repair 0,000547396 4,206 
AT1G04020 GO:0006260 DNA Replication 5,98527E-16 6,306 GO:0006281 DNA Repair 0,002568843 3,074 
AT1G04130 GO:0006260 DNA Replication 8,34314E-09 3,599 GO:0006281 DNA Repair 3,74635E-05 2,815 
AT1G04170 GO:0006260 DNA Replication 3,11032E-09 3,99 GO:0006281 DNA Repair not significant not significant 
AT1G04190 GO:0006260 DNA Replication 2,64821E-09 3,891 GO:0006281 DNA Repair not significant not significant 
AT1G04270 GO:0006260 DNA Replication 1,35874E-08 4,208 GO:0006281 DNA Repair not significant not significant 
AT1G04340 GO:0006260 DNA Replication 1,72724E-09 4,647 GO:0006281 DNA Repair not significant not significant 
AT1G04480 GO:0006260 DNA Replication 5,29221E-12 4,821 GO:0006281 DNA Repair not significant not significant 
AT1G04510 GO:0006260 DNA Replication 4,05055E-08 3,65 GO:0006281 DNA Repair not significant not significant 
AT1G04520 GO:0006260 DNA Replication 5,94665E-05 5,266 GO:0006281 DNA Repair not significant not significant 
AT1G04590 GO:0006260 DNA Replication 1,66315E-10 4,952 GO:0006281 DNA Repair not significant not significant 
AT1G04650 GO:0006260 DNA Replication 1,75638E-11 4,018 GO:0006281 DNA Repair 1,90147E-05 2,86 
AT1G04730 GO:0006260 DNA Replication 7,08043E-15 4,518 GO:0006281 DNA Repair 3,66578E-06 2,979 
AT1G04760 GO:0006260 DNA Replication 1,02033E-08 6,261 GO:0006281 DNA Repair 0,026686839 3,497 
AT1G04810 GO:0006260 DNA Replication 3,49614E-07 3,424 GO:0006281 DNA Repair 0,004522105 2,477 
AT1G04820 GO:0006260 DNA Replication 0,03370792 3,62 GO:0006281 DNA Repair not significant not significant 
AT1G04870 GO:0006260 DNA Replication 9,76247E-12 4,244 GO:0006281 DNA Repair 0,006783097 2,455 
AT1G04900 GO:0006260 DNA Replication 4,06887E-15 4,631 GO:0006281 DNA Repair 3,0435E-06 3,035 
The p values for DNA replication and DNA repair, represent that the specific functional annotation (DNA replication and/or DNA repair) for a particular gene is significantly 
enriched for either of these processes according to the functional annotation of the genes contained in the coexpression neighborhood of that particular gene. They are defined 
by the hypergeometric distribution adjusted by the Bonferroni correction for multiple hypotheses testing. 
FE=Fold enrichment values for the GO terms DNA repair (GO0006281) and DNA replication (GO0006260) for both Arabidopsis and Homo sapiens were calculated as the ratio of 
the relative occurrence in a set of genes (coexpression neighborhood) to the relative occurrence in the genome. 
Due to space restriction, only a fraction of the 3,251 enriched genes is shown, the complete list can be found in the electronic version of the thesis. 
Appendix-B 
E2F motif mapping in Arabidopsis genes 
 
AGI Code Start End Strand Site 
AT1G01370 
744 751 - id "box_1_1_TTTssCGC"; site "TTTCCCGC"; 
696 703 - id "box_1_1_TTTssCGC"; site "TTTCCCGC"; 
AT1G01940 192 199 - id "box_1_1_TTTssCGC"; site "TTTGGCGC"; 
AT1G02370 249 256 - id "box_1_1_TTTssCGC"; site "TTAGCCGC"; 
AT1G02870 939 946 - id "box_1_1_TTTssCGC"; site "GTTCGCGG"; 
AT1G02970 511 518 - id "box_1_1_TTTssCGC"; site "TTGCGCGC"; 
AT1G03110 71 78 + id "box_1_1_TTTssCGC"; site "TTTGGCGC"; 
AT1G03180 587 594 + id "box_1_1_TTTssCGC"; site "ATACGCGC"; 
AT1G03530 364 371 + id "box_1_1_TTTssCGC"; site "TTAGCCGC"; 
AT1G03780 
955 962 + id "box_1_1_TTTssCGC"; site "TTCCCCGC"; 
780 787 - id "box_1_1_TTTssCGC"; site "TTTCCCCC"; 
AT1G03820 815 822 - id "box_1_1_TTTssCGC"; site "ATTCGCGG"; 
AT1G03960 
809 816 + id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
517 524 - id "box_1_1_TTTssCGC"; site "TTTGCCGG"; 
AT1G03980 517 524 + id "box_1_1_TTTssCGC"; site "TTCGGCGC"; 
AT1G04010 181 188 - id "box_1_1_TTTssCGC"; site "TCTCCCGC"; 
AT1G04020 294 301 + id "box_1_1_TTTssCGC"; site "TCTCCCGC"; 
AT1G04520 926 933 + id "box_1_1_TTTssCGC"; site "TTTCCCCC"; 
AT1G04590 354 361 + id "box_1_1_TTTssCGC"; site "TTTCCCCC"; 
AT1G04730 
655 662 + id "box_1_1_TTTssCGC"; site "TTTCCCGC"; 
675 682 + id "box_1_1_TTTssCGC"; site "ATTCCCGC"; 
AT1G04760 809 816 + id "box_1_1_TTTssCGC"; site "ACTCGCGC"; 
AT1G04870 458 465 + id "box_1_1_TTTssCGC"; site "TTTGCCGC"; 
AT1G04930 891 898 + id "box_1_1_TTTssCGC"; site "GTTCGCGC"; 
AT1G04940 
160 167 + id "box_1_1_TTTssCGC"; site "TTTCCCCC"; 
317 324 - id "box_1_1_TTTssCGC"; site "TATGGCGC"; 
AT1G05120 880 887 + id "box_1_1_TTTssCGC"; site "TTTCCCGC"; 
AT1G05440 440 447 - id "box_1_1_TTTssCGC"; site "TTTCGCGG"; 
AT1G05490 684 691 + id "box_1_1_TTTssCGC"; site "TTTGGCGG"; 
AT1G05710 973 980 + id "box_1_1_TTTssCGC"; site "TTTAGCGC"; 
AT1G05950 
746 753 + id "box_1_1_TTTssCGC"; site "ATTGGCGC"; 
916 923 + id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
AT1G06490 
226 233 + id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
501 508 + id "box_1_1_TTTssCGC"; site "GTTCCCGC"; 
AT1G06590 
677 684 + id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
747 754 - id "box_1_1_TTTssCGC"; site "TTTCCCCC"; 
AT1G07270 
867 874 + id "box_1_1_TTTssCGC"; site "TTTCCCGC"; 
839 846 - id "box_1_1_TTTssCGC"; site "TCTCCCGC"; 
AT1G07360 
143 150 + id "box_1_1_TTTssCGC"; site "GTTCCCGC"; 
147 154 - id "box_1_1_TTTssCGC"; site "ATTGGCGG"; 
AT1G07370 
255 262 + id "box_1_1_TTTssCGC"; site "ATTGGCGG"; 
259 266 - id "box_1_1_TTTssCGC"; site "GTTCCCGC"; 
AT1G07620 338 345 - id "box_1_1_TTTssCGC"; site "TTACCCGC"; 
AT1G07840 317 324 - id "box_1_1_TTTssCGC"; site "TTTAGCGC"; 
AT1G07970 931 938 - id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
AT1G08130 
914 921 + id "box_1_1_TTTssCGC"; site "TCTGCCGC"; 
918 925 - id "box_1_1_TTTssCGC"; site "ATTGGCGG"; 
AT1G08410 
245 252 - id "box_1_1_TTTssCGC"; site "ATTCGCGG"; 
4 11 - id "box_1_1_TTTssCGC"; site "TTTCCCGG"; 
 
Due to space restriction, only a fraction of the 1,031 enriched genes is shown, the complete list can be found in the electronic version of the thesis. 
Appendix-C 
Orthologous genes between Arabidopsis and Homo sapiens  
AGI Code HGNC Name OrthoMCLDB Family Copy Number in Arabidopsis Copy Number in Homo sapiens 
AT1G01940 PPIL3 OG1_3641 1 1 
AT1G02970 WEE1 OG1_3370 1 1 
AT1G03110 WDR4 OG1_2940 1 2 
AT1G03530 NAF1 OG1_4750 1 1 
AT1G03780 TPX2 OG1_6753 1 2 
AT1G03980 ATG4B OG1_9247 2 2 
AT1G04010 PSAP OG1_5604 2 1 
AT1G04020 BARD1 OG1_7792 1 1 
AT1G04730 CHTF18 OG1_2311 1 2 
AT1G05490 PRX OG1_6330 1 2 
AT1G06590 APC5 OG1_7876 1 1 
AT1G07270 CDC6 OG1_2922 2 1 
AT1G07360 RBM22 OG1_2116 2 1 
AT1G07370 PCNA OG1_1458 2 1 
AT1G07840 NGDN OG1_3147 2 2 
AT1G08130 LIG1 OG1_716 2 1 
AT1G08410 LSG1 OG1_1799 2 1 
AT1G09450 GSG2 OG1_4958 1 1 
AT1G09830 GART OG1_459 2 2 
AT1G09870 MINPP1 OG1_6042 1 1 
AT1G10490 NAT10 OG1_1511 2 1 
AT1G11800 TDP2 OG1_6359 1 2 
AT1G13330 PSMC3IP OG1_4322 1 2 
AT1G14300 C8ORF30A OG1_4374 1 1 
AT1G14850 NUP155 OG1_2628 1 1 
AT1G16280 DDX49 OG1_2768 1 1 
AT1G16900 ALG9 OG1_3576 1 1 
AT1G18340 GTF2H3 OG1_2316 1 1 
AT1G19340 METTL4 OG1_6537 1 1 
AT1G19880 RCC1 OG1_6058 1 1 
AT1G20200 PSMD3 OG1_1757 2 1 
AT1G20720 BRIP1 OG1_6764 2 1 
AT1G20920 DDX46 OG1_1424 2 2 
AT1G21690 RFC4 OG1_2523 1 1 
AT1G22270 TRMT112 OG1_2043 2 2 
AT1G23280 MAK16 OG1_1742 1 1 
AT1G26170 IPO9 OG1_4338 1 2 
AT1G26840 ORC6L OG1_9395 1 1 
AT1G27400 RPL17 OG1_636 2 2 
AT1G27880 RECQL4 OG1_5740 1 1 
AT1G34065 SLC25A26 OG1_2517 2 1 
AT1G35530 FANCM OG1_3289 1 1 
AT1G35660 C10ORF137 OG1_4377 1 2 
AT1G44900 MCM2 OG1_1910 1 1 
AT1G48270 GPR157 OG1_8477 1 1 
AT1G49540 ELP2 OG1_1736 1 1 
AT1G50230 STK36 OG1_6110 2 1 
AT1G50370 PPP6C OG1_2383 2 1 
AT1G51510 RBM8A OG1_4202 1 1 
AT1G51610 SLC30A9 OG1_4334 1 1 
AT1G51710 USP14 OG1_1469 2 1 
AT1G51980 UQCRC2 OG1_1970 2 1 
AT1G56290 CWF19L2 OG1_3953 1 1 
AT1G64350 SEH1L OG1_3392 1 1 
AT1G65470 CHAF1A OG1_3266 1 2 
AT1G65650 UCHL5 OG1_2223 2 1 
AT1G66740 ASF1A OG1_1558 2 2 
AT1G67120 MDN1 OG1_788 1 1 
AT1G67320 PRIM2 OG1_2044 1 1 
AT1G67490 MOGS OG1_3205 2 1 
AT1G67630 POLA2 OG1_2509 1 1 
AT1G69420 ZDHHC11 OG1_4658 1 2 
AT1G71220 UGGT1 OG1_1621 1 2 
AT1G72320 C14ORF21 OG1_7325 1 1 
AT1G74150 KLHDC3 OG1_6134 2 1 
AT1G74260 PFAS OG1_973 1 1 
AT1G74560 SET OG1_1915 2 2 
AT1G75990 PSMD3 OG1_1757 2 1 
AT1G76120 PUS1 OG1_1823 2 1 
AT1G76140 PREP OG1_3306 2 1 
AT1G76170 CTU1 OG1_1570 2 1 
AT1G76260 TSSC1 OG1_4398 2 1 
AT1G76400 RPN1 OG1_2169 2 1 
AT1G77050 DDX54 OG1_2404 1 1 
AT1G77350 KRTCAP2 OG1_9515 1 1 
AT1G77720 TTK OG1_2772 1 1 
AT1G78650 POLD3 OG1_6541 1 1 
AT1G80070 PRPF8 OG1_1367 2 1 
AT1G80190 GINS1 OG1_3381 1 1 
AT1G80670 RAE1 OG1_2743 1 1 
AT2G01690 VAC14 OG1_2051 1 1 
AT2G02810 SLC35B1 OG1_1928 2 1 
AT2G03510 ERLIN1 OG1_5251 1 2 
AT2G03820 NMD3 OG1_1804 1 1 
AT2G07340 PFDN1 OG1_4641 1 1 
AT2G07690 MCM5 OG1_2371 1 1 
AT2G14050 MCM9 OG1_5056 1 2 
AT2G15790 PPID OG1_3968 1 1 
AT2G16440 MCM4 OG1_1730 1 2 
AT2G17370 HMGCR OG1_1286 2 2 
AT2G17510 DIS3L OG1_621 1 2 
AT2G18510 SF3B4 OG1_1722 1 1 
AT2G18740 SNRPEL1 OG1_2012 2 2 
AT2G18760 ERCC6 OG1_3049 1 2 
AT2G19430 THOC6 OG1_6007 1 2 
AT2G20000 CDC27 OG1_1435 2 1 
AT2G20330 WDR70 OG1_2816 1 1 
AT2G20980 MCM10 OG1_3461 1 2 
AT2G21790 RRM1 OG1_433 1 1 
AT2G22260 ALKBH3 OG1_11419 1 1 
AT2G22400 NSUN2 OG1_1432 2 2 
AT2G23890 NT5DC3 OG1_3912 1 2 
AT2G23930 SNRPG OG1_2530 2 2 
AT2G24490 RPA4 OG1_3153 2 1 
AT2G25740 CRBN OG1_4343 1 1 
AT2G26990 COPS2 OG1_4236 1 1 
AT2G27120 POLE OG1_1347 2 1 
AT2G27470 POLE3 OG1_2695 1 1 
AT2G28450 TRMT2A OG1_283 2 2 
AT2G29570 PCNA OG1_1458 2 1 
AT2G29580 RBM22 OG1_2116 2 1 
AT2G29680 ORC1L OG1_2922 2 1 
AT2G30920 COQ3 OG1_2081 1 1 
AT2G31320 PARP1 OG1_3296 1 1 
AT2G31660 IPO7 OG1_1952 2 1 
AT2G31970 RAD50 OG1_1207 1 1 
AT2G34040 API5 OG1_6132 2 1 
AT2G34260 WDR55 OG1_3318 1 2 
AT2G35040 ATIC OG1_1671 1 1 
AT2G36070 TIMM44 OG1_1759 2 1 
AT2G36170 UBA52 OG1_2217 2 2 
AT2G36620 RPL24 OG1_1653 2 1 
AT2G37560 ORC2L OG1_2692 1 1 
AT2G39990 EIF3F OG1_2765 1 1 
AT2G40360 BOP1 OG1_2040 1 1 
AT2G40550 MCMBP OG1_3827 1 2 
AT2G40780 EIF1AD OG1_6798 1 1 
AT2G41460 APEX2 OG1_1755 2 1 
AT2G41500 PRPF4 OG1_2270 1 1 
AT2G42120 POLD2 OG1_2310 1 1 
AT2G42810 PPP5C OG1_2512 1 1 
AT2G44065 RPL8 OG1_1010 1 2 
AT2G44660 ALG6 OG1_3390 1 1 
AT2G44860 RSL24D1 OG1_1532 1 1 
AT2G44980 CHD1L OG1_8538 1 2 
AT2G45280 RAD51C OG1_5972 1 1 
AT2G45700 DCLRE1A OG1_2504 2 2 
AT2G45730 TRMT6 OG1_2433 1 2 
AT2G46470 OXA1L OG1_3057 2 2 
AT2G47330 DDX42 OG1_6120 1 2 
AT3G02220 C9orf85 OG1_8053 1 2 
AT3G02820 TIPIN OG1_4524 1 1 
AT3G03600 MRPS2 OG1_1772 1 1 
AT3G03920 GAR1 OG1_2399 2 1 
AT3G04770 RPSAP12 OG1_1085 2 2 
AT3G05480 RAD9A OG1_4175 1 1 
AT3G06530 HEATR1 OG1_2704 1 1 
AT3G06930 CARM1 OG1_5041 2 1 
AT3G07050 GNL3 OG1_1613 1 2 
AT3G07300 EIF2B2 OG1_2285 1 1 
AT3G07590 SNRPD1 OG1_2149 2 1 
AT3G07740 TADA2B OG1_701 2 2 
AT3G07750 EXOSC7 OG1_3957 1 1 
AT3G08960 IPO11 OG1_2762 1 1 
AT3G08980 IMMP2L OG1_3608 1 2 
AT3G09660 MCM8 OG1_3248 1 2 
AT3G09720 DDX52 OG1_2353 1 1 
AT3G12170 DNAJC9 OG1_2789 2 1 
AT3G12270 PRMT3 OG1_8639 1 1 
AT3G12280 RBL2 OG1_7838 1 1 
AT3G12380 ACTR5 OG1_4157 1 1 
AT3G12530 GINS2 OG1_3131 1 1 
AT3G12860 NOP56 OG1_1924 2 1 
AT3G13445 TBP OG1_592 2 2 
AT3G13940 POLR1E OG1_3422 1 2 
AT3G14890 PNKP OG1_2225 1 1 
AT3G15970 RANBP3 OG1_3230 2 2 
AT3G16310 NUP35 OG1_6539 1 1 
AT3G16650 PLRG1 OG1_1864 2 1 
AT3G16810 KIAA0020 OG1_2372 1 1 
AT3G16980 POLR2I OG1_2317 2 1 
AT3G17590 SMARCB1 OG1_1831 1 2 
AT3G18100 SNAPC4 OG1_2738 1 1 
AT3G18524 MSH2 OG1_1651 1 1 
AT3G18630 UNG OG1_1198 1 1 
AT3G19210 RAD54B OG1_820 1 2 
AT3G20430 PHAX OG1_6996 1 1 
AT3G20630 USP5 OG1_568 1 2 
AT3G24515 UBE2T OG1_10323 1 1 
AT3G25100 CDC45 OG1_3219 1 1 
AT3G25150 G3BP2 OG1_4742 1 1 
AT3G26410 TRMT11 OG1_1716 1 1 
AT3G42660 WDHD1 OG1_3269 1 2 
AT3G45100 PIGA OG1_517 1 1 
AT3G45880 PLA2G4B OG1_5619 1 1 
AT3G46940 DUT OG1_867 1 1 
AT3G47460 SMC2 OG1_1035 2 2 
AT3G47630 C3ORF31 OG1_3762 1 1 
AT3G48150 CDC23 OG1_2976 1 1 
AT3G49010 RPL13 OG1_1161 2 2 
AT3G49080 MRPS9 OG1_518 2 1 
AT3G49990 LTV1 OG1_3956 1 1 
AT3G51800 PA2G4 OG1_1822 1 1 
AT3G52140 KIAA0664 OG1_1795 1 1 
AT3G52640 NCSTN OG1_5058 1 2 
AT3G53760 TUBGCP4 OG1_6531 1 1 
AT3G53890 RPS21 OG1_1563 2 2 
AT3G54280 BTAF1 OG1_1433 1 1 
AT3G54350 MCRS1 OG1_4764 1 2 
AT3G54610 KAT2A OG1_932 1 2 
AT3G55005 FGFR1OP OG1_10518 2 1 
AT3G55160 THADA OG1_2166 1 2 
AT3G56990 NOL10 OG1_1969 1 2 
AT3G57000 EMG1 OG1_1920 1 1 
AT3G57060 NCAPD2 OG1_2123 1 1 
AT3G57290 EIF3E OG1_2151 1 1 
AT3G57660 POLR1A OG1_1691 1 1 
AT3G57940 NAT10 OG1_1511 2 1 
AT3G58580 CCRN4L OG1_632 2 2 
AT3G59380 FNTA OG1_2004 1 2 
AT3G59540 RPL38 OG1_1460 2 1 
AT3G59820 LETM1 OG1_1356 2 1 
AT3G60360 UTP11L OG1_2117 2 1 
AT3G60660 C18orf24(SKA1) OG1_8754 1 1 
AT3G60740 TBCD OG1_2578 1 2 
AT3G61620 EXOSC4 OG1_2003 1 1 
AT4G00850 SS18 OG1_6103 2 2 
AT4G01270 TRAIP OG1_6475 1 1 
AT4G02060 MCM7 OG1_2697 1 1 
AT4G02460 PMS2 OG1_1441 2 1 
AT4G07410 CIRH1A OG1_2954 2 1 
AT4G08790 NIT1 OG1_3371 1 1 
AT4G09140 MLH1 OG1_916 1 1 
AT4G10050 PPME1 OG1_2320 1 2 
AT4G14110 COPS8 OG1_8087 1 1 
AT4G14790 SUPV3L1 OG1_2019 2 2 
AT4G14970 FANCD2 OG1_6005 1 1 
AT4G15890 NCAPD3 OG1_4557 1 1 
AT4G16970 CDC7 OG1_2273 1 1 
AT4G17020 GTF2H4 OG1_1903 1 1 
AT4G19610 RBM19 OG1_1429 1 1 
AT4G20350 ALKBH6 OG1_4791 1 1 
AT4G21090 FDX1L OG1_1170 2 2 
AT4G21100 DDB1 OG1_3779 1 1 
AT4G22720 OSGEPL1 OG1_236 2 2 
AT4G22970 ESPL1 OG1_2939 1 1 
AT4G23860 UBR7 OG1_3452 1 1 
AT4G25550 NUDT21 OG1_3796 1 1 
AT4G25630 FBL OG1_1420 2 1 
AT4G26430 COPS6 OG1_5776 2 1 
AT4G26720 PPP4C OG1_2652 2 1 
AT4G26870 DARS OG1_982 2 1 
AT4G28200 UTP6 OG1_2984 1 1 
AT4G29910 ORC5L OG1_4008 1 1 
AT4G31200 CHERP OG1_7454 1 1 
AT4G31210 TOP3A OG1_405 2 2 
AT4G31770 DBR1 OG1_1937 1 2 
AT4G32050 NCDN OG1_9263 1 2 
AT4G35910 CTU2 OG1_6769 1 1 
AT4G38120 HEATR6 OG1_7411 1 2 
AT4G39160 BDP1 OG1_2627 1 2 
AT5G01230 FTSJ1 OG1_1205 1 2 
AT5G02530 THOC4 OG1_2414 2 2 
AT5G05560 ANAPC1 OG1_2053 1 1 
AT5G05660 NFXL1 OG1_10472 1 1 
AT5G06000 EIF3G OG1_2401 2 1 
AT5G06110 DNAJC2 OG1_2035 2 1 
AT5G06410 HSCB OG1_2656 1 1 
AT5G06680 TUBGCP3 OG1_3045 1 2 
AT5G07660 SMC6 OG1_1524 2 1 
AT5G08420 KRR1 OG1_1415 1 2 
AT5G11100 ESYT3 OG1_2615 2 2 
AT5G11240 WDR43 OG1_2237 2 1 
AT5G11980 COG8 OG1_4146 1 1 
AT5G12980 RQCD1 OG1_1503 2 1 
AT5G13050 MTHFS OG1_1978 1 1 
AT5G13480 WDR33 OG1_2142 1 1 
AT5G13520 LTA4H OG1_2700 1 1 
AT5G13780 NAA10 OG1_685 1 2 
AT5G14030 SSR2 OG1_6964 1 1 
AT5G14250 COPS3 OG1_5080 1 1 
AT5G14530 WDR82 OG1_1754 2 1 
AT5G14580 PNPT1 OG1_2596 2 1 
AT5G14600 TRMT61B OG1_1242 1 2 
AT5G15540 NIPBL OG1_1959 1 2 
AT5G15750 IMP3 OG1_2045 1 2 
AT5G15920 SMC5 OG1_1151 1 2 
AT5G16690 ORC3L OG1_5029 1 1 
AT5G18620 MARCA5 OG1_569 2 2 
AT5G19130 GPAA1 OG1_3954 1 1 
AT5G19300 C9orf114 OG1_1886 1 2 
AT5G19660 MBTPS1 OG1_4550 1 2 
AT5G19680 PPP1R7 OG1_1753 1 2 
AT5G20040 TRIT1 OG1_650 2 2 
AT5G20890 CCT2 OG1_2174 1 1 
AT5G22330 RUVBL1 OG1_1918 1 1 
AT5G22370 GPN2 OG1_2520 1 1 
AT5G25450 UQCRB OG1_3053 2 2 
AT5G26110 TP53RK OG1_2405 1 1 
AT5G26680 FEN1 OG1_1800 1 1 
AT5G27470 SARS OG1_176 2 2 
AT5G27740 RFC3 OG1_1856 1 1 
AT5G37630 NCAPG OG1_3108 1 1 
AT5G38460 ALG6 OG1_3144 1 1 
AT5G38720 RRP7 OG1_3100 1 2 
AT5G38840 SLC4A1AP OG1_4786 1 1 
AT5G40530 RRP8 OG1_2109 1 1 
AT5G40660 ATPAF2 OG1_3851 1 1 
AT5G41190 NOB1 OG1_1515 1 1 
AT5G41760 SLC35A3 OG1_1552 1 2 
AT5G41880 PRIM1 OG1_1547 1 1 
AT5G42740 GPI OG1_399 2 2 
AT5G42970 COPS4 OG1_4875 1 1 
AT5G43500 ACTR8 OG1_4779 1 1 
AT5G44560 CHMP2B OG1_6322 2 1 
AT5G44740 POLH OG1_3262 1 1 
AT5G44750 REV1 OG1_2970 1 1 
AT5G45140 POLR2B OG1_1070 1 1 
AT5G46280 MCM3 OG1_1729 1 1 
AT5G46840 RBM34 OG1_2521 1 2 
AT5G47680 RG9MTD2 OG1_1228 1 2 
AT5G49010 GINS4 OG1_3794 1 1 
AT5G49110 FANCI OG1_5757 1 2 
AT5G50810 TIMM8A OG1_2503 1 2 
AT5G52910 TIMELESS OG1_6411 1 1 
AT5G54260 MRE11A OG1_1737 1 2 
AT5G55130 MOCS3 OG1_718 1 1 
AT5G55300 TOP1 OG1_838 2 1 
AT5G56740 HAT1 OG1_3081 1 1 
AT5G57410 SSX2IP OG1_7230 2 1 
AT5G57450 XRCC3 OG1_3964 1 1 
AT5G58640 SELT OG1_4646 2 1 
AT5G59240 RPS8 OG1_703 2 1 
AT5G60040 POLR2A OG1_803 1 1 
AT5G60730 ASNA1 OG1_911 2 2 
AT5G61220 LYRM4 OG1_3934 1 1 
AT5G61770 PPAN OG1_2248 1 2 
AT5G61970 SRP68 OG1_2771 1 2 
AT5G63010 WDR85 OG1_2387 1 1 
AT5G63960 POLD1 OG1_1344 1 1 
AT5G64420 MYBBP1A OG1_3771 1 1 
AT5G64630 CHAF1B OG1_1934 1 1 
AT5G64670 MRPL15 OG1_915 2 1 
AT5G64830 PDCD2L OG1_6064 1 1 
AT5G65900 DDX18 OG1_1863 2 1 
AT5G66750 HELLS OG1_2891 1 1 
AT5G67100 POLA1 OG1_1631 1 1 
AT5G67510 RPL26L1 OG1_992 2 2 
AT5G67530 PPIL2 OG1_3436 1 1 
 
HGNC: Homo sapiens official gene symbol 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix-D 
Pair of primers used for the identification of Homozygous and Hemizygous lines and primers used for QPCR experiments in Arabidopsis 
AGI Code 
TAIR 
Annotation 
SALK Line LP Primer RP Primer QPCR-FW QPCR-RV 
AT1G01940 F22M8.7 061120.53.75.X-Intronic AGAGGTAACACACCAACAGGC GATGCAGAAAGATCTCGAACG ATTCAAGGAGGAGACCCCAAGG CGTTGGTGTTTGGACCGCTG 
AT1G03110 TRM82 025857.27.50.X-Exonic TGGTTGAAACCCAGTCTTACG ACACCAAACTTGTCCGCATAG 
  
AT1G03530 ATNAF1 013589.53.50.X-Exonic AGAGAGGCATAAAGCTTTGGC TTTCAGAAACAACCGGTTCTG 
  
AT1G04020 ATBARD1 031862.53.75.X-Exonic TTAGGATTCGGACTGCTTTCC TGGCGGAATTTACTAACATGC TGATCCAAGACCTAAGCATCAGG CACCACATATCCGCTTCCTTGC 
AT1G06590 F12K11.7 024997.29.40.X-Intronic ATTCATTCTCCCGAGAGCTTC CTCAAATTTAGCCATCGCAAG CAGATGAGCTTCAAGCTTTGGA TTCCACATCTTGAGGGTTCTCG 
AT1G08410 T27G7.9 119395.38.15.X-Exonic TTTCTTTCATTCACCGGTCAG CTGCAAGGCTGATTCTGAAAG 
  
AT1G10490 T10O24.10 070262.56.00.X-Intronic TGTTTGTTTGCAGCAATTTTG CGAATTCATCGTTGCTTAAGG 
  
AT1G13330 AHP2 136002.41.85.X-Exonic ACAGCAATCGGGTATAAAGGC GCACAAATTGAAACCCAAGTG 
  
AT1G49540 ATELP2 106485.50.75.X-Intronic GAATAATTTGGCACAAAAGCG GCTCCCAGGTCATAAAGCTTC GCTTGACGGTGACGCACTTGG TTGTGTGCTTCAACCTTTGCCA 
AT1G72320 APUM23 052992.53.50.X-Intronic GAATCTTTTGCCGTTTCAGTG CTAACCTCTGGCTGCTCTGAC CCCTTGTTGGTGCAGTATGCTCC TCCCCTGAAGTATCAAACAACCC 
AT1G74150 F9E11.8 088010.26.55.X-Exonic CATCCCCAAGATATGGTTGTC AAAGGACAAAGGAAAAAGATCAAG GCACGAGATAGCCACACTTGC CCCTTCTACCATAGCAACAACC 
AT1G76260 DWA2 143341.50.65.X-Exonic ATTACGTACATGGGCACGTTC TCGCATCCTAATGAAATTTGG 
  
AT2G15790 CYCLOP40 033511.51.20.X-Intronic TTGATTGTCTTTGGAGTCGTTG GTGTTCTTTATCCGCATACCG 
  
AT2G19430 ATTHO6 051022.41.15.X-Exonic ACAATATGCGCAAGAATCACC CGGTTTAGGGATTGCTTTCTC ACTCGCTTGTGTCTCAATCGGC GCAAAGCATCTTCGTCTTCACCA 
AT2G28450 T1B3.3 039998.52.40.X-Exonic CAGACAATCGTTAGACAATCTTAAGC CATAGCCTTGGCTTTCTTTCC 
  
AT2G40550 ETG1 145460.18.05.X-Exonic AAATTAACCGGAATGGGTTTG ATGACTCAGATTGATGCCTGG TTGCAACCAGGCACCTTGAA CAAATCGGCGGGCATTATGT 
AT2G34260 F13P17.10 063054.55.75.X-Intronic AGACGGGACTTTGTCTGTCTG AGGTTCCACAACTTCATCACC 
  
AT3G02220 F14P3.13 028532.34.35.X-Exonic TAAACCCAACAAGGCAACAAG CAAACCTCATCAAGCAGCTTC GGTGTGTGCAAAGTGTTGTCAAAGTG AATAGGGTCCTTCGATCTCTTTCCC 
AT3G07050 F17A9.21 099852.47.75.X-Exonic TATTGGACTGCCTAATGTCGG TTCCGTCTGCGTCTTAGACTC 
  
AT3G26410 ATTRM11 122158.32.05.X-Exonic TTCACCATCGTTAGCAGAACC CTTTGGTGATTTGGTTGTTGC CTGCGATCCACCTTACGGGG GCCTGCCTTTCATCACCAACA 
AT3G42660 T12K4.110 052512.12.95.X-Exonic AAGAACAAGTGTGGCCCTTTC TATGCTGGGAACTTCAAAACG 
  
AT3G49990 F3A4.70 090801.18.60.X-Exonic TGCTCCACGACATTACTTTGG CTCGAATCTCGATAACCTCCC GGCTTATGATGCGTCTCGTGTGA TCTTCTTCCAAATCCTCAACATCAG 
AT3G55160 T26I12.40 006621.56.00.X-Exonic GAATGGACATGCTCTGAAAGC CTTCTGAACATCCGTAGCGAG CTGGGTAGGCGGTGTTGGGA GTTTCAGTGCCTCCCCAAGTTCA 
AT3G56990 EDA7 098429.45.45.X-Exonic TCCCGACAGCTACTTGAAGAC CAGGTGCGTTTTCTTTCTTTG 
  
AT3G60660 T4C21.70 041743.49.40.X-Exonic GCAAATTTGCAATATTTTCATCC CTTCTGCAACTTCCCTTGTTG GCCAAGCAGTACGAGCAACATTC CTCAAGGGTGAGCCTTCCTCTCA 
AT4G00850 GIF3 052744.30.10.X-Exonic TCGTGAAGAAAGTAAAAATGAAAGG TGGATGTACAATCATGAGTTTGG 
  
AT4G01270 F2N1.19 056467.55.00.X-Exonic ATCGAAGAAGATCCGGTTTTG AACGCAATGTTCAATCCTCC 
  
AT4G07410 F28D6.14 022607.45.25.X-Exonic TGTTCCGATGCTTATTTCTGC CCCCAGGAAACTCTTGATACC CGGGAAGCCTGTGGAAGAAGAT CCCACGAATAAAACAGGGTGG 
AT4G15890 DL3985W 094776.23.50.X-Intronic TGGTTTGAAAATGGTTGCTTC AGCGATAGAAGGAATCGAAGG 
  
AT4G20350 F9F13.6 138864.18.85.X-Exonic ATCCTGACCAAGGGATTATGG TGGAGAAGGAGAAGATTTGGG 
  
AT4G22970 AESP 037016.52.60.X-Intronic AGCTGCATTAGATCACATGGG TAATTCCGCAAATTCAACCAG 
  
AT4G35910 T19K4.40 030197.20.30.X-Intronic CGTTGAGCGATAGTTTTGGAC GGCCCGCTAAATAGATCAGAC 
  
AT4G38120 F20D10.240 066582.56.00.X-Exonic GTGCATCCACAACTTGTGAAG CTGGATTTAAGGGAACCGAAG CAGGCAGGATGTGACCAATGG GCTGCTGATCTGACTGAAGGTGTTT 
AT5G05660 ATNFXL2 017558.18.75.X-Exonic GAAACTGAGGGCTTCAAGGAG ATTTCGGACAGTTCCAGACAG 
  
AT5G11240 F2I11.130 052897.39.70.X-Exonic CAGGGAAAGATGAATTTGGTG ACCGCTGTATATGCAAGATGC 
  
AT5G14600 T15N1.90 024680.34.10.X-Exonic GTTCCTTCTGCAGCAAAGATG GGCTTTCGAAGAATGGATCTC 
  
AT5G22370 EMB1705 059852.56.00.X-Intronic TCCAGCCAGTCAATGTTTTTC AAACGAGGTTTAGGAATTGGG TCTCCTTATCCACAATGCTTCACA AGCAGAGCGAGGATCTTGACTAA 
AT5G40530 MNF13.4 102154.30.95.X-Intronic CGGCTTTCACAAAGTCTTTTG CAAAAACCAACAACATGGAGG 
  
AT5G49110 K20J1.8 055483.52.00.X-Exonic AGTCCAACACATGTCCTCCAC TGAGTTTGGTGATTCGAAAGG CGCGCAAAACTCTAATGACGTAGA GAGATGGCAAGTTTCAGAACGCTC 
AT5G61770 PAN-LIKE 088929.56.00.X-Exonic TTATCAGCCAACTCATGGGAC TCAGCCTGTTGGAGTATCTCG 
  
  
LBa1 Primer for all TGGTTCACGTAGTGGGCCATCG 
   
 
 
 
 
 
 
 
Appendix-E 
Overview Arabidopsis microarray experiments (213 CEL files) 
CEL_header Experimental parameters Tissue 
ATGE_1_A.CEL.ATGE_1_B.CEL.ATGE_1_C.CEL  gene_knock_out;organism_part;developmental_stage cotyledons 
ATGE_10_A.CEL.ATGE_10_B.CEL.ATGE_10_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf #4, 1cm long 
ATGE_100_A.CEL.ATGE_100_B.CEL.ATGE_100_C.CEL  gene_knock_out;organism_part;developmental_stage seedling, green parts 
ATGE_12_A.CEL.ATGE_12_B.CEL.ATGE_12_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf # 2 
ATGE_13_A.CEL.ATGE_13_B.CEL.ATGE_13_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf # 4 
ATGE_15_A.CEL.ATGE_15_B.CEL.ATGE_15_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf # 8 
ATGE_16_A.CEL.ATGE_16_B.CEL.ATGE_16_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf # 10 
ATGE_17_A.CEL.ATGE_17_B.CEL.ATGE_17_C.CEL  gene_knock_out;organism_part;developmental_stage rosette leaf # 12 
ATGE_19_A.CEL.ATGE_19_B.CEL.ATGE_19_C.CEL  gene_knock_out;organism_part;developmental_stage leaf 7, petiol 
ATGE_2_A.CEL.ATGE_2_B.CEL.ATGE_2_C.CEL  gene_knock_out;organism_part;developmental_stage hypocotyl 
ATGE_20_A.CEL.ATGE_20_B.CEL.ATGE_20_C.CEL  gene_knock_out;organism_part;developmental_stage leaf 7, proximal half 
ATGE_21_A.CEL.ATGE_21_B.CEL.ATGE_21_C.CEL  gene_knock_out;organism_part;developmental_stage leaf 7, distal half 
ATGE_23_A.CEL.ATGE_23_B.CEL.ATGE_23_C.CEL  gene_knock_out;organism_part;developmental_stage developmental drift; whole plant 
after transition 
ATGE_25_A.CEL.ATGE_25_B.CEL.ATGE_25_C.CEL  gene_knock_out;organism_part;developmental_stage senescing leaves 
ATGE_26_A.CEL.ATGE_26_B.CEL.ATGE_26_C.CEL  gene_knock_out;organism_part;developmental_stage cauline leaves 
ATGE_27_A.CEL.ATGE_27_B.CEL.ATGE_27_C.CEL  gene_knock_out;organism_part;developmental_stage stem, 2nd internode 
ATGE_28_A2.CEL.ATGE_28_B2.CEL.ATGE_28_C2.CEL  gene_knock_out;organism_part;developmental_stage 1st node 
ATGE_29_A2.CEL.ATGE_29_B2.CEL.ATGE_29_C2.CEL  gene_knock_out;organism_part;developmental_stage shoot apex, inflorescence (after 
bolting) 
ATGE_3_A.CEL.ATGE_3_B.CEL.ATGE_3_C.CEL  gene_knock_out;organism_part;developmental_stage roots 
ATGE_31_A2.CEL.ATGE_31_B2.CEL.ATGE_31_C2.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 9 
ATGE_32_A2.CEL.ATGE_32_B2.CEL.ATGE_32_C2.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 10/11 
ATGE_33_A.CEL.ATGE_33_B.CEL.ATGE_33_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 12 
ATGE_34_A.CEL.ATGE_34_B.CEL.ATGE_34_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 12, sepals 
ATGE_35_A.CEL.ATGE_35_B.CEL.ATGE_35_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 12, petals 
ATGE_36_A.CEL.ATGE_36_B.CEL.ATGE_36_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 12, stamens 
ATGE_37_A.CEL.ATGE_37_B.CEL.ATGE_37_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 12, carpels 
ATGE_39_A.CEL.ATGE_39_B.CEL.ATGE_39_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15 
ATGE_40_A.CEL.ATGE_40_B.CEL.ATGE_40_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15, pedicels 
ATGE_41_A.CEL.ATGE_41_B.CEL.ATGE_41_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15, sepals 
ATGE_42_B.CEL.ATGE_42_C.CEL.ATGE_42_D.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15, petals 
ATGE_43_A.CEL.ATGE_43_B.CEL.ATGE_43_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15, stamen 
ATGE_45_A.CEL.ATGE_45_B.CEL.ATGE_45_C.CEL  gene_knock_out;organism_part;developmental_stage flowers stage 15, carpels 
ATGE_5_A.CEL.ATGE_5_B.CEL.ATGE_5_C.CEL  gene_knock_out;organism_part;developmental_stage leaves 1 + 2 
ATGE_6_A.CEL.ATGE_6_B.CEL.ATGE_6_C.CEL  gene_knock_out;organism_part;developmental_stage shoot apex, vegetative 
ATGE_7_A2.CEL.ATGE_7_B2.CEL.ATGE_7_C2.CEL  gene_knock_out;organism_part;developmental_stage seedling, green parts 
ATGE_73_A.CEL.ATGE_73_B.CEL.ATGE_73_C.CEL  gene_knock_out;organism_part;developmental_stage mature pollen 
ATGE_77_D.CEL.ATGE_77_E.CEL.ATGE_77_F.CEL  gene_knock_out;organism_part;developmental_stage siliques, w/  seeds stage 4 
ATGE_78_D.CEL.ATGE_78_E.CEL.ATGE_78_F.CEL  gene_knock_out;organism_part;developmental_stage siliques, w/  seeds stage 5 
ATGE_79_A.CEL.ATGE_79_B.CEL.ATGE_79_C.CEL  gene_knock_out;organism_part;developmental_stage seeds, stage 6, w/o siliques 
ATGE_81_A.CEL.ATGE_81_B.CEL.ATGE_81_C.CEL  gene_knock_out;organism_part;developmental_stage seeds, stage 7, w/o siliques 
ATGE_82_A.CEL.ATGE_82_B.CEL.ATGE_82_C.CEL  gene_knock_out;organism_part;developmental_stage seeds, stage 8, w/o siliques 
ATGE_83_A.CEL.ATGE_83_B.CEL.ATGE_83_C.CEL  gene_knock_out;organism_part;developmental_stage seeds, stage 9, w/o siliques 
ATGE_84_A.CEL.ATGE_84_B.CEL.ATGE_84_D.CEL  gene_knock_out;organism_part;developmental_stage seeds, stage 10, w/o siliques 
ATGE_91_A.CEL.ATGE_91_B.CEL.ATGE_91_C.CEL  gene_knock_out;organism_part;developmental_stage leaf 
ATGE_93_A.CEL.ATGE_93_B.CEL.ATGE_93_C.CEL  gene_knock_out;organism_part;developmental_stage root 
ATGE_96_A.CEL.ATGE_96_B.CEL.ATGE_96_C.CEL  gene_knock_out;organism_part;developmental_stage seedling, green parts 
AtGen_A.10_22.2_REP2_ATH1.CEL.AtGen_A.11_22.3_REP3  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.13_23.1_REP1_ATH1.CEL.AtGen_A.14_23.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.17_24.1_REP1_ATH1.CEL.AtGen_A.18_24.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.21_25.1_REP1_ATH1.CEL.AtGen_A.23_25.3_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.25_26.1_REP1_ATH1.CEL.AtGen_A.26_26.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.33_28.1_REP1_ATH1.CEL.AtGen_A.34_28.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.37_29.1_REP1_ATH1.CEL.AtGen_A.38_29.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.53_33.1_REP1_ATH1.CEL.AtGen_A.54_33.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_A.61_35.1_REP1_ATH1.CEL.AtGen_A.62_35.2_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_B.1_1.1.1_REP1_ATH1.CEL.AtGen_B.15_2.1.1_REP2 gene_knock_out;organism_part;developmental_stage leaves 
AtGen_B.22_2.1.4_REP2_ATH1.CEL.AtGen_B.36_3.1.4_REP3 gene_knock_out;organism_part;developmental_stage leaves 
AtGen_C.10_1.Pi.6_REP1_ATH1.CEL.AtGen_C.11_2.Pi.6_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_C.13_1.Pi.12_REP1_ATH1.CEL.AtGen_C.14_2.Pi.12_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_C.4_1.C.12_REP1_ATH1.CEL.AtGen_C.5_2.C.12_REP2  gene_knock_out;organism_part;developmental_stage leaves 
AtGen_C.7_1.C.24_REP1_ATH1.CEL.AtGen_C.8_2.C.24_REP2  gene_knock_out;organism_part;developmental_stage leaves 
BC1811.cel.BC1812.cel.BC1821.cel  leaves 
DH001_ATH1_A1.UNM1.CEL.DH001_ATH1_A4.UNM2.CEL Pollen Size Pollen 
KE001_ATH1_A1.edwards.26.CEL wait;change_light whole seedlings 
KE001_ATH1_A10.edwards.62.CEL wait;change_light whole seedlings 
KE001_ATH1_A2.edwards.30.CEL wait;change_light whole seedlings 
KL001_ATH1_A1.Linds.cot.CEL.KL001_ATH1_A2.Linds.cot developmental_stage;organism_part embryo cotyledon 
KL001_ATH1_A1.Linds.roo.CEL.KL001_ATH1_A2.Linds.roo developmental_stage;organism_part embryo root 
MB002_ATH1_A1.Eland.ch1.CEL atmosphere hypocotyls 
T0_APH.cel time after drug removal (0 hours) Cell suspension 
T0_SUC.cel sucrose (3%, 0 hours) Cell suspension 
T10_APH.cel time after drug removal (10 hours) Cell suspension 
T10_SUC.cel sucrose (3%, 10 hours) Cell suspension 
T12_APH.cel time after drug removal (12 hours) Cell suspension 
T12_SUC.cel sucrose (3%, 12 hours) Cell suspension 
T14_APH.cel time after drug removal (14 hours) Cell suspension 
T16_APH.cel time after drug removal (16 hours) Cell suspension 
T19_APH.cel time after drug removal (19 hours) Cell suspension 
T2_APH.cel time after drug removal (2 hours) Cell suspension 
T2_SUC.cel sucrose (3%, 2 hours) Cell suspension 
Appendix-F 
Candidate genes associated with and increased or a decreased relapse risk. 
HGNC Probe ID AGI Code Pearson AVG Pearson STD LR pval Hrsig R0M0 R0M1 R1M0 R1M1 Sensitivity Specificity 
TIMM44 203093_s_at AT2G36070 0.60868739 0.265818141 6.90E-12 6.7 796 0 594 10 0.016556291 0.983443709 
SS18 216684_s_at AT4G00850 0.63626925 0.258871522 0.00E+00 5.34 788 8 559 45 0.074503311 0.989949749 
ALG9 219374_s_at AT1G16900 0.86975696 0.095623252 6.96E-10 4.24 792 4 588 16 0.026490066 0.994974874 
MSH2 209421_at AT3G18524 0.68797482 0.160569896 0.00E+00 4.2 783 13 562 42 0.069536424 0.983668342 
UCHL5 219960_s_at AT1G65650 0.61070483 0.237425296 2.36E-13 3.85 790 6 577 27 0.044701987 0.992462312 
MRPL15 218027_at AT5G64670 0.78835419 0.12825637 0.00E+00 3.83 778 18 548 56 0.092715232 0.977386935 
NCAPG 218663_at AT5G37630 0.87148291 0.064239652 0.00E+00 3.68 758 38 477 127 0.210264901 0.952261307 
RQCD1 213098_at AT5G12980 0.72789826 0.105665314 6.02E-05 3.54 793 3 595 9 0.014900662 0.996231156 
CDC27 217881_s_at AT2G20000 0.74024192 0.170930825 2.61E-08 3.5 792 4 586 18 0.029801325 0.994974874 
WDHD1 216228_s_at AT3G42660 0.83721064 0.063028601 1.96E-07 3.35 792 4 587 17 0.028145695 0.994974874 
UTP11L 218235_s_at AT3G60360 0.84130984 0.082723405 0.00E+00 3.32 753 43 475 129 0.213576159 0.945979899 
G3BP2 208840_s_at AT3G25150 0.71757203 0.226500747 0.00E+00 3.22 761 35 486 118 0.195364238 0.956030151 
GPI 208308_s_at AT5G42740 0.61996047 0.188569598 0.00E+00 3.12 751 45 488 116 0.19205298 0.943467337 
PUS1 218670_at AT1G76120 0.65304756 0.26197654 0.00E+00 2.84 761 35 513 91 0.150662252 0.956030151 
NUDT21 202697_at AT4G25550 0.66546747 0.240168096 0.00E+00 2.83 753 43 487 117 0.193708609 0.945979899 
FANCI 213008_at AT5G49110 0.69309327 0.178177336 0.00E+00 2.75 696 100 400 204 0.337748344 0.874371859 
PREP 37950_at AT1G76140 0.63559122 0.275683492 0.00E+00 2.73 743 53 481 123 0.203642384 0.933417085 
NIPBL 207108_s_at AT5G15540 0.7699285 0.175647792 0.00E+00 2.73 740 56 469 135 0.223509934 0.929648241 
ASF1A 203428_s_at AT1G66740 0.83543495 0.090679032 0.00E+00 2.7 729 67 447 157 0.259933775 0.915829146 
DDX42 201788_at AT2G47330 0.83448745 0.085426955 0.00E+00 2.69 757 39 498 106 0.175496689 0.951005025 
BRIP1 221703_at AT1G20720 0.98411267 0.007866108 3.06E-07 2.64 786 10 577 27 0.044701987 0.987437186 
MCM7 210983_s_at AT4G02060 0.76546711 0.144314877 0.00E+00 2.64 720 76 436 168 0.278145695 0.904522613 
PRIM2 215708_s_at AT1G67320 0.72873879 0.152538781 8.88E-16 2.62 768 28 530 74 0.122516556 0.964824121 
CCT2 201947_s_at AT5G20890 0.75764993 0.157482813 0.00E+00 2.62 654 142 328 276 0.456953642 0.82160804 
ORC1L 205085_at AT2G29680 0.68743875 0.183270069 6.73E-09 2.59 782 14 567 37 0.061258278 0.98241206 
SUPV3L1 212894_at AT4G14790 0.84191451 0.07053449 0.00E+00 2.58 677 119 396 208 0.344370861 0.850502513 
THADA 220212_s_at AT3G55160 0.64048471 0.155796043 3.28E-06 2.55 785 11 580 24 0.039735099 0.986180905 
KRR1 203202_at AT5G08420 0.85300488 0.091123187 0.00E+00 2.51 750 46 490 114 0.188741722 0.942211055 
PPP1R7 213465_s_at AT5G19680 0.75396309 0.150433549 0.00E+00 2.48 732 64 467 137 0.226821192 0.91959799 
ORC5L 211212_s_at AT4G29910 0.63360404 0.266625574 0.00E+00 2.46 751 45 502 102 0.168874172 0.943467337 
RAD54B 219494_at AT3G19210 0.77007629 0.172267704 0.00E+00 2.4 679 117 396 208 0.344370861 0.853015075 
SMC2 204240_s_at AT3G47460 0.86295863 0.069431955 0.00E+00 2.39 661 135 370 234 0.387417219 0.83040201 
MRE11A 205395_s_at AT5G54260 0.85817705 0.074471837 0.00E+00 2.39 721 75 457 147 0.243377483 0.905778894 
IPO9 217885_at AT1G26170 0.82837389 0.079799126 0.00E+00 2.37 656 140 359 245 0.405629139 0.824120603 
COPS2 202467_s_at AT2G26990 0.65071151 0.239918601 0.00E+00 2.37 691 105 396 208 0.344370861 0.868090452 
TPX2 210052_s_at AT1G03780 0.77311378 0.137710492 0.00E+00 2.33 521 275 244 360 0.59602649 0.654522613 
SSX2IP 203016_s_at AT5G57410 0.76670941 0.13463994 2.84E-13 2.3 755 41 519 85 0.140728477 0.948492462 
RFC4 204023_at AT1G21690 0.7905501 0.209836937 0.00E+00 2.26 609 187 317 287 0.475165563 0.765075377 
RFC3 204127_at AT5G27740 0.61480232 0.262808478 1.42E-13 2.26 746 50 512 92 0.152317881 0.93718593 
GINS1 206102_at AT1G80190 0.78551565 0.121806683 0.00E+00 2.25 351 445 130 474 0.784768212 0.440954774 
KLHDC3 214383_x_at AT1G74150 0.72943001 0.197383885 3.00E-12 2.24 757 39 521 83 0.137417219 0.951005025 
HMGCR 202539_s_at AT2G17370 0.84070569 0.103322146 0.00E+00 2.24 662 134 373 231 0.382450331 0.831658291 
POLR1E 218997_at AT3G13940 0.9415535 0.026452247 6.55E-05 2.21 782 14 579 25 0.041390728 0.98241206 
MCM10 220651_s_at AT2G20980 0.73561783 0.153913738 0.00E+00 2.2 591 205 314 290 0.48013245 0.742462312 
COPS3 202078_at AT5G14250 0.83578533 0.110810567 0.00E+00 2.2 702 94 434 170 0.281456954 0.881909548 
GART 212378_at AT1G09830 0.69755657 0.210520223 0.00E+00 2.18 694 102 430 174 0.28807947 0.871859296 
TTK 204822_at AT1G77720 0.76132818 0.126247879 0.00E+00 2.17 573 223 303 301 0.498344371 0.719849246 
MCM4 212141_at AT2G16440 0.65943772 0.178904217 0.00E+00 2.17 576 220 307 297 0.491721854 0.72361809 
TIPIN 219258_at AT3G02820 0.76446636 0.168786681 0.00E+00 2.17 696 100 428 176 0.291390728 0.874371859 
NUP155 206550_s_at AT1G14850 0.88659662 0.057832599 0.00E+00 2.15 642 154 384 220 0.364238411 0.806532663 
PIGA 205281_s_at AT3G45100 0.63391605 0.2677255 0.00E+00 2.15 685 111 414 190 0.314569536 0.860552764 
SMC6 218781_at AT5G07660 0.68440707 0.159533585 0.00E+00 2.15 669 127 391 213 0.352649007 0.840452261 
MCM2 202107_s_at AT1G44900 0.76824888 0.124363569 0.00E+00 2.14 406 390 175 429 0.710264901 0.510050251 
NMD3 218036_x_at AT2G03820 0.92192046 0.043430234 0.00E+00 2.14 702 94 434 170 0.281456954 0.881909548 
GINS2 221521_s_at AT3G12530 0.73462878 0.188282718 0.00E+00 2.14 656 140 379 225 0.372516556 0.824120603 
UQCRC2 200883_at AT1G51980 0.80453867 0.094671509 0.00E+00 2.13 695 101 424 180 0.298013245 0.873115578 
BARD1 205345_at AT1G04020 0.68643971 0.205851759 0.00E+00 2.12 632 164 343 261 0.432119205 0.793969849 
HEATR1 218594_at AT3G06530 0.77626087 0.185872925 7.64E-12 2.11 742 54 508 96 0.158940397 0.932160804 
WDR70 219193_at AT2G20330 0.61691593 0.229753276 7.77E-16 2.1 698 98 452 152 0.251655629 0.876884422 
NGDN 213794_s_at AT1G07840 0.83403413 0.097555717 0.00E+00 2.08 536 260 257 347 0.574503311 0.673366834 
HAT1 203138_at AT5G56740 0.6582754 0.190383623 0.00E+00 2.05 633 163 360 244 0.40397351 0.795226131 
THOC6 218848_at AT2G19430 0.62006229 0.222688947 0.00E+00 2.03 644 152 383 221 0.36589404 0.809045226 
ORC2L 204853_at AT2G37560 0.74807186 0.14750598 0.00E+00 2.03 626 170 350 254 0.420529801 0.786432161 
TIMELESS 203046_s_at AT5G52910 0.84935131 0.08641097 0.00E+00 2.03 632 164 379 225 0.372516556 0.793969849 
PSMC3IP 213951_s_at AT1G13330 0.75522124 0.13419301 2.22E-16 2.01 435 361 197 407 0.67384106 0.546482412 
NCAPD2 201774_s_at AT3G57060 0.70407065 0.231329434 0.00E+00 1.99 612 184 353 251 0.415562914 0.768844221 
CHMP2B 202536_at AT5G44560 0.63837987 0.29046114 0.00E+00 1.99 595 201 333 271 0.448675497 0.747487437 
RUVBL1 201614_s_at AT5G22330 0.74538315 0.140097544 6.99E-15 1.98 684 112 427 177 0.293046358 0.859296482 
POLR2B 201803_at AT5G45140 0.81712924 0.11874805 0.00E+00 1.98 539 257 275 329 0.544701987 0.677135678 
OXA1L 208717_at AT2G46470 0.79448895 0.133052134 1.64E-14 1.97 688 108 429 175 0.289735099 0.864321608 
POLD3 212836_at AT1G78650 0.85203395 0.108586771 6.66E-16 1.95 640 156 379 225 0.372516556 0.804020101 
PRPF4 209162_s_at AT2G41500 0.71945812 0.159126269 3.33E-16 1.94 609 187 346 258 0.427152318 0.765075377 
EXOSC4 91684_g_at AT3G61620 0.71260035 0.238778707 2.17E-12 1.92 701 95 455 149 0.246688742 0.880653266 
FTSJ1 213937_s_at AT5G01230 0.75524786 0.144494717 3.31E-07 1.92 753 43 537 67 0.110927152 0.945979899 
COPS4 218042_at AT5G42970 0.78900503 0.110006478 5.44E-15 1.92 643 153 378 226 0.374172185 0.807788945 
ANAPC5 211036_x_at AT1G06590 0.83529444 0.073477797 5.22E-02 0 790 6 595 9 0.014900662 0.992462312 
MRPS2 218001_at AT3G03600 0.69599212 0.163244191 2.00E-15 1.89 592 204 323 281 0.465231788 0.743718593 
CDC6 203968_s_at AT1G07270 0.92459048 0.063907248 3.44E-15 1.88 568 228 325 279 0.46192053 0.713567839 
SEH1L 221931_s_at AT1G64350 0.75674629 0.132540093 1.01E-14 1.87 576 220 317 287 0.475165563 0.72361809 
SLC30A9 202614_at AT1G51610 0.7938513 0.132330034 1.31E-14 1.86 556 240 300 304 0.503311258 0.698492462 
RAE1 211318_s_at AT1G80670 0.90723341 0.101719922 2.87E-08 1.86 736 60 512 92 0.152317881 0.924623116 
UNG 202330_s_at AT3G18630 0.78900301 0.104449445 1.28E-14 1.86 518 278 272 332 0.549668874 0.650753769 
CHERP 202230_s_at AT4G31200 0.66985266 0.20161356 2.39E-13 1.86 644 152 402 202 0.334437086 0.809045226 
HEATR6 65493_at AT4G38120 0.99297572 0.003684096 4.43E-09 1.86 726 70 498 106 0.175496689 0.912060302 
ERLIN1 202444_s_at AT2G03510 0.81152349 0.153692383 6.80E-10 1.82 714 82 472 132 0.218543046 0.896984925 
PRPF8 200000_s_at AT1G80070 0.66434502 0.220063617 4.04E-07 1.8 739 57 520 84 0.139072848 0.92839196 
RBM34 212591_at AT5G46840 0.83669523 0.093070272 2.56E-11 1.8 382 414 178 426 0.705298013 0.479899497 
RAD50 208393_s_at AT2G31970 0.77787699 0.133078988 4.62E-13 1.79 527 269 293 311 0.514900662 0.662060302 
CDC7 204510_at AT4G16970 0.71919212 0.139222663 3.95E-13 1.79 546 250 312 292 0.483443709 0.685929648 
MCM5 216237_s_at AT2G07690 0.69373737 0.201346394 1.01E-12 1.78 546 250 324 280 0.463576159 0.685929648 
EIF2B2 202461_at AT3G07300 0.87690403 0.08560612 1.85E-12 1.77 569 227 323 281 0.465231788 0.714824121 
MCM3 201555_at AT5G46280 0.83431809 0.089795107 3.76E-12 1.77 464 332 238 366 0.605960265 0.582914573 
COPS8 202142_at AT4G14110 0.80184409 0.121577454 2.32E-12 1.76 553 243 318 286 0.473509934 0.694723618 
POLR2I 212955_s_at AT3G16980 0.67411813 0.248916047 1.07E-11 1.75 471 325 242 362 0.599337748 0.591708543 
EMG1 209233_at AT3G57000 0.82111594 0.121869855 2.00E-08 1.75 709 87 481 123 0.203642384 0.890703518 
FBL 211623_s_at AT4G25630 0.78555188 0.104742198 1.66E-10 1.75 657 139 416 188 0.311258278 0.825376884 
PSMD3 201388_at AT1G20200 0.97735211 0.015360622 4.86E-12 1.74 542 254 304 300 0.496688742 0.680904523 
CRBN 218142_s_at AT2G25740 0.77541972 0.140158366 1.86E-08 1.74 712 84 477 127 0.210264901 0.894472362 
RPS21 214097_at AT3G53890 0.82987719 0.110477542 8.17E-08 1.74 712 84 490 114 0.188741722 0.894472362 
POLA1 204835_at AT5G67100 0.72013032 0.128396549 9.63E-11 1.72 425 371 217 387 0.640728477 0.533919598 
DDX49 210811_s_at AT1G16280 0.61148256 0.226964844 1.40E-10 1.71 622 174 381 223 0.369205298 0.781407035 
RRM1 201477_s_at AT2G21790 0.62470604 0.177515198 1.69E-10 1.7 621 175 376 228 0.377483444 0.780150754 
PPME1 49077_at AT4G10050 0.85230234 0.144826697 2.27E-02 1.69 784 12 585 19 0.031456954 0.984924623 
PPP4C 208932_at AT4G26720 0.6757567 0.2435104 1.51E-09 1.69 640 156 412 192 0.317880795 0.804020101 
POLE3 208828_at AT2G27470 0.7164997 0.175638479 1.08E-10 1.68 515 281 290 314 0.51986755 0.646984925 
BTAF1 209430_at AT3G54280 0.63275054 0.198993119 2.57E-10 1.68 599 197 365 239 0.395695364 0.752512563 
RBM22 218134_s_at AT1G07360 0.72022275 0.161831944 1.85E-10 1.67 545 251 319 285 0.471854305 0.684673367 
RAD51C 209849_s_at AT2G45280 0.98083011 0.012477606 8.13E-08 1.67 299 497 141 463 0.766556291 0.375628141 
COPS6 201405_s_at AT4G26430 0.66248345 0.237768115 3.32E-10 1.66 540 256 301 303 0.501655629 0.67839196 
TUBGCP3 203690_at AT5G06680 0.71341887 0.155767678 5.12E-10 1.66 551 245 325 279 0.46192053 0.692211055 
LSG1 221536_s_at AT1G08410 0.68844994 0.129326482 1.40E-09 1.64 579 217 349 255 0.42218543 0.727386935 
NT5DC3 218786_at AT2G23890 0.61284856 0.222999732 1.32E-03 1.63 760 36 558 46 0.07615894 0.954773869 
MBTPS1 217543_s_at AT5G19660 0.73573087 0.151719428 2.59E-05 1.63 741 55 518 86 0.142384106 0.930904523 
PRMT3 213320_at AT3G12270 0.60680028 0.310134764 4.01E-09 1.61 513 283 296 308 0.509933775 0.644472362 
PSAP 200866_s_at AT1G04010 0.84064512 0.099477995 6.76E-03 1.59 767 29 568 36 0.059602649 0.963567839 
CARM1 212512_s_at AT3G06930 0.6839318 0.239314304 4.87E-08 1.58 409 387 223 381 0.630794702 0.513819095 
SARS 200802_at AT5G27470 0.8469821 0.126113507 4.06E-05 1.58 723 73 509 95 0.157284768 0.908291457 
SLC35B1 202433_at AT2G02810 0.89864314 0.074206819 2.46E-06 1.55 668 128 452 152 0.251655629 0.83919598 
ATIC 208758_at AT2G35040 0.60423038 0.280261204 1.31E-07 1.55 428 368 232 372 0.61589404 0.537688442 
SNRPD1 202691_at AT3G07590 0.65668789 0.172017879 4.64E-07 1.55 374 422 196 408 0.675496689 0.469849246 
MINPP1 209585_s_at AT1G09870 0.7593823 0.120999841 1.20E-07 1.54 498 298 293 311 0.514900662 0.625628141 
C10orf137 213410_at AT1G35660 0.71226094 0.32471898 3.34E-07 1.52 547 249 335 269 0.445364238 0.68718593 
PNKP 218961_s_at AT3G14890 0.72105206 0.155687812 8.20E-07 1.52 620 176 400 204 0.337748344 0.778894472 
RECQL4 213520_at AT1G27880 0.80014395 0.076912046 1.36E-06 1.51 591 205 388 216 0.357615894 0.742462312 
ACTR5 222147_s_at AT3G12380 0.79265805 0.058181845 4.08E-07 1.51 524 272 320 284 0.470198675 0.658291457 
WEE1 212533_at AT1G02970 0.65448077 0.237952022 1.57E-05 1.5 270 526 148 456 0.754966887 0.33919598 
MAK16 211686_s_at AT1G23280 0.83237786 0.090363758 1.45E-06 1.5 604 192 382 222 0.367549669 0.75879397 
NCAPD3 212789_at AT4G15890 0.77397579 0.13166661 1.83E-06 1.5 601 195 391 213 0.352649007 0.755025126 
GINS4 211767_at AT5G49010 0.75902586 0.100391814 5.77E-05 1.5 694 102 481 123 0.203642384 0.871859296 
MCMBP 217905_at AT2G40550 0.70274818 0.14063244 1.76E-04 1.49 704 92 496 108 0.178807947 0.884422111 
ASNA1 202024_at AT5G60730 0.85227229 0.087767503 1.09E-06 1.49 437 359 249 355 0.587748344 0.548994975 
CHD1L 212539_at AT2G44980 0.84491047 0.095279091 6.04E-05 1.48 680 116 471 133 0.220198675 0.854271357 
FGFR1OP 205588_s_at AT3G55005 0.805991 0.124711039 8.69E-06 1.45 574 222 367 237 0.392384106 0.721105528 
SSR2 200652_at AT5G14030 0.74681055 0.136884133 2.40E-05 1.45 333 463 181 423 0.700331126 0.418341709 
LYRM4 218561_s_at AT5G61220 0.79878712 0.134512933 4.96E-06 1.45 471 325 272 332 0.549668874 0.591708543 
TBCD 201759_at AT3G60740 0.61284893 0.132531471 5.53E-03 1.41 729 67 529 75 0.124172185 0.915829146 
POLA2 204441_s_at AT1G67630 0.72646992 0.141328194 5.88E-05 1.39 493 303 317 287 0.475165563 0.619346734 
EIF3G 208887_at AT5G06000 0.82134094 0.129331057 3.38E-04 1.39 656 140 447 157 0.259933775 0.824120603 
TSSC1 217968_at AT1G76260 0.79584097 0.108697179 6.97E-05 1.38 432 364 261 343 0.567880795 0.542713568 
SLC35A3 209865_at AT5G41760 0.83800471 0.094157922 1.38E-04 1.37 446 350 261 343 0.567880795 0.560301508 
USP14 201672_s_at AT1G51710 0.69704146 0.190151305 2.45E-04 1.36 379 417 229 375 0.620860927 0.476130653 
DUT 208955_at AT3G46940 0.79848005 0.149769644 1.34E-04 1.36 501 295 315 289 0.478476821 0.629396985 
API5 214960_at AT2G34040 0.7479402 0.1477951 3.96E-04 1.34 460 336 276 328 0.543046358 0.577889447 
DARS 201623_s_at AT4G26870 0.72714203 0.166104259 5.46E-03 1.33 191 605 116 488 0.80794702 0.239949749 
MCRS1 202556_s_at AT3G54350 0.78743661 0.10687724 1.12E-03 1.31 387 409 242 362 0.599337748 0.486180905 
MYBBP1A 219098_at AT5G64420 0.78717152 0.120076095 6.11E-02 1.31 112 684 70 534 0.88410596 0.140703518 
LTA4H 208771_s_at AT5G13520 0.72051947 0.141450142 6.65E-03 1.25 386 410 244 360 0.59602649 0.484924623 
DCLRE1A 209804_at AT2G45700 0.74924222 0.112311763 1.47E-02 1.23 592 204 401 203 0.336092715 0.743718593 
GPAA1 201618_x_at AT5G19130 0.65025995 0.304762371 1.04E-02 1.23 405 391 261 343 0.567880795 0.50879397 
MTHFS 203433_at AT5G13050 0.69564673 0.168507176 2.97E-02 1.22 640 156 446 158 0.261589404 0.804020101 
TBP 203135_at AT3G13445 0.72877833 0.129608041 2.46E-02 1.21 363 433 236 368 0.609271523 0.456030151 
ALG6 219649_at AT5G38460 0.76814438 0.151402303 2.04E-01 0.85 54 742 55 549 0.908940397 0.067839196 
DDX54 219111_s_at AT1G77050 0.7062805 0.087233365 1.82E-02 0.823 273 523 249 355 0.587748344 0.342964824 
NCSTN 208759_at AT3G52640 0.69269045 0.113432472 1.30E-02 0.808 456 340 398 206 0.341059603 0.572864322 
POLE 216026_s_at AT2G27120 0.65059751 0.164983576 3.29E-03 0.773 185 611 193 411 0.680463576 0.23241206 
NIT1 202891_at AT4G08790 0.90150646 0.077780839 1.65E-03 0.772 282 514 260 344 0.569536424 0.354271357 
USP5 206031_s_at AT3G20630 0.68415662 0.134289814 2.13E-04 0.738 377 419 345 259 0.428807947 0.47361809 
PFAS 213302_at AT1G74260 0.9043251 0.038652581 1.36E-03 0.718 581 215 489 115 0.190397351 0.729899497 
MOCS3 206141_at AT5G55130 0.78175433 0.208999787 1.93E-05 0.694 183 613 205 399 0.660596026 0.229899497 
RBM19 205115_s_at AT4G19610 0.64815136 0.194513572 8.23E-04 0.662 53 743 75 529 0.875827815 0.066582915 
MLH1 202520_s_at AT4G09140 0.8867449 0.059092255 1.21E-02 0.64 26 770 33 571 0.945364238 0.032663317 
TOP3A 204946_s_at AT4G31210 0.6642811 0.151241424 1.65E-11 0.557 129 667 188 416 0.688741722 0.162060302 
RAD9A 204828_at AT3G05480 0.87026652 0.05986052 0.00E+00 0.432 84 712 160 444 0.735099338 0.105527638 
DDX52 210320_s_at AT3G09720 0.94381975 0.025055472 1.96E-05 0.407 6 790 22 582 0.963576159 0.007537688 
KIAA0664 212456_at AT3G52140 0.88515005 0.063919775 5.55E-02 0.374 780 16 601 3 0.004966887 0.979899497 
METTL4 219698_s_at AT1G19340 0.781601 0.135021393 3.75E-09 0.33 5 791 27 577 0.955298013 0.006281407 
PPIL2 217407_x_at AT5G67530 0.62504848 0.168309225 0.00E+00 0.284 17 779 77 527 0.872516556 0.021356784 
 
Hrsig: Hazard Ratio: Increased or decrease Relapse risk probability. For Example when TIMM44 is expressed above the threshold, the probability of relapse is 6.7 times higher 
that when the gene is expressed below the threshold 
R0M0: Number of patients that did not relapse and the corresponding expression value for the indicated gene is below the threshold 
R0M1: Number of patients that did not relapse and the corresponding expression value for the indicated gene is above the threshold 
R1M0: Number of patients that relapse and the corresponding expression value for the indicated gene is below the threshold 
R1M1: Number of patients relapse and the corresponding expression value for the indicated gene is above the threshold 
Sensitivity: Is the proportion of relapsing patients predicted to do so 
Specificity: Is defined as the proportion of patients who did not relapse and who were assigned a low probability of relapse 
 
 
 
 
 
 
 
 
 
 
Appendix-G 
References, characteristics and clinical parameters of the breast cancer clinical studies included in the analysis 
ID GSE12276 GSE1456 GSE2034 GSE3494 GSE4922 GSE6532 GSE6532 GSE7390 GSE9195 
Authors Bos Pawitan Wang Miller Ivshina Loi2007 Loi2007 Desmedt Loi2008 
Platform GPL570 GPL96 GPL96 GPL96 GPL96 GPL570 GPL96 GPL96 GPL570 
#Samples 204 159 286 251 289 87 327 198 77 
Scale Int log Int log log log log log log 
Base log NA e NA e e 2 2 2 2 
chemo 0 167 0 0 0 0 0 0 0 0 
chemo 1 37 0 0 0 0 0 0 0 0 
chemo NA 0 159 286 251 289 87 327 198 77 
e.dmfs 0 57 0 196 0 0 59 225 136 67 
e.dmfs 1 147 0 90 0 0 28 68 62 10 
e.dmfs NA 0 159 0 251 289 0 34 0 0 
e.rfs 0 19 119 179 181 160 59 195 107 64 
e.rfs 1 185 40 107 55 89 28 111 91 13 
e.rfs NA 0 0 0 15 40 0 21 0 0 
ER 0 88 0 77 34 34 0 45 64 0 
ER 1 116 0 209 213 211 0 264 134 0 
ER NA 0 159 0 4 44 87 18 0 77 
Grade G0 15 0 0 0 0 0 0 0 0 
Grade G1 65 28 89 67 68 17 68 30 14 
Grade G2 2 58 7 128 166 37 143 83 20 
Grade G3 122 61 190 54 55 16 64 83 24 
Grade NA 0 12 0 2 0 17 52 2 19 
Her 0 166 0 240 0 0 0 0 0 0 
Her 1 38 0 46 0 0 0 0 0 0 
Her NA 0 159 0 251 289 87 327 198 77 
Hormther 0 166 0 0 0 0 0 0 0 0 
Hormther 1 38 0 0 0 0 0 0 0 0 
Hormther NA 0 159 286 251 289 87 327 198 77 
Node 0 0 0 0 158 159 29 221 0 41 
Node 1 0 0 0 84 81 58 85 0 36 
Node NA 204 159 286 9 49 0 21 198 0 
p53 0 0 0 0 193 189 0 0 0 0 
p53 1 0 0 0 58 58 0 0 0 0 
p53 NA 204 159 286 193 42 87 327 198 77 
PR 0 112 0 120 61 0 21 2 0 18 
PR 1 92 0 166 190 0 64 46 0 59 
PR NA 0 159 0 61 289 0 279 198 0 
 
The number of samples analyzed per parameter is indicated for each study. 
